QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) | |||||||||||
OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) | |||||||||||
OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
(Address of principal executive office) | (Zip Code) |
Large accelerated filer o | Accelerated filer o | |||||||||||||||||||
Title of Each Class | Trading Symbol(s) | Name of Exchange on Which Registered | ||||||
N/A | N/A | N/A |
Class | Outstanding at August 7, 2023* | |||||||
Class I shares of beneficial interest, $0.01 par value | ||||||||
Class S shares of beneficial interest, $0.01 par value | ||||||||
Class D shares of beneficial interest, $0.01 par value |
PART I — FINANCIAL INFORMATION | |||||||||||
Consolidated Financial Statements: | |||||||||||
June 30, 2023 (unaudited) | September 30, 2022 | |||||||||||||
ASSETS | ||||||||||||||
Assets: | ||||||||||||||
Investments – Non-control/Non-affiliate, at fair value (cost June 30, 2023: $ | $ | $ | ||||||||||||
Cash and cash equivalents | ||||||||||||||
Restricted cash | ||||||||||||||
Due from affiliates | ||||||||||||||
Interest receivable | ||||||||||||||
Receivables from unsettled transactions | ||||||||||||||
Deferred financing costs | ||||||||||||||
Deferred offering costs | ||||||||||||||
Derivative asset at fair value | ||||||||||||||
Other assets | ||||||||||||||
Total assets | $ | $ | ||||||||||||
LIABILITIES AND NET ASSETS | ||||||||||||||
Liabilities: | ||||||||||||||
Accounts payable, accrued expenses and other liabilities | $ | $ | ||||||||||||
Dividends payable | ||||||||||||||
Base management fee and incentive fee payable | ||||||||||||||
Payable for share repurchases | ||||||||||||||
Due to affiliates | ||||||||||||||
Interest payable | ||||||||||||||
Payables from unsettled transactions | ||||||||||||||
Deferred tax liability | ||||||||||||||
Credit facilities payable | ||||||||||||||
Total liabilities | ||||||||||||||
Commitments and contingencies (Note 11) | ||||||||||||||
Net assets: | ||||||||||||||
Common shares, $ | ||||||||||||||
Additional paid-in-capital | ||||||||||||||
Accumulated distributable earnings (loss) | ( | ( | ||||||||||||
Total net assets (equivalent to $ | ||||||||||||||
Total liabilities and net assets | $ | $ |
NET ASSET VALUE PER SHARE | June 30, 2023 (unaudited) | September 30, 2022 | ||||||||||||
Class I Shares: | ||||||||||||||
Net assets | $ | $ | ||||||||||||
Common shares outstanding ($ | ||||||||||||||
Net asset value per share | $ | $ | ||||||||||||
Class S Shares: | ||||||||||||||
Net assets | $ | $ | ||||||||||||
Common shares outstanding ($ | ||||||||||||||
Net asset value per share | $ | $ | ||||||||||||
Class D Shares: | ||||||||||||||
Net assets | $ | $ | ||||||||||||
Common shares outstanding ($ | ||||||||||||||
Net asset value per share | $ | $ |
Three months ended June 30, 2023 | Three months ended June 30, 2022 | Nine months ended June 30, 2023 | For the period from December 10, 2021 (commencement of operations) to June 30, 2022 | |||||||||||||||||||||||
Interest income: | ||||||||||||||||||||||||||
Non-control/Non-affiliate investments | $ | $ | $ | $ | ||||||||||||||||||||||
Interest on cash and cash equivalents | ||||||||||||||||||||||||||
Total interest income | ||||||||||||||||||||||||||
PIK interest income: | ||||||||||||||||||||||||||
Non-control/Non-affiliate investments | ||||||||||||||||||||||||||
Total PIK interest income | ||||||||||||||||||||||||||
Fee income: | ||||||||||||||||||||||||||
Non-control/Non-affiliate investments | ||||||||||||||||||||||||||
Total fee income | ||||||||||||||||||||||||||
Total investment income | ||||||||||||||||||||||||||
Expenses: | ||||||||||||||||||||||||||
Base management fee | ||||||||||||||||||||||||||
Investment income incentive fee | ||||||||||||||||||||||||||
Professional fees | ||||||||||||||||||||||||||
Class S distribution and shareholder servicing fees | ||||||||||||||||||||||||||
Board of trustees fees | ||||||||||||||||||||||||||
Organization expenses | ||||||||||||||||||||||||||
Amortization of continuous offering costs | ||||||||||||||||||||||||||
Interest expense | ||||||||||||||||||||||||||
Administrator expense | ||||||||||||||||||||||||||
General and administrative expenses | ||||||||||||||||||||||||||
Total expenses | ||||||||||||||||||||||||||
Management and incentive fees waived (Note 9) | ( | ( | ( | |||||||||||||||||||||||
Expense reimbursements (support) (Note 9) | ( | ( | ( | |||||||||||||||||||||||
Net expenses | ||||||||||||||||||||||||||
Net investment income | ||||||||||||||||||||||||||
Unrealized appreciation (depreciation): | ||||||||||||||||||||||||||
Non-control/Non-affiliate investments | ( | ( | ||||||||||||||||||||||||
Foreign currency forward contracts | ||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) | ( | ( | ||||||||||||||||||||||||
Realized gains (losses): | ||||||||||||||||||||||||||
Non-control/Non-affiliate investments | ( | ( | ( | |||||||||||||||||||||||
Foreign currency forward contracts | ( | ( | ||||||||||||||||||||||||
Net realized gains (losses) | ( | ( | ( | ( | ||||||||||||||||||||||
Provision for income tax (expense) benefit | ( | ( | ( | ( | ||||||||||||||||||||||
Net realized and unrealized gains (losses), net of taxes | ( | ( | ||||||||||||||||||||||||
Net increase (decrease) in net assets resulting from operations | $ | $ | ( | $ | $ | ( |
Three months ended June 30, 2023 | Three months ended June 30, 2022 | Nine months ended June 30, 2023 | For the period from December 10, 2021 (commencement of operations) to June 30, 2022 | |||||||||||||||||||||||
Operations: | ||||||||||||||||||||||||||
Net investment income | $ | $ | $ | $ | ||||||||||||||||||||||
Net unrealized appreciation (depreciation) | ( | ( | ||||||||||||||||||||||||
Net realized gains (losses) | ( | ( | ( | ( | ||||||||||||||||||||||
Provision for income tax (expense) benefit | ( | ( | ( | ( | ||||||||||||||||||||||
Net increase (decrease) in net assets resulting from operations | ( | ( | ||||||||||||||||||||||||
Distributions to common shareholders: | ||||||||||||||||||||||||||
Class I | ( | ( | ( | |||||||||||||||||||||||
Class S | ( | ( | ||||||||||||||||||||||||
Class D | ||||||||||||||||||||||||||
Net decrease in net assets resulting from distributions | ( | ( | ( | |||||||||||||||||||||||
Share transactions: | ||||||||||||||||||||||||||
Class I: | ||||||||||||||||||||||||||
Issuance of Common shares | ||||||||||||||||||||||||||
Issuance of Common shares under dividend reinvestment plan | ||||||||||||||||||||||||||
Net increase from share transactions | ||||||||||||||||||||||||||
Class S: | ||||||||||||||||||||||||||
Issuance of Common shares | ||||||||||||||||||||||||||
Issuance of Common shares under dividend reinvestment plan | ||||||||||||||||||||||||||
Repurchased shares, net of early repurchase deduction | ( | ( | ||||||||||||||||||||||||
Net increase from share transactions | ||||||||||||||||||||||||||
Class D: | ||||||||||||||||||||||||||
Issuance of Common shares | ||||||||||||||||||||||||||
Issuance of Common shares under dividend reinvestment plan | ||||||||||||||||||||||||||
Net increase from share transactions | ||||||||||||||||||||||||||
Total increase (decrease) in net assets | ||||||||||||||||||||||||||
Net assets at beginning of period | ||||||||||||||||||||||||||
Net assets at end of period | $ | $ | $ | $ | ||||||||||||||||||||||
Net asset value per common share | $ | $ | $ | $ | ||||||||||||||||||||||
Common shares outstanding at end of period |
Nine months ended June 30, 2023 | For the period from December 10, 2021 (commencement of operations) to June 30, 2022 | |||||||||||||
Operating activities: | ||||||||||||||
Net increase (decrease) in net assets resulting from operations | $ | $ | ( | |||||||||||
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities: | ||||||||||||||
Net unrealized (appreciation) depreciation | ( | |||||||||||||
Net realized (gains) losses | ||||||||||||||
PIK interest income | ( | ( | ||||||||||||
Accretion of original issue discount on investments | ( | ( | ||||||||||||
Amortization of deferred financing costs | ||||||||||||||
Amortization of deferred offering costs | ||||||||||||||
Deferred taxes | ( | ( | ||||||||||||
Purchases of investments | ( | ( | ||||||||||||
Proceeds from the sales and repayments of investments | ||||||||||||||
Changes in operating assets and liabilities: | ||||||||||||||
(Increase) decrease in due from affiliates | ( | ( | ||||||||||||
(Increase) decrease in interest receivable | ( | ( | ||||||||||||
(Increase) decrease in receivables from unsettled transactions | ( | |||||||||||||
(Increase) decrease in other assets | ( | ( | ||||||||||||
Increase (decrease) in accounts payable, accrued expenses and other liabilities | ||||||||||||||
Increase (decrease) in base management fee and incentive fees payable | ||||||||||||||
Increase (decrease) in due to affiliates | ||||||||||||||
Increase (decrease) in interest payable | ||||||||||||||
Increase (decrease) in payables from unsettled transactions | ( | |||||||||||||
Net cash used in operating activities | ( | ( | ||||||||||||
Financing activities: | ||||||||||||||
Distributions paid in cash | ( | ( | ||||||||||||
Borrowings under credit facilities | ||||||||||||||
Repayments of borrowings under credit facilities | ( | |||||||||||||
Borrowings of secured borrowings | ||||||||||||||
Proceeds from secured borrowings | ( | |||||||||||||
Proceeds from issuance of common shares | ||||||||||||||
Deferred financing costs paid | ( | ( | ||||||||||||
Deferred offering costs paid | ( | ( | ||||||||||||
Subscription received in advance | ||||||||||||||
Net cash provided by financing activities | ||||||||||||||
Effect of exchange rate changes on foreign currency | ( | ( | ||||||||||||
Net increase (decrease) in cash and cash equivalents and restricted cash | ||||||||||||||
Cash and cash equivalents and restricted cash, beginning of period | ||||||||||||||
Cash and cash equivalents and restricted cash, end of period | $ | $ | ||||||||||||
Supplemental information: | ||||||||||||||
Cash paid for interest | $ | $ | ||||||||||||
Non-cash financing activities: | ||||||||||||||
Accrued deferred financing costs | $ | $ | ||||||||||||
Deferred offering costs incurred | ||||||||||||||
Distribution payable | ||||||||||||||
Reinvestment of dividends during the period | ||||||||||||||
Shares repurchases accrued but not yet paid | ||||||||||||||
Reconciliation to the Statement of Assets and Liabilities | June 30, 2023 | September 30, 2022 | ||||||||||||
Cash and cash equivalents | $ | $ | ||||||||||||
Restricted cash | ||||||||||||||
Total cash and cash equivalents and restricted cash | $ | $ |
Portfolio Company | Industry | Type of Investment (1)(2)(3) | Index | Spread | Cash Interest Rate (4)(5) | PIK | Maturity Date | Shares | Principal (6) | Cost | Fair Value | Notes | ||||||||||||||||||||||||||
Non-Control/Non-Affiliate Investments | (7) | |||||||||||||||||||||||||||||||||||||
107-109 Beech OAK22 LLC | Real Estate Development | First Lien Revolver | 2/27/2026 | $ | $ | $ | (8)(9) | |||||||||||||||||||||||||||||||
107 Fair Street LLC | Real Estate Development | First Lien Term Loan | 5/31/2024 | (8)(9)(11) | ||||||||||||||||||||||||||||||||||
112-126 Van Houten Real22 LLC | Real Estate Development | First Lien Term Loan | 5/4/2024 | (8)(9)(11) | ||||||||||||||||||||||||||||||||||
AB BSL CLO 4 | Multi-Sector Holdings | CLO Notes | SOFR+ | 4/20/2036 | (5)(10) | |||||||||||||||||||||||||||||||||
Access CIG, LLC | Diversified Support Services | First Lien Term Loan | L+ | 2/27/2025 | (5) | |||||||||||||||||||||||||||||||||
Access CIG, LLC | Diversified Support Services | Second Lien Term Loan | L+ | 2/27/2026 | (5)(8) | |||||||||||||||||||||||||||||||||
ADC Therapeutics SA | Biotechnology | First Lien Term Loan | SOFR+ | 8/15/2029 | (5)(8)(10) | |||||||||||||||||||||||||||||||||
ADC Therapeutics SA | Biotechnology | First Lien Term Loan | SOFR+ | 8/15/2029 | ( | ( | (5)(8)(9)(10) | |||||||||||||||||||||||||||||||
ADC Therapeutics SA | Biotechnology | Warrants | (8)(10) | |||||||||||||||||||||||||||||||||||
AIP RD Buyer Corp. | Distributors | Second Lien Term Loan | SOFR+ | 12/21/2029 | (5)(8) | |||||||||||||||||||||||||||||||||
AIP RD Buyer Corp. | Distributors | Common Stock | (8) | |||||||||||||||||||||||||||||||||||
Altice France S.A. | Integrated Telecommunication Services | First Lien Term Loan | L+ | 8/14/2026 | (5)(10) | |||||||||||||||||||||||||||||||||
Altice France S.A. | Integrated Telecommunication Services | Fixed Rate Bond | 10/15/2029 | (10) | ||||||||||||||||||||||||||||||||||
Alto Pharmacy Holdings, Inc. | Health Care Technology | First Lien Term Loan | SOFR+ | 10/14/2027 | (5)(8) | |||||||||||||||||||||||||||||||||
Alto Pharmacy Holdings, Inc. | Health Care Technology | Warrants | (8) | |||||||||||||||||||||||||||||||||||
American Auto Auction Group, LLC | Consumer Finance | Second Lien Term Loan | SOFR+ | 1/2/2029 | (5)(8) | |||||||||||||||||||||||||||||||||
American Rock Salt Company LLC | Diversified Metals & Mining | First Lien Term Loan | SOFR+ | 6/9/2028 | (5) | |||||||||||||||||||||||||||||||||
American Tire Distributors, Inc. | Distributors | First Lien Term Loan | SOFR+ | 10/20/2028 | (5) | |||||||||||||||||||||||||||||||||
Amynta Agency Borrower Inc. | Property & Casualty Insurance | First Lien Term Loan | SOFR+ | 2/28/2028 | (5) | |||||||||||||||||||||||||||||||||
Anastasia Parent, LLC | Personal Care Products | First Lien Term Loan | SOFR+ | 8/11/2025 | (5) | |||||||||||||||||||||||||||||||||
Ardonagh Midco 3 PLC | Insurance Brokers | First Lien Term Loan | E+ | 7/14/2026 | € | (5)(8)(10) | ||||||||||||||||||||||||||||||||
Ardonagh Midco 3 PLC | Insurance Brokers | First Lien Term Loan | SOFR+ | 7/14/2026 | $ | (5)(8)(9)(10) | ||||||||||||||||||||||||||||||||
ARES LXIV CLO | Multi-Sector Holdings | CLO Notes | SOFR+ | 4/15/2035 | (5)(10) | |||||||||||||||||||||||||||||||||
ARES LXVIII CLO | Multi-Sector Holdings | CLO Notes | SOFR+ | 4/25/2035 | (5)(10) | |||||||||||||||||||||||||||||||||
ASP-R-PAC Acquisition Co LLC | Paper & Plastic Packaging Products & Materials | First Lien Term Loan | SOFR+ | 12/29/2027 | (5)(8)(10) | |||||||||||||||||||||||||||||||||
ASP-R-PAC Acquisition Co LLC | Paper & Plastic Packaging Products & Materials | First Lien Revolver | SOFR+ | 12/29/2027 | ( | ( | (5)(8)(9)(10) | |||||||||||||||||||||||||||||||
Astra Acquisition Corp. | Application Software | First Lien Term Loan | L+ | 10/25/2028 | (5) | |||||||||||||||||||||||||||||||||
Asurion, LLC | Property & Casualty Insurance | First Lien Term Loan | SOFR+ | 8/19/2028 | (5) | |||||||||||||||||||||||||||||||||
Asurion, LLC | Property & Casualty Insurance | First Lien Term Loan | SOFR+ | 8/19/2028 | (5) | |||||||||||||||||||||||||||||||||
Asurion, LLC | Property & Casualty Insurance | Second Lien Term Loan | SOFR+ | 1/20/2029 | (5) | |||||||||||||||||||||||||||||||||
athenahealth Group Inc. | Health Care Technology | First Lien Term Loan | SOFR+ | 2/15/2029 | (5) | |||||||||||||||||||||||||||||||||
athenahealth Group Inc. | Health Care Technology | First Lien Term Loan | SOFR+ | 2/15/2029 | ( | ( | (5)(9) | |||||||||||||||||||||||||||||||
athenahealth Group Inc. | Health Care Technology | Preferred Equity | (8) | |||||||||||||||||||||||||||||||||||
Avalara, Inc. | Application Software | First Lien Term Loan | SOFR+ | 10/19/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
Avalara, Inc. | Application Software | First Lien Revolver | SOFR+ | 10/19/2028 | ( | ( | (5)(8)(9) |
Portfolio Company | Industry | Type of Investment (1)(2)(3) | Index | Spread | Cash Interest Rate (4)(5) | PIK | Maturity Date | Shares | Principal (6) | Cost | Fair Value | Notes | ||||||||||||||||||||||||||
BioXcel Therapeutics, Inc. | Pharmaceuticals | First Lien Term Loan | 4/19/2027 | $ | $ | $ | (8)(10) | |||||||||||||||||||||||||||||||
BioXcel Therapeutics, Inc. | Pharmaceuticals | First Lien Term Loan | 9/30/2032 | (8)(10)(12) | ||||||||||||||||||||||||||||||||||
BioXcel Therapeutics, Inc. | Pharmaceuticals | First Lien Term Loan | 4/19/2027 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
BioXcel Therapeutics, Inc. | Pharmaceuticals | First Lien Term Loan | 9/30/2032 | (8)(9)(10)(12) | ||||||||||||||||||||||||||||||||||
BioXcel Therapeutics, Inc. | Pharmaceuticals | First Lien Term Loan | 4/19/2027 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
BioXcel Therapeutics, Inc. | Pharmaceuticals | First Lien Term Loan | 9/30/2032 | (8)(9)(10)(12) | ||||||||||||||||||||||||||||||||||
BioXcel Therapeutics, Inc. | Pharmaceuticals | Warrants | (8)(10) | |||||||||||||||||||||||||||||||||||
CCO Holdings LLC | Cable & Satellite | Fixed Rate Bond | 5/1/2032 | (10) | ||||||||||||||||||||||||||||||||||
CD&R Firefly Bidco Limited | Other Specialty Retail | First Lien Term Loan | SONIA+ | 6/21/2028 | £ | (5)(10) | ||||||||||||||||||||||||||||||||
Clear Channel Outdoor Holdings, Inc. | Advertising | First Lien Term Loan | SOFR+ | 8/21/2026 | $ | (5)(10) | ||||||||||||||||||||||||||||||||
Clear Channel Outdoor Holdings, Inc. | Advertising | Fixed Rate Bond | 8/15/2027 | (10) | ||||||||||||||||||||||||||||||||||
Colony Holding Corporation | Distributors | First Lien Term Loan | SOFR+ | 5/13/2026 | (5)(8) | |||||||||||||||||||||||||||||||||
Colony Holding Corporation | Distributors | First Lien Term Loan | SOFR+ | 5/13/2026 | (5)(8) | |||||||||||||||||||||||||||||||||
Condor Merger Sub Inc. | Systems Software | Fixed Rate Bond | 2/15/2030 | |||||||||||||||||||||||||||||||||||
Convergeone Holdings, Inc. | IT Consulting & Other Services | First Lien Term Loan | L+ | 1/4/2026 | (5) | |||||||||||||||||||||||||||||||||
Coupa Holdings, LLC | Application Software | First Lien Term Loan | SOFR+ | 2/27/2030 | (5)(8) | |||||||||||||||||||||||||||||||||
Coupa Holdings, LLC | Application Software | First Lien Term Loan | SOFR+ | 2/27/2030 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Coupa Holdings, LLC | Application Software | First Lien Revolver | SOFR+ | 2/27/2029 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Covetrus, Inc. | Health Care Distributors | First Lien Term Loan | SOFR+ | 10/13/2029 | (5) | |||||||||||||||||||||||||||||||||
Cuppa Bidco BV | Soft Drinks & Non-alcoholic Beverages | First Lien Term Loan | E+ | 7/30/2029 | € | (5)(10) | ||||||||||||||||||||||||||||||||
Curium Bidco S.à.r.l. | Biotechnology | First Lien Term Loan | L+ | 7/9/2026 | $ | (5)(10) | ||||||||||||||||||||||||||||||||
Curium Bidco S.à.r.l. | Biotechnology | First Lien Term Loan | L+ | 12/2/2027 | (5)(10) | |||||||||||||||||||||||||||||||||
CVAUSA Management, LLC | Health Care Services | First Lien Term Loan | SOFR+ | 5/22/2029 | (5)(8) | |||||||||||||||||||||||||||||||||
CVAUSA Management, LLC | Health Care Services | First Lien Term Loan | SOFR+ | 5/22/2029 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
CVAUSA Management, LLC | Health Care Services | First Lien Term Loan | SOFR+ | 5/22/2029 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
CVAUSA Management, LLC | Health Care Services | First Lien Revolver | SOFR+ | 5/22/2029 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Dealer Tire Financial, LLC | Distributors | First Lien Term Loan | SOFR+ | 12/14/2027 | (5) | |||||||||||||||||||||||||||||||||
Delta Leasing SPV II LLC | Specialized Finance | Subordinated Debt Term Loan | 8/31/2029 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
Delta Leasing SPV II LLC | Specialized Finance | Preferred Equity | (8)(10) | |||||||||||||||||||||||||||||||||||
Delta Leasing SPV II LLC | Specialized Finance | Common Stock | (8)(10) | |||||||||||||||||||||||||||||||||||
Delta Leasing SPV II LLC | Specialized Finance | Warrants | (8)(10) | |||||||||||||||||||||||||||||||||||
DirecTV Financing, LLC | Cable & Satellite | First Lien Term Loan | SOFR+ | 8/2/2027 | (5) | |||||||||||||||||||||||||||||||||
DirecTV Financing, LLC | Cable & Satellite | Fixed Rate Bond | 8/15/2027 | |||||||||||||||||||||||||||||||||||
DTI Holdco, Inc. | Research & Consulting Services | First Lien Term Loan | SOFR+ | 4/26/2029 | (5) | |||||||||||||||||||||||||||||||||
Dukes Root Control Inc. | Environmental & Facilities Services | First Lien Term Loan | SOFR+ | 12/8/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
Dukes Root Control Inc. | Environmental & Facilities Services | First Lien Term Loan | SOFR+ | 12/8/2028 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
Dukes Root Control Inc. | Environmental & Facilities Services | First Lien Revolver | SOFR+ | 12/8/2028 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
Establishment Labs Holdings Inc. | Health Care Technology | First Lien Term Loan | 4/21/2027 | (8)(10) |
Portfolio Company | Industry | Type of Investment (1)(2)(3) | Index | Spread | Cash Interest Rate (4)(5) | PIK | Maturity Date | Shares | Principal (6) | Cost | Fair Value | Notes | ||||||||||||||||||||||||||
Establishment Labs Holdings Inc. | Health Care Technology | First Lien Term Loan | 4/21/2027 | $ | $ | $ | (8)(10) | |||||||||||||||||||||||||||||||
Establishment Labs Holdings Inc. | Health Care Technology | First Lien Term Loan | 4/21/2027 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
Establishment Labs Holdings Inc. | Health Care Technology | First Lien Term Loan | 4/21/2027 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
Frontier Communications Holdings, LLC | Integrated Telecommunication Services | First Lien Term Loan | SOFR+ | 10/8/2027 | (5)(10) | |||||||||||||||||||||||||||||||||
Frontier Communications Holdings, LLC | Integrated Telecommunication Services | Fixed Rate Bond | 1/15/2030 | (10) | ||||||||||||||||||||||||||||||||||
Galileo Parent, Inc. | Aerospace & Defense | First Lien Term Loan | SOFR+ | 5/3/2029 | (5)(8) | |||||||||||||||||||||||||||||||||
Galileo Parent, Inc. | Aerospace & Defense | First Lien Revolver | SOFR+ | 5/3/2029 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
Gibson Brands, Inc. | Leisure Products | First Lien Term Loan | SOFR+ | 8/11/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
Global Aircraft Leasing Co Ltd | Trading Companies & Distributors | Fixed Rate Bond | 9/15/2024 | (10) | ||||||||||||||||||||||||||||||||||
GoldenTree Loan Management EUR CLO 2 DAC | Multi-Sector Holdings | CLO Notes | E+ | 1/20/2032 | € | (5)(10) | ||||||||||||||||||||||||||||||||
Grove Hotel Parcel Owner, LLC | Hotels, Resorts & Cruise Lines | First Lien Term Loan | SOFR+ | 6/21/2027 | $ | (5)(8) | ||||||||||||||||||||||||||||||||
Grove Hotel Parcel Owner, LLC | Hotels, Resorts & Cruise Lines | First Lien Term Loan | SOFR+ | 6/21/2027 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Grove Hotel Parcel Owner, LLC | Hotels, Resorts & Cruise Lines | First Lien Revolver | SOFR+ | 6/21/2027 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Harbor Purchaser Inc. | Education Services | First Lien Term Loan | SOFR+ | 4/9/2029 | (5) | |||||||||||||||||||||||||||||||||
Harrow Health, Inc. | Pharmaceuticals | First Lien Term Loan | SOFR+ | 1/19/2026 | (5)(8)(10) | |||||||||||||||||||||||||||||||||
Harrow Health, Inc. | Pharmaceuticals | First Lien Term Loan | SOFR+ | 1/19/2026 | ( | ( | (5)(8)(9)(10) | |||||||||||||||||||||||||||||||
Horizon Aircraft Finance I Ltd. | Specialized Finance | CLO Notes | 12/15/2038 | (10) | ||||||||||||||||||||||||||||||||||
HUB Pen Company, LLC | Other Specialty Retail | First Lien Term Loan | SOFR+ | 12/31/2027 | (5)(8) | |||||||||||||||||||||||||||||||||
HUB Pen Company, LLC | Other Specialty Retail | First Lien Revolver | SOFR+ | 12/31/2027 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
IAMGOLD Corporation | Gold | Second Lien Term Loan | SOFR+ | 5/16/2028 | (5)(8)(10) | |||||||||||||||||||||||||||||||||
iCIMs, Inc. | Application Software | First Lien Term Loan | SOFR+ | 8/18/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
iCIMs, Inc. | Application Software | First Lien Term Loan | SOFR+ | 8/18/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
iCIMs, Inc. | Application Software | First Lien Term Loan | SOFR+ | 8/18/2028 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
iCIMs, Inc. | Application Software | First Lien Revolver | SOFR+ | 8/18/2028 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
Impel Neuropharma, Inc. | Health Care Technology | First Lien Term Loan | 2/15/2031 | (8)(12) | ||||||||||||||||||||||||||||||||||
Impel Neuropharma, Inc. | Health Care Technology | First Lien Term Loan | SOFR+ | 3/17/2027 | (5)(8) | |||||||||||||||||||||||||||||||||
Innocoll Pharmaceuticals Limited | Health Care Technology | First Lien Term Loan | 1/26/2027 | (8)(10) | ||||||||||||||||||||||||||||||||||
Innocoll Pharmaceuticals Limited | Health Care Technology | First Lien Term Loan | 1/26/2027 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
Innocoll Pharmaceuticals Limited | Health Care Technology | First Lien Term Loan | 1/26/2027 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
Innocoll Pharmaceuticals Limited | Health Care Technology | Warrants | (8)(10) | |||||||||||||||||||||||||||||||||||
Inventus Power, Inc. | Electrical Components & Equipment | First Lien Term Loan | SOFR+ | 6/30/2025 | (5)(8) | |||||||||||||||||||||||||||||||||
Inventus Power, Inc. | Electrical Components & Equipment | First Lien Revolver | SOFR+ | 6/30/2025 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Iris Holding, Inc. | Metal, Glass & Plastic Containers | First Lien Term Loan | SOFR+ | 6/28/2028 | (5)(10) | |||||||||||||||||||||||||||||||||
IW Buyer LLC | Electrical Components & Equipment | First Lien Term Loan | SOFR+ | 6/28/2029 | (5)(8) | |||||||||||||||||||||||||||||||||
IW Buyer LLC | Electrical Components & Equipment | First Lien Revolver | SOFR+ | 6/28/2029 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
Kindercare Learning Centers Kindercare Portfolio | Diversified Real Estate Activities | CLO Notes | SOFR+ | 8/15/2038 | (5)(10) |
Portfolio Company | Industry | Type of Investment (1)(2)(3) | Index | Spread | Cash Interest Rate (4)(5) | PIK | Maturity Date | Shares | Principal (6) | Cost | Fair Value | Notes | ||||||||||||||||||||||||||
Kings Buyer, LLC | Environmental & Facilities Services | First Lien Term Loan | SOFR+ | 10/29/2027 | $ | $ | $ | (5)(8) | ||||||||||||||||||||||||||||||
Kings Buyer, LLC | Environmental & Facilities Services | First Lien Revolver | SOFR+ | 10/29/2027 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
LABL, Inc. | Office Services & Supplies | First Lien Term Loan | SOFR+ | 10/29/2028 | (5) | |||||||||||||||||||||||||||||||||
Latam Airlines Group S.A. | Passenger Airlines | First Lien Term Loan | SOFR+ | 10/12/2027 | (5)(10) | |||||||||||||||||||||||||||||||||
LSL Holdco, LLC | Health Care Distributors | First Lien Term Loan | SOFR+ | 1/31/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
LSL Holdco, LLC | Health Care Distributors | First Lien Term Loan | SOFR+ | 1/31/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
LSL Holdco, LLC | Health Care Distributors | First Lien Revolver | SOFR+ | 1/31/2028 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
LTI Holdings, Inc. | Electronic Components | First Lien Term Loan | SOFR+ | 9/6/2025 | (5) | |||||||||||||||||||||||||||||||||
Madison Park Funding LXIII | Multi-Sector Holdings | CLO Notes | SOFR+ | 4/21/2035 | (5)(10) | |||||||||||||||||||||||||||||||||
Mauser Packaging Solutions Holding Company | Metal, Glass & Plastic Containers | First Lien Term Loan | SOFR+ | 8/14/2026 | (5) | |||||||||||||||||||||||||||||||||
Mauser Packaging Solutions Holding Company | Metal, Glass & Plastic Containers | Fixed Rate Bond | 8/15/2026 | |||||||||||||||||||||||||||||||||||
McAfee Corp. | Systems Software | First Lien Term Loan | SOFR+ | 3/1/2029 | (5) | |||||||||||||||||||||||||||||||||
Medline Borrower, LP | Health Care Supplies | First Lien Term Loan | SOFR+ | 10/23/2028 | (5) | |||||||||||||||||||||||||||||||||
Mesoblast, Inc. | Biotechnology | First Lien Term Loan | 11/19/2026 | (8)(10) | ||||||||||||||||||||||||||||||||||
Mesoblast, Inc. | Biotechnology | First Lien Term Loan | 11/19/2026 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
Mesoblast, Inc. | Biotechnology | First Lien Term Loan | 11/19/2026 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
Mesoblast, Inc. | Biotechnology | Warrants | (8)(10) | |||||||||||||||||||||||||||||||||||
Mesoblast, Inc. | Biotechnology | Warrants | (8)(10) | |||||||||||||||||||||||||||||||||||
MHE Intermediate Holdings, LLC | Diversified Support Services | First Lien Term Loan | SOFR+ | 7/21/2027 | (5)(8) | |||||||||||||||||||||||||||||||||
MHE Intermediate Holdings, LLC | Diversified Support Services | First Lien Term Loan | SOFR+ | 7/21/2027 | (5)(8) | |||||||||||||||||||||||||||||||||
Mitchell International, Inc. | Application Software | First Lien Term Loan | L+ | 10/15/2028 | (5) | |||||||||||||||||||||||||||||||||
Mitchell International, Inc. | Application Software | Second Lien Term Loan | SOFR+ | 10/15/2029 | (5) | |||||||||||||||||||||||||||||||||
MND Holdings III Corp | Other Specialty Retail | First Lien Term Loan | SOFR+ | 5/9/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
MND Holdings III Corp | Other Specialty Retail | First Lien Revolver | SOFR+ | 5/9/2028 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
MRI Software LLC | Application Software | First Lien Term Loan | SOFR+ | 2/10/2026 | (5)(8) | |||||||||||||||||||||||||||||||||
MRI Software LLC | Application Software | First Lien Term Loan | SOFR+ | 2/10/2026 | (5)(8) | |||||||||||||||||||||||||||||||||
MRI Software LLC | Application Software | First Lien Term Loan | SOFR+ | 2/10/2026 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
New Enterprise Stone & Lime Co Inc | Construction Materials | Fixed Rate Bond | 7/15/2028 | |||||||||||||||||||||||||||||||||||
NFP Corp. | Diversified Financial Services | Fixed Rate Bond | 8/15/2028 | |||||||||||||||||||||||||||||||||||
NFP Corp. | Diversified Financial Services | Fixed Rate Bond | 8/15/2028 | |||||||||||||||||||||||||||||||||||
North Star Acquisitionco, LLC | Education Services | First Lien Term Loan | SOFR+ | 5/3/2029 | (5)(8) | |||||||||||||||||||||||||||||||||
North Star Acquisitionco, LLC | Education Services | First Lien Term Loan | SOFR+ | 5/3/2029 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
North Star Acquisitionco, LLC | Education Services | First Lien Revolver | SOFR+ | 5/3/2029 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
OEConnection LLC | Application Software | Second Lien Term Loan | SOFR+ | 9/25/2027 | (5)(8) |
Portfolio Company | Industry | Type of Investment (1)(2)(3) | Index | Spread | Cash Interest Rate (4)(5) | PIK | Maturity Date | Shares | Principal (6) | Cost | Fair Value | Notes | ||||||||||||||||||||||||||
OFSI BSL CLO XI, Ltd. | Multi-Sector Holdings | CLO Notes | SOFR+ | 7/18/2031 | $ | $ | $ | (5)(10) | ||||||||||||||||||||||||||||||
OneOncology, LLC | Health Care Services | First Lien Term Loan | SOFR+ | 6/9/2030 | (5)(8) | |||||||||||||||||||||||||||||||||
OneOncology, LLC | Health Care Services | First Lien Term Loan | SOFR+ | 6/9/2030 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
OneOncology, LLC | Health Care Services | First Lien Revolver | SOFR+ | 6/9/2030 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Oranje Holdco, Inc. | Systems Software | First Lien Term Loan | SOFR+ | 2/1/2029 | (5)(8) | |||||||||||||||||||||||||||||||||
Oranje Holdco, Inc. | Systems Software | First Lien Revolver | SOFR+ | 2/1/2029 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Park Place Technologies, LLC | Internet Services & Infrastructure | First Lien Term Loan | SOFR+ | 11/10/2027 | (5) | |||||||||||||||||||||||||||||||||
PetSmart LLC | Other Specialty Retail | First Lien Term Loan | SOFR+ | 2/11/2028 | (5) | |||||||||||||||||||||||||||||||||
Pluralsight, LLC | Application Software | First Lien Term Loan | SOFR+ | 4/6/2027 | (5)(8) | |||||||||||||||||||||||||||||||||
Pluralsight, LLC | Application Software | First Lien Revolver | SOFR+ | 4/6/2027 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
PPW Aero Buyer, Inc. | Aerospace & Defense | First Lien Term Loan | SOFR+ | 2/15/2029 | (5)(8) | |||||||||||||||||||||||||||||||||
PPW Aero Buyer, Inc. | Aerospace & Defense | First Lien Revolver | SOFR+ | 2/15/2029 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Profrac Holdings II, LLC | Industrial Machinery & Supplies & Components | First Lien Term Loan | SOFR+ | 3/4/2025 | (5)(8) | |||||||||||||||||||||||||||||||||
Profrac Holdings II, LLC | Industrial Machinery & Supplies & Components | First Lien Term Loan | SOFR+ | 3/4/2025 | (5)(8) | |||||||||||||||||||||||||||||||||
Renaissance Holding Corp. | Education Services | First Lien Term Loan | SOFR+ | 4/7/2030 | (5) | |||||||||||||||||||||||||||||||||
Salus Workers' Compensation, LLC | Diversified Financial Services | First Lien Term Loan | SOFR+ | 10/7/2026 | (5)(8) | |||||||||||||||||||||||||||||||||
Salus Workers' Compensation, LLC | Diversified Financial Services | First Lien Revolver | SOFR+ | 10/7/2026 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Salus Workers' Compensation, LLC | Diversified Financial Services | Warrants | (8) | |||||||||||||||||||||||||||||||||||
SCIH Salt Holdings Inc. | Diversified Metals & Mining | First Lien Term Loan | SOFR+ | 3/16/2027 | (5) | |||||||||||||||||||||||||||||||||
SCIH Salt Holdings Inc. | Diversified Metals & Mining | Fixed Rate Bond | 5/1/2028 | |||||||||||||||||||||||||||||||||||
SCP Eye Care Services, LLC | Health Care Services | Second Lien Term Loan | SOFR+ | 10/7/2030 | (5)(8) | |||||||||||||||||||||||||||||||||
SCP Eye Care Services, LLC | Health Care Services | Second Lien Term Loan | SOFR+ | 10/7/2030 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
SCP Eye Care Services, LLC | Health Care Services | Common Stock | (8) | |||||||||||||||||||||||||||||||||||
scPharmaceuticals Inc. | Pharmaceuticals | First Lien Term Loan | SOFR+ | 10/13/2027 | (5)(8) | |||||||||||||||||||||||||||||||||
scPharmaceuticals Inc. | Pharmaceuticals | First Lien Term Loan | SOFR+ | 10/13/2027 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
scPharmaceuticals Inc. | Pharmaceuticals | First Lien Term Loan | SOFR+ | 10/13/2027 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
scPharmaceuticals Inc. | Pharmaceuticals | Warrants | (8) | |||||||||||||||||||||||||||||||||||
SEI Holding I Corporation | Trading Companies & Distributors | First Lien Term Loan | SOFR+ | 3/27/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
SEI Holding I Corporation | Trading Companies & Distributors | First Lien Term Loan | SOFR+ | 3/27/2028 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
SEI Holding I Corporation | Trading Companies & Distributors | First Lien Revolver | SOFR+ | 3/27/2028 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Seres Therapeutics, Inc. | Biotechnology | First Lien Term Loan | SOFR+ | 4/27/2029 | (5)(8)(10) | |||||||||||||||||||||||||||||||||
Seres Therapeutics, Inc. | Biotechnology | First Lien Term Loan | SOFR+ | 4/27/2029 | (5)(8)(10) | |||||||||||||||||||||||||||||||||
Seres Therapeutics, Inc. | Biotechnology | First Lien Term Loan | SOFR+ | 4/27/2029 | (5)(8)(9)(10) | |||||||||||||||||||||||||||||||||
Seres Therapeutics, Inc. | Biotechnology | First Lien Term Loan | SOFR+ | 4/27/2029 | (5)(8)(9)(10) | |||||||||||||||||||||||||||||||||
Seres Therapeutics, Inc. | Biotechnology | Warrants | (8)(10) | |||||||||||||||||||||||||||||||||||
SM Wellness Holdings, Inc. | Health Care Services | First Lien Term Loan | SOFR+ | 4/17/2028 | (5)(8) |
Portfolio Company | Industry | Type of Investment (1)(2)(3) | Index | Spread | Cash Interest Rate (4)(5) | PIK | Maturity Date | Shares | Principal (6) | Cost | Fair Value | Notes | ||||||||||||||||||||||||||
Southern Veterinary Partners, LLC | Health Care Facilities | First Lien Term Loan | SOFR+ | 10/5/2027 | $ | $ | $ | (5) | ||||||||||||||||||||||||||||||
SPX Flow, Inc. | Industrial Machinery & Supplies & Components | First Lien Term Loan | SOFR+ | 4/5/2029 | (5) | |||||||||||||||||||||||||||||||||
Sunshine Luxembourg VII Sarl | Personal Care Products | First Lien Term Loan | SOFR+ | 10/1/2026 | (5)(10) | |||||||||||||||||||||||||||||||||
Superior Industries International, Inc. | Auto Parts & Equipment | First Lien Term Loan | SOFR+ | 12/16/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
Supreme Fitness Group NY Holdings, LLC | Leisure Facilities | First Lien Term Loan | SOFR+ | 12/31/2026 | (5)(8)(13) | |||||||||||||||||||||||||||||||||
Supreme Fitness Group NY Holdings, LLC | Leisure Facilities | First Lien Term Loan | SOFR+ | 12/31/2026 | (5)(8)(9)(13) | |||||||||||||||||||||||||||||||||
Supreme Fitness Group NY Holdings, LLC | Leisure Facilities | First Lien Term Loan | SOFR+ | 12/31/2026 | (5)(8)(9)(13) | |||||||||||||||||||||||||||||||||
Supreme Fitness Group NY Holdings, LLC | Leisure Facilities | First Lien Revolver | SOFR+ | 12/31/2026 | (5)(8)(13) | |||||||||||||||||||||||||||||||||
Tacala, LLC | Restaurants | First Lien Term Loan | L+ | 2/5/2027 | (5) | |||||||||||||||||||||||||||||||||
Tacala, LLC | Restaurants | Second Lien Term Loan | L+ | 2/4/2028 | (5) | |||||||||||||||||||||||||||||||||
Ten-X LLC | Interactive Media & Services | First Lien Term Loan | SOFR+ | 5/26/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
THL Zinc Ventures Ltd | Diversified Metals & Mining | First Lien Term Loan | 5/23/2026 | (8)(10) | ||||||||||||||||||||||||||||||||||
TIBCO Software Inc. | Application Software | First Lien Term Loan | SOFR+ | 3/30/2029 | (5) | |||||||||||||||||||||||||||||||||
Touchstone Acquisition, Inc. | Health Care Supplies | First Lien Term Loan | SOFR+ | 12/29/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
Transit Buyer LLC | Diversified Support Services | First Lien Term Loan | SOFR+ | 1/31/2029 | (5)(8) | |||||||||||||||||||||||||||||||||
Transit Buyer LLC | Diversified Support Services | First Lien Term Loan | SOFR+ | 1/31/2029 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Trinitas CLO XV DAC | Multi-Sector Holdings | CLO Notes | L+ | 4/22/2034 | (5)(10) | |||||||||||||||||||||||||||||||||
Uniti Group LP | Other Specialized REITs | Fixed Rate Bond | 2/15/2029 | (10) | ||||||||||||||||||||||||||||||||||
Uniti Group LP | Other Specialized REITs | Fixed Rate Bond | 4/15/2028 | (10) | ||||||||||||||||||||||||||||||||||
Wellfleet CLO 2022-2, Ltd. | Multi-Sector Holdings | CLO Notes | SOFR+ | 10/18/2035 | (5)(10) | |||||||||||||||||||||||||||||||||
WP CPP Holdings, LLC | Aerospace & Defense | First Lien Term Loan | L+ | 4/30/2025 | (5) | |||||||||||||||||||||||||||||||||
WWEX Uni Topco Holdings, LLC | Air Freight & Logistics | First Lien Term Loan | SOFR+ | 7/26/2028 | (5) | |||||||||||||||||||||||||||||||||
Total Non-Control/Non-Affiliate Investments ( | $ | $ | ||||||||||||||||||||||||||||||||||||
Cash and Cash Equivalents and Restricted Cash ( | $ | $ | ||||||||||||||||||||||||||||||||||||
Total Portfolio Investments, Cash and Cash Equivalents and Restricted Cash ( | $ | $ |
Derivative Instrument | Notional Amount to be Purchased | Notional Amount to be Sold | Maturity Date | Counterparty | Cumulative Unrealized Appreciation /(Depreciation) | |||||||||||||||||||||||||||
Foreign currency forward contract | $ | € | 8/10/2023 | Bank of New York Mellon | $ | |||||||||||||||||||||||||||
Foreign currency forward contract | $ | £ | 8/10/2023 | Bank of New York Mellon | $ | ( | ||||||||||||||||||||||||||
$ |
Portfolio Company | Industry | Type of Investment (1)(2)(3) | Index | Spread | Cash Interest Rate (4)(5) | PIK | Maturity Date | Shares | Principal (6) | Cost | Fair Value | Notes | ||||||||||||||||||||||||||
Non-Control/Non-Affiliate Investments | (7) | |||||||||||||||||||||||||||||||||||||
Access CIG, LLC | Diversified Support Services | First Lien Term Loan | L+ | 2/27/2025 | $ | $ | $ | (5) | ||||||||||||||||||||||||||||||
Access CIG, LLC | Diversified Support Services | Second Lien Term Loan | L+ | 2/27/2026 | (5) | |||||||||||||||||||||||||||||||||
ADC Therapeutics SA | Biotechnology | First Lien Term Loan | SOFR+ | 8/15/2029 | (5)(8)(10) | |||||||||||||||||||||||||||||||||
ADC Therapeutics SA | Biotechnology | First Lien Term Loan | SOFR+ | 8/15/2029 | ( | ( | (5)(8)(9)(10) | |||||||||||||||||||||||||||||||
ADC Therapeutics SA | Biotechnology | Warrants | (8)(10) | |||||||||||||||||||||||||||||||||||
AIP RD Buyer Corp. | Distributors | Second Lien Term Loan | SOFR+ | 12/23/2029 | (5)(8) | |||||||||||||||||||||||||||||||||
AIP RD Buyer Corp. | Distributors | Common Stock | (8) | |||||||||||||||||||||||||||||||||||
Altice France S.A. | Integrated Telecommunication Services | First Lien Term Loan | L+ | 8/14/2026 | (5)(10) | |||||||||||||||||||||||||||||||||
Altice France S.A. | Integrated Telecommunication Services | Fixed Rate Bond | 10/15/2029 | (10) | ||||||||||||||||||||||||||||||||||
American Auto Auction Group, LLC | Consumer Finance | Second Lien Term Loan | SOFR+ | 1/2/2029 | (5)(8) | |||||||||||||||||||||||||||||||||
American Rock Salt Company LLC | Diversified Metals & Mining | First Lien Term Loan | L+ | 6/9/2028 | (5) | |||||||||||||||||||||||||||||||||
American Tire Distributors, Inc. | Distributors | First Lien Term Loan | L+ | 10/20/2028 | (5) | |||||||||||||||||||||||||||||||||
Anastasia Parent, LLC | Personal Products | First Lien Term Loan | L+ | 8/11/2025 | (5) | |||||||||||||||||||||||||||||||||
Apex Group Treasury LLC | Other Diversified Financial Services | First Lien Term Loan | SOFR+ | 7/27/2028 | (5)(10) | |||||||||||||||||||||||||||||||||
APX Group Inc. | Electrical Components & Equipment | First Lien Term Loan | L+ | 7/10/2028 | (5)(10) | |||||||||||||||||||||||||||||||||
APX Group Inc. | Electrical Components & Equipment | Fixed Rate Bond | 7/15/2029 | (10) | ||||||||||||||||||||||||||||||||||
Ardonagh Midco 3 PLC | Insurance Brokers | First Lien Term Loan | E+ | 7/14/2026 | € | ( | (5)(8)(9)(10) | |||||||||||||||||||||||||||||||
ASP Unifrax Holdings, Inc. | Trading Companies & Distributors | First Lien Term Loan | L+ | 12/12/2025 | $ | (5) | ||||||||||||||||||||||||||||||||
ASP Unifrax Holdings, Inc. | Trading Companies & Distributors | Fixed Rate Bond | 9/30/2029 | |||||||||||||||||||||||||||||||||||
ASP Unifrax Holdings, Inc. | Trading Companies & Distributors | Fixed Rate Bond | 9/30/2028 | |||||||||||||||||||||||||||||||||||
ASP-R-PAC Acquisition Co LLC | Paper Packaging | First Lien Term Loan | L+ | 12/29/2027 | (5)(8)(10) | |||||||||||||||||||||||||||||||||
ASP-R-PAC Acquisition Co LLC | Paper Packaging | First Lien Revolver | L+ | 12/29/2027 | ( | ( | (5)(8)(9)(10) | |||||||||||||||||||||||||||||||
Astra Acquisition Corp. | Application Software | First Lien Term Loan | L+ | 10/25/2028 | (5) | |||||||||||||||||||||||||||||||||
Asurion, LLC | Property & Casualty Insurance | First Lien Term Loan | SOFR+ | 8/19/2028 | (5) | |||||||||||||||||||||||||||||||||
Asurion, LLC | Property & Casualty Insurance | Second Lien Term Loan | L+ | 1/20/2029 | (5) | |||||||||||||||||||||||||||||||||
athenahealth Group Inc. | Health Care Technology | Preferred Equity | (8) | |||||||||||||||||||||||||||||||||||
Battery Park CLO II Ltd | Multi-Sector Holdings | CLO Notes | SOFR+ | 10/20/2035 | (5)(10) | |||||||||||||||||||||||||||||||||
BioXcel Therapeutics, Inc. | Pharmaceuticals | First Lien Term Loan | 4/19/2027 | (8)(10) | ||||||||||||||||||||||||||||||||||
BioXcel Therapeutics, Inc. | Pharmaceuticals | First Lien Term Loan | 4/19/2027 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
BioXcel Therapeutics, Inc. | Pharmaceuticals | First Lien Term Loan | 9/30/2032 | (8)(10)(11) | ||||||||||||||||||||||||||||||||||
BioXcel Therapeutics, Inc. | Pharmaceuticals | First Lien Term Loan | 9/30/2032 | (8)(9)(10)(11) | ||||||||||||||||||||||||||||||||||
BioXcel Therapeutics, Inc. | Pharmaceuticals | Warrants | (8)(10) | |||||||||||||||||||||||||||||||||||
Blackhawk Network Holdings, Inc. | Data Processing & Outsourced Services | First Lien Term Loan | L+ | 6/15/2025 | (5) | |||||||||||||||||||||||||||||||||
Boxer Parent Company Inc. | Systems Software | First Lien Term Loan | L+ | 10/2/2025 | (5) | |||||||||||||||||||||||||||||||||
Boxer Parent Company Inc. | Systems Software | Fixed Rate Bond | 10/2/2025 |
Portfolio Company | Industry | Type of Investment (1)(2)(3) | Index | Spread | Cash Interest Rate (4)(5) | PIK | Maturity Date | Shares | Principal (6) | Cost | Fair Value | Notes | ||||||||||||||||||||||||||
BYJU's Alpha, Inc. | Application Software | First Lien Term Loan | L+ | 11/24/2026 | $ | $ | $ | (5)(10) | ||||||||||||||||||||||||||||||
Carvana Co. | Automotive Retail | Fixed Rate Bond | 10/1/2025 | (10) | ||||||||||||||||||||||||||||||||||
CCO Holdings LLC | Cable & Satellite | Fixed Rate Bond | 5/1/2032 | (10) | ||||||||||||||||||||||||||||||||||
Cengage Learning, Inc. | Education Services | First Lien Term Loan | L+ | 7/14/2026 | (5) | |||||||||||||||||||||||||||||||||
CITGO Petroleum Corp. | Oil & Gas Refining & Marketing | First Lien Term Loan | L+ | 3/28/2024 | (5) | |||||||||||||||||||||||||||||||||
Clear Channel Outdoor Holdings, Inc. | Advertising | First Lien Term Loan | L+ | 8/21/2026 | (5)(10) | |||||||||||||||||||||||||||||||||
Clear Channel Outdoor Holdings, Inc. | Advertising | Fixed Rate Bond | 8/15/2027 | (10) | ||||||||||||||||||||||||||||||||||
Clear Channel Outdoor Holdings, Inc. | Advertising | Fixed Rate Bond | 4/15/2028 | (10) | ||||||||||||||||||||||||||||||||||
Condor Merger Sub Inc. | Systems Software | Fixed Rate Bond | 2/15/2030 | |||||||||||||||||||||||||||||||||||
Convergeone Holdings, Inc. | IT Consulting & Other Services | First Lien Term Loan | L+ | 1/4/2026 | (5) | |||||||||||||||||||||||||||||||||
Covetrus, Inc. | Health Care Distributors | First Lien Term Loan | SOFR+ | 9/20/2029 | (5) | |||||||||||||||||||||||||||||||||
Dealer Tire, LLC | Distributors | First Lien Term Loan | L+ | 12/12/2025 | (5) | |||||||||||||||||||||||||||||||||
Delivery Hero FinCo LLC | Internet & Direct Marketing Retail | First Lien Term Loan | SOFR+ | 8/12/2027 | (5)(10) | |||||||||||||||||||||||||||||||||
Delta Leasing SPV II LLC | Specialized Finance | Subordinated Debt Term Loan | 8/31/2029 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
Delta Leasing SPV II LLC | Specialized Finance | Preferred Equity | (8)(10) | |||||||||||||||||||||||||||||||||||
Delta Leasing SPV II LLC | Specialized Finance | Common Stock | (8)(10) | |||||||||||||||||||||||||||||||||||
Delta Leasing SPV II LLC | Specialized Finance | Warrants | (8)(10) | |||||||||||||||||||||||||||||||||||
DirecTV Financing, LLC | Cable & Satellite | First Lien Term Loan | L+ | 8/2/2027 | (5) | |||||||||||||||||||||||||||||||||
DirecTV Financing, LLC | Cable & Satellite | Fixed Rate Bond | 8/15/2027 | |||||||||||||||||||||||||||||||||||
Domtar Corp | Paper Products | First Lien Term Loan | L+ | 11/30/2028 | (5) | |||||||||||||||||||||||||||||||||
DTI Holdco, Inc. | Research & Consulting Services | First Lien Term Loan | SOFR+ | 4/26/2029 | (5) | |||||||||||||||||||||||||||||||||
Eagle Parent Corp. | Industrial Machinery | First Lien Term Loan | SOFR+ | 4/1/2029 | (5) | |||||||||||||||||||||||||||||||||
Establishment Labs Holdings Inc. | Health Care Technology | First Lien Term Loan | 4/21/2027 | (8)(10) | ||||||||||||||||||||||||||||||||||
Establishment Labs Holdings Inc. | Health Care Technology | First Lien Term Loan | 4/21/2027 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
Frontier Communications Holdings, LLC | Integrated Telecommunication Services | First Lien Term Loan | L+ | 10/8/2027 | (5)(10) | |||||||||||||||||||||||||||||||||
Frontier Communications Holdings, LLC | Integrated Telecommunication Services | Fixed Rate Bond | 1/15/2030 | (10) | ||||||||||||||||||||||||||||||||||
Gibson Brands, Inc. | Leisure Products | First Lien Term Loan | L+ | 8/11/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
Grove Hotel Parcel Owner, LLC | Hotels, Resorts & Cruise Lines | First Lien Term Loan | SOFR+ | 6/21/2027 | (5)(8) | |||||||||||||||||||||||||||||||||
Grove Hotel Parcel Owner, LLC | Hotels, Resorts & Cruise Lines | First Lien Term Loan | SOFR+ | 6/21/2027 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Grove Hotel Parcel Owner, LLC | Hotels, Resorts & Cruise Lines | First Lien Revolver | SOFR+ | 6/21/2027 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Harbor Purchaser Inc. | Education Services | First Lien Term Loan | SOFR+ | 4/9/2029 | (5) | |||||||||||||||||||||||||||||||||
iCIMs, Inc. | Application Software | First Lien Term Loan | SOFR+ | 8/18/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
iCIMs, Inc. | Application Software | First Lien Term Loan | SOFR+ | 8/18/2028 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
iCIMs, Inc. | Application Software | First Lien Revolver | SOFR+ | 8/18/2028 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Impel Neuropharma, Inc. | Health Care Technology | First Lien Term Loan | 2/15/2031 | (8)(11) | ||||||||||||||||||||||||||||||||||
Impel Neuropharma, Inc. | Health Care Technology | First Lien Term Loan | SOFR+ | 3/17/2027 | (5)(8) |
Portfolio Company | Industry | Type of Investment (1)(2)(3) | Index | Spread | Cash Interest Rate (4)(5) | PIK | Maturity Date | Shares | Principal (6) | Cost | Fair Value | Notes | ||||||||||||||||||||||||||
Innocoll Pharmaceuticals Limited | Health Care Technology | First Lien Term Loan | 1/26/2027 | $ | $ | $ | (8)(10) | |||||||||||||||||||||||||||||||
Innocoll Pharmaceuticals Limited | Health Care Technology | First Lien Term Loan | 1/26/2027 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
Innocoll Pharmaceuticals Limited | Health Care Technology | Warrants | (8)(10) | |||||||||||||||||||||||||||||||||||
Iris Holding, Inc. | Metal & Glass Containers | First Lien Term Loan | SOFR+ | 6/28/2028 | (5)(10) | |||||||||||||||||||||||||||||||||
Jamestown CLO XII Ltd. | Multi-Sector Holdings | CLO Notes | L+ | 4/20/2032 | (5)(10) | |||||||||||||||||||||||||||||||||
Kings Buyer, LLC | Environmental & Facilities Services | First Lien Term Loan | L+ | 10/29/2027 | (5)(8) | |||||||||||||||||||||||||||||||||
Kings Buyer, LLC | Environmental & Facilities Services | First Lien Revolver | L+ | 10/29/2027 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
KKR Apple Bidco, LLC | Airport Services | First Lien Term Loan | SOFR+ | 9/22/2028 | (5) | |||||||||||||||||||||||||||||||||
LABL Inc | Office Services & Supplies | First Lien Term Loan | L+ | 10/29/2028 | (5) | |||||||||||||||||||||||||||||||||
LSL Holdco, LLC | Health Care Distributors | First Lien Term Loan | L+ | 1/31/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
LSL Holdco, LLC | Health Care Distributors | First Lien Revolver | L+ | 1/31/2028 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
LTI Holdings, Inc. | Electronic Components | First Lien Term Loan | L+ | 9/6/2025 | (5) | |||||||||||||||||||||||||||||||||
McAfee Corp. | Systems Software | First Lien Term Loan | SOFR+ | 3/1/2029 | (5) | |||||||||||||||||||||||||||||||||
Mesoblast, Inc. | Biotechnology | First Lien Term Loan | 11/19/2026 | (8)(10) | ||||||||||||||||||||||||||||||||||
Mesoblast, Inc. | Biotechnology | First Lien Term Loan | 11/19/2026 | (8)(9)(10) | ||||||||||||||||||||||||||||||||||
Mesoblast, Inc. | Biotechnology | Warrants | (8)(10) | |||||||||||||||||||||||||||||||||||
MHE Intermediate Holdings, LLC | Diversified Support Services | First Lien Term Loan | SOFR+ | 7/21/2027 | (5)(8) | |||||||||||||||||||||||||||||||||
Mitchell International, Inc. | Application Software | Second Lien Term Loan | L+ | 10/15/2029 | (5) | |||||||||||||||||||||||||||||||||
MRI Software LLC | Application Software | First Lien Term Loan | L+ | 2/10/2026 | (5)(8) | |||||||||||||||||||||||||||||||||
MRI Software LLC | Application Software | First Lien Term Loan | L+ | 2/10/2026 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
NFP Corp. | Other Diversified Financial Services | Fixed Rate Bond | 8/15/2028 | |||||||||||||||||||||||||||||||||||
Nidda BondCo GmbH | Health Care Services | Fixed Rate Bond | 9/30/2024 | € | (10) | |||||||||||||||||||||||||||||||||
OEConnection LLC | Application Software | Second Lien Term Loan | L+ | 9/25/2027 | $ | (5)(8) | ||||||||||||||||||||||||||||||||
OFSI BSL CLO XI, Ltd. | Multi-Sector Holdings | CLO Notes | SOFR+ | 7/18/2031 | (5)(10) | |||||||||||||||||||||||||||||||||
Park Place Technologies, LLC | Internet Services & Infrastructure | First Lien Term Loan | SOFR+ | 11/10/2027 | (5) | |||||||||||||||||||||||||||||||||
Peloton Interactive, Inc. | Leisure Products | First Lien Term Loan | SOFR+ | 5/25/2027 | (5)(10) | |||||||||||||||||||||||||||||||||
PetSmart LLC | Specialty Stores | First Lien Term Loan | L+ | 2/11/2028 | (5) | |||||||||||||||||||||||||||||||||
PFNY Holdings, LLC | Leisure Facilities | First Lien Term Loan | L+ | 12/31/2026 | (5)(8) | |||||||||||||||||||||||||||||||||
PFNY Holdings, LLC | Leisure Facilities | First Lien Term Loan | L+ | 12/31/2026 | (5)(8)(9) | |||||||||||||||||||||||||||||||||
PFNY Holdings, LLC | Leisure Facilities | First Lien Revolver | L+ | 12/31/2026 | ( | ( | (5)(8)(9) | |||||||||||||||||||||||||||||||
Profrac Holdings II, LLC | Industrial Machinery | First Lien Term Loan | SOFR+ | 3/4/2025 | (5)(8) | |||||||||||||||||||||||||||||||||
Radiology Partners Inc. | Health Care Distributors | First Lien Term Loan | L+ | 7/9/2025 | (5) | |||||||||||||||||||||||||||||||||
Radiology Partners Inc. | Health Care Distributors | Fixed Rate Bond | 2/1/2028 | |||||||||||||||||||||||||||||||||||
Renaissance Holding Corp. | Diversified Banks | First Lien Term Loan | L+ | 5/30/2025 | (5) | |||||||||||||||||||||||||||||||||
RP Escrow Issuer LLC | Health Care Distributors | Fixed Rate Bond | 12/15/2025 | |||||||||||||||||||||||||||||||||||
SM Wellness Holdings, Inc. | Health Care Services | First Lien Term Loan | L+ | 4/17/2028 | (5)(8) |
Portfolio Company | Industry | Type of Investment (1)(2)(3) | Index | Spread | Cash Interest Rate (4)(5) | PIK | Maturity Date | Shares | Principal (6) | Cost | Fair Value | Notes | ||||||||||||||||||||||||||
Southern Veterinary Partners, LLC | Health Care Facilities | First Lien Term Loan | L+ | 10/5/2027 | $ | $ | $ | (5) | ||||||||||||||||||||||||||||||
SPX Flow, Inc. | Industrial Machinery | First Lien Term Loan | SOFR+ | 4/5/2029 | (5) | |||||||||||||||||||||||||||||||||
Surgery Center Holdings, Inc. | Health Care Facilities | First Lien Term Loan | L+ | 8/31/2026 | (5) | |||||||||||||||||||||||||||||||||
Tacala, LLC | Restaurants | Second Lien Term Loan | L+ | 2/4/2028 | (5) | |||||||||||||||||||||||||||||||||
TIBCO Software Inc. | Application Software | First Lien Term Loan | SOFR+ | 3/30/2029 | (5) | |||||||||||||||||||||||||||||||||
Touchstone Acquisition, Inc. | Health Care Supplies | First Lien Term Loan | L+ | 12/29/2028 | (5)(8) | |||||||||||||||||||||||||||||||||
Uniti Group LP | Specialized REITs | Fixed Rate Bond | 2/15/2029 | (10) | ||||||||||||||||||||||||||||||||||
Uniti Group LP | Specialized REITs | Fixed Rate Bond | 4/15/2028 | (10) | ||||||||||||||||||||||||||||||||||
Vertiv Group Corporation | Electrical Components & Equipment | Fixed Rate Bond | 11/15/2028 | (10) | ||||||||||||||||||||||||||||||||||
Wellfleet CLO 2022-2, Ltd. | Multi-Sector Holdings | CLO Notes | SOFR+ | 10/18/2035 | (5)(10) | |||||||||||||||||||||||||||||||||
WP CPP Holdings, LLC | Aerospace & Defense | First Lien Term Loan | L+ | 4/30/2025 | (5) | |||||||||||||||||||||||||||||||||
WWEX Uni Topco Holdings, LLC | Air Freight & Logistics | First Lien Term Loan | L+ | 7/26/2028 | (5) | |||||||||||||||||||||||||||||||||
Zayo Group Holdings, Inc. | Alternative Carriers | First Lien Term Loan | L+ | 3/9/2027 | (5) | |||||||||||||||||||||||||||||||||
Zayo Group Holdings, Inc. | Alternative Carriers | Fixed Rate Bond | 3/1/2027 | |||||||||||||||||||||||||||||||||||
Total Non-Control/Non-Affiliate Investments ( | $ | $ | ||||||||||||||||||||||||||||||||||||
Cash and Cash Equivalents ( | $ | $ | ||||||||||||||||||||||||||||||||||||
Total Portfolio Investments, Cash and Cash Equivalents ( | $ | $ |
Derivative Instrument | Notional Amount to be Purchased | Notional Amount to be Sold | Maturity Date | Counterparty | Cumulative Unrealized Appreciation /(Depreciation) | |||||||||||||||||||||||||||
Foreign currency forward contract | $ | € | 11/10/2022 | Bank of New York Mellon | $ | |||||||||||||||||||||||||||
$ |
June 30, 2023 | September 30, 2022 | |||||||||||||||||||||||||
Cost: | % of Total Investments | % of Total Investments | ||||||||||||||||||||||||
Senior Secured Debt | $ | % | $ | % | ||||||||||||||||||||||
Subordinated Debt | % | % | ||||||||||||||||||||||||
Preferred Equity | % | % | ||||||||||||||||||||||||
Common Equity and Warrants | % | % | ||||||||||||||||||||||||
Total | $ | % | $ | % |
June 30, 2023 | September 30, 2022 | |||||||||||||||||||||||||||||||||||||
Fair Value: | % of Total Investments | % of Net Assets | % of Total Investments | % of Net Assets | ||||||||||||||||||||||||||||||||||
Senior Secured Debt | $ | % | % | $ | % | % | ||||||||||||||||||||||||||||||||
Subordinated Debt | % | % | % | % | ||||||||||||||||||||||||||||||||||
Preferred Equity | % | % | % | % | ||||||||||||||||||||||||||||||||||
Common Equity and Warrants | % | % | % | % | ||||||||||||||||||||||||||||||||||
Total | $ | % | % | $ | % | % |
June 30, 2023 | September 30, 2022 | |||||||||||||||||||||||||
Fair Value | % of Debt Investments | Fair Value | % of Debt Investments | |||||||||||||||||||||||
Floating rate | $ | % | $ | % | ||||||||||||||||||||||
Fixed rate | % | % | ||||||||||||||||||||||||
Total | $ | % | $ | % |
June 30, 2023 | September 30, 2022 | |||||||||||||||||||||||||
Cost: | % of Total Investments | % of Total Investments | ||||||||||||||||||||||||
United States | $ | % | $ | % | ||||||||||||||||||||||
India | % | % | ||||||||||||||||||||||||
United Kingdom | % | ( | ( | % | ||||||||||||||||||||||
Canada | % | % | ||||||||||||||||||||||||
Luxembourg | % | % | ||||||||||||||||||||||||
France | % | % | ||||||||||||||||||||||||
Costa Rica | % | % | ||||||||||||||||||||||||
Chile | % | % | ||||||||||||||||||||||||
Switzerland | % | % | ||||||||||||||||||||||||
Netherlands | % | % | ||||||||||||||||||||||||
Cayman Islands | % | % | ||||||||||||||||||||||||
Germany | % | % | ||||||||||||||||||||||||
Ireland | % | % | ||||||||||||||||||||||||
Total | $ | % | $ | % |
June 30, 2023 | September 30, 2022 | |||||||||||||||||||||||||||||||||||||
Fair Value: | % of Total Investments | % of Net Assets | % of Total Investments | % of Net Assets | ||||||||||||||||||||||||||||||||||
United States | $ | % | % | $ | % | % | ||||||||||||||||||||||||||||||||
India | % | % | % | % | ||||||||||||||||||||||||||||||||||
United Kingdom | % | % | % | % | ||||||||||||||||||||||||||||||||||
Canada | % | % | % | % | ||||||||||||||||||||||||||||||||||
Luxembourg | % | % | % | % | ||||||||||||||||||||||||||||||||||
France | % | % | % | % | ||||||||||||||||||||||||||||||||||
Chile | % | % | % | % | ||||||||||||||||||||||||||||||||||
Costa Rica | % | % | % | % | ||||||||||||||||||||||||||||||||||
Netherlands | % | % | % | % | ||||||||||||||||||||||||||||||||||
Switzerland | % | % | % | % | ||||||||||||||||||||||||||||||||||
Cayman Islands | % | % | % | % | ||||||||||||||||||||||||||||||||||
Germany | % | % | % | % | ||||||||||||||||||||||||||||||||||
Ireland | % | % | % | % | ||||||||||||||||||||||||||||||||||
Total | $ | % | % | $ | % | % |
June 30, 2023 | September 30, 2022 | ||||||||||||||||||||||
Cost: | % of Total Investments | % of Total Investments | |||||||||||||||||||||
Application Software | $ | % | $ | % | |||||||||||||||||||
Other Specialty Retail | % | % | |||||||||||||||||||||
Electrical Components & Equipment | % | % | |||||||||||||||||||||
Diversified Metals & Mining | % | % | |||||||||||||||||||||
Health Care Technology | % | % | |||||||||||||||||||||
Education Services | % | % | |||||||||||||||||||||
Aerospace & Defense | % | % | |||||||||||||||||||||
Health Care Services | % | % | |||||||||||||||||||||
Distributors | % | % | |||||||||||||||||||||
Integrated Telecommunication Services | % | % | |||||||||||||||||||||
Biotechnology | % | % | |||||||||||||||||||||
Auto Parts & Equipment | % | % | |||||||||||||||||||||
Systems Software | % | % | |||||||||||||||||||||
Health Care Distributors | % | % | |||||||||||||||||||||
Property & Casualty Insurance | % | % | |||||||||||||||||||||
Gold | % | % | |||||||||||||||||||||
Trading Companies & Distributors | % | % | |||||||||||||||||||||
Interactive Media & Services | % | % | |||||||||||||||||||||
Industrial Machinery & Supplies & Components | % | % | |||||||||||||||||||||
Diversified Support Services | % | % | |||||||||||||||||||||
Pharmaceuticals | % | % | |||||||||||||||||||||
Multi-Sector Holdings | % | % | |||||||||||||||||||||
Diversified Financial Services | % | % | |||||||||||||||||||||
Metal, Glass & Plastic Containers | % | % | |||||||||||||||||||||
Cable & Satellite | % | % | |||||||||||||||||||||
Health Care Supplies | % | % | |||||||||||||||||||||
Environmental & Facilities Services | % | % | |||||||||||||||||||||
Hotels, Resorts & Cruise Lines | % | % | |||||||||||||||||||||
Personal Care Products | % | % | |||||||||||||||||||||
Office Services & Supplies | % | % | |||||||||||||||||||||
Real Estate Development | % | % | |||||||||||||||||||||
Specialized Finance | % | % | |||||||||||||||||||||
Insurance Brokers | % | ( | ( | % | |||||||||||||||||||
Research & Consulting Services | % | % | |||||||||||||||||||||
Passenger Airlines | % | % | |||||||||||||||||||||
Restaurants | % | % | |||||||||||||||||||||
Soft Drinks & Non-alcoholic Beverages | % | % | |||||||||||||||||||||
Leisure Facilities | % | % | |||||||||||||||||||||
Advertising | % | % | |||||||||||||||||||||
Consumer Finance | % | % | |||||||||||||||||||||
Electronic Components | % | % | |||||||||||||||||||||
Air Freight & Logistics | % | % | |||||||||||||||||||||
Paper & Plastic Packaging Products & Materials | % | % | |||||||||||||||||||||
Leisure Products | % | % | |||||||||||||||||||||
Internet Services & Infrastructure | % | % | |||||||||||||||||||||
Diversified Real Estate Activities | % | % | |||||||||||||||||||||
IT Consulting & Other Services | % | % | |||||||||||||||||||||
Other Specialized REITs | % | % | |||||||||||||||||||||
Health Care Facilities | % | % | |||||||||||||||||||||
Construction Materials | % | % | |||||||||||||||||||||
Industrial Machinery | % | % | |||||||||||||||||||||
Alternative Carriers | % | % | |||||||||||||||||||||
Other Diversified Financial Services | % | % | |||||||||||||||||||||
Metal & Glass Containers | % | % | |||||||||||||||||||||
Data Processing & Outsourced Services | % | % | |||||||||||||||||||||
Personal Products | % | % | |||||||||||||||||||||
Internet & Direct Marketing Retail | % | % | |||||||||||||||||||||
Paper Packaging | % | % | |||||||||||||||||||||
Oil & Gas Refining & Marketing | % | % | |||||||||||||||||||||
Specialized REITs | % | % | |||||||||||||||||||||
Airport Services | % | % | |||||||||||||||||||||
Paper Products | % | % | |||||||||||||||||||||
Diversified Banks | % | % | |||||||||||||||||||||
Specialty Stores | % | % | |||||||||||||||||||||
Automotive Retail | % | % | |||||||||||||||||||||
Total | $ | % | $ | % |
June 30, 2023 | September 30, 2022 | ||||||||||||||||||||||||||||||||||
Fair Value: | % of Total Investments | % of Net Assets | % of Total Investments | % of Net Assets | |||||||||||||||||||||||||||||||
Application Software | % | % | $ | % | % | ||||||||||||||||||||||||||||||
Other Specialty Retail | % | % | % | % | |||||||||||||||||||||||||||||||
Electrical Components & Equipment | % | % | % | % | |||||||||||||||||||||||||||||||
Diversified Metals & Mining | % | % | % | % | |||||||||||||||||||||||||||||||
Education Services | % | % | % | % | |||||||||||||||||||||||||||||||
Health Care Technology | % | % | % | % | |||||||||||||||||||||||||||||||
Aerospace & Defense | % | % | % | % | |||||||||||||||||||||||||||||||
Health Care Services | % | % | % | % | |||||||||||||||||||||||||||||||
Distributors | % | % | % | % | |||||||||||||||||||||||||||||||
Integrated Telecommunication Services | % | % | % | % | |||||||||||||||||||||||||||||||
Auto Parts & Equipment | % | % | % | % | |||||||||||||||||||||||||||||||
Biotechnology | % | % | % | % | |||||||||||||||||||||||||||||||
Systems Software | % | % | % | % | |||||||||||||||||||||||||||||||
Health Care Distributors | % | % | % | % | |||||||||||||||||||||||||||||||
Gold | % | % | % | % | |||||||||||||||||||||||||||||||
Property & Casualty Insurance | % | % | % | % | |||||||||||||||||||||||||||||||
Trading Companies & Distributors | % | % | % | % | |||||||||||||||||||||||||||||||
Industrial Machinery & Supplies & Components | % | % | % | % | |||||||||||||||||||||||||||||||
Interactive Media & Services | % | % | % | % | |||||||||||||||||||||||||||||||
Diversified Support Services | % | % | % | % | |||||||||||||||||||||||||||||||
Multi-Sector Holdings | % | % | % | % | |||||||||||||||||||||||||||||||
Pharmaceuticals | % | % | % | % | |||||||||||||||||||||||||||||||
Diversified Financial Services | % | % | % | % | |||||||||||||||||||||||||||||||
Cable & Satellite | % | % | % | % | |||||||||||||||||||||||||||||||
Health Care Supplies | % | % | % | % | |||||||||||||||||||||||||||||||
Metal, Glass & Plastic Containers | % | % | % | % | |||||||||||||||||||||||||||||||
Environmental & Facilities Services | % | % | % | % | |||||||||||||||||||||||||||||||
Hotels, Resorts & Cruise Lines | % | % | % | % | |||||||||||||||||||||||||||||||
Personal Care Products | % | % | % | % | |||||||||||||||||||||||||||||||
Insurance Brokers | % | % | % | % | |||||||||||||||||||||||||||||||
Office Services & Supplies | % | % | % | % | |||||||||||||||||||||||||||||||
Specialized Finance | % | % | % | % | |||||||||||||||||||||||||||||||
Real Estate Development | % | % | % | % | |||||||||||||||||||||||||||||||
Research & Consulting Services | % | % | % | % | |||||||||||||||||||||||||||||||
Passenger Airlines | % | % | % | % | |||||||||||||||||||||||||||||||
Soft Drinks & Non-alcoholic Beverages | % | % | % | % | |||||||||||||||||||||||||||||||
Restaurants | % | % | % | % | |||||||||||||||||||||||||||||||
Leisure Facilities | % | % | % | % | |||||||||||||||||||||||||||||||
Advertising | % | % | % | % | |||||||||||||||||||||||||||||||
Electronic Components | % | % | % | % | |||||||||||||||||||||||||||||||
Air Freight & Logistics | % | % | % | % | |||||||||||||||||||||||||||||||
Consumer Finance | % | % | % | % | |||||||||||||||||||||||||||||||
Internet Services & Infrastructure | % | % | % | % | |||||||||||||||||||||||||||||||
Diversified Real Estate Activities | % | % | % | % | |||||||||||||||||||||||||||||||
Paper & Plastic Packaging Products & Materials | % | % | % | % | |||||||||||||||||||||||||||||||
Leisure Products | % | % | % | % | |||||||||||||||||||||||||||||||
Health Care Facilities | % | % | % | % | |||||||||||||||||||||||||||||||
IT Consulting & Other Services | % | % | % | % | |||||||||||||||||||||||||||||||
Other Specialized REITs | % | % | % | % | |||||||||||||||||||||||||||||||
Construction Materials | % | % | % | % | |||||||||||||||||||||||||||||||
Industrial Machinery | % | % | % | % | |||||||||||||||||||||||||||||||
Other Diversified Financial Services | % | % | % | % | |||||||||||||||||||||||||||||||
Metal & Glass Containers | % | % | % | % | |||||||||||||||||||||||||||||||
Alternative Carriers | % | % | % | % | |||||||||||||||||||||||||||||||
Data Processing & Outsourced Services | % | % | % | % | |||||||||||||||||||||||||||||||
Personal Products | % | % | % | % | |||||||||||||||||||||||||||||||
Paper Packaging | % | % | % | % | |||||||||||||||||||||||||||||||
Internet & Direct Marketing Retail | % | % | % | % |
June 30, 2023 | September 30, 2022 | ||||||||||||||||||||||||||||||||||
Fair Value: | % of Total Investments | % of Net Assets | % of Total Investments | % of Net Assets | |||||||||||||||||||||||||||||||
Oil & Gas Refining & Marketing | $ | % | % | $ | % | % | |||||||||||||||||||||||||||||
Airport Services | % | % | % | % | |||||||||||||||||||||||||||||||
Specialized REITs | % | % | % | % | |||||||||||||||||||||||||||||||
Paper Products | % | % | % | % | |||||||||||||||||||||||||||||||
Diversified Banks | % | % | % | % | |||||||||||||||||||||||||||||||
Specialty Stores | % | % | % | % | |||||||||||||||||||||||||||||||
Automotive Retail | % | % | % | % | |||||||||||||||||||||||||||||||
Total | $ | % | % | $ | % | % |
Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||
Senior secured debt | $ | $ | $ | $ | ||||||||||||||||||||||
Subordinated debt | ||||||||||||||||||||||||||
Common equity and warrants | ||||||||||||||||||||||||||
Preferred equity | ||||||||||||||||||||||||||
Total investments at fair value | $ | $ | $ | $ | ||||||||||||||||||||||
Derivative assets | $ | $ | $ | $ | ||||||||||||||||||||||
Total assets at fair value | $ | $ | $ | $ |
Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||
Senior secured debt | $ | $ | $ | $ | ||||||||||||||||||||||
Subordinated debt | ||||||||||||||||||||||||||
Common equity and warrants | ||||||||||||||||||||||||||
Preferred equity | ||||||||||||||||||||||||||
Total investments at fair value | $ | $ | $ | $ | ||||||||||||||||||||||
Derivative assets | $ | $ | $ | $ | ||||||||||||||||||||||
Total assets at fair value | $ | $ | $ | $ |
Senior Secured Debt | Subordinated Debt | Preferred Equity | Common Equity and Warrants | Total | ||||||||||||||||||||||||||||
Fair value as of March 31, 2023 | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Purchases | ||||||||||||||||||||||||||||||||
Sales and repayments | ( | ( | ||||||||||||||||||||||||||||||
Transfers out (a) | ( | ( | ||||||||||||||||||||||||||||||
Capitalized PIK interest income | ||||||||||||||||||||||||||||||||
Accretion of OID | ||||||||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) | ||||||||||||||||||||||||||||||||
Fair value as of June 30, 2023 | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) relating to Level 3 assets still held at June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023 | $ | $ | $ | $ | $ |
Senior Secured Debt | Subordinated Debt | Preferred Equity | Common Equity | Total | ||||||||||||||||||||||||||||
Fair value as of March 31, 2022 | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Purchases | ||||||||||||||||||||||||||||||||
Sales and repayments | ( | ( | ||||||||||||||||||||||||||||||
Transfers in (a) | ||||||||||||||||||||||||||||||||
Capitalized PIK interest income | ||||||||||||||||||||||||||||||||
Accretion of OID | ||||||||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) | ( | ( | ( | ( | ||||||||||||||||||||||||||||
Fair value as of June 30, 2022 | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) relating to Level 3 assets still held at June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statements of Operations for the three months ended June 30, 2022 | $ | ( | $ | $ | ( | $ | ( | $ | ( |
Senior Secured Debt | Subordinated Debt | Preferred Equity | Common Equity and Warrants | Total | ||||||||||||||||||||||||||||
Fair value as of September 30, 2022 | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Purchases | ||||||||||||||||||||||||||||||||
Sales and repayments | ( | ( | ||||||||||||||||||||||||||||||
Transfers in (a) | ||||||||||||||||||||||||||||||||
Capitalized PIK interest income | ||||||||||||||||||||||||||||||||
Accretion of OID | ||||||||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) | ( | |||||||||||||||||||||||||||||||
Fair value as of June 30, 2023 | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) relating to Level 3 assets still held at June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2023 | $ | $ | $ | ( | $ | $ |
Senior Secured Debt | Subordinated Debt | Preferred Equity | Common Equity | Total | ||||||||||||||||||||||||||||
Purchases | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Sales and repayments | ( | ( | ( | |||||||||||||||||||||||||||||
Capitalized PIK interest income | ||||||||||||||||||||||||||||||||
Accretion of OID | ||||||||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) | ( | ( | ( | ( | ||||||||||||||||||||||||||||
Fair value as of June 30, 2022 | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) relating to Level 3 assets still held at June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statements of Operations for the period from December 10, 2021 (commencement of operations) to June 30, 2022 | $ | ( | $ | $ | ( | $ | ( | $ | ( |
Asset | Fair Value | Valuation Technique | Unobservable Input | Range | Weighted Average (a) | ||||||||||||||||||||||||||||||||||||
Senior secured debt | $ | Market Yield | Market Yield | (b) | - | ||||||||||||||||||||||||||||||||||||
Transaction Precedent | NA | (c) | N/A | - | N/A | N/A | |||||||||||||||||||||||||||||||||||
Broker Quotations | Broker Quoted Price | (d) | N/A | - | N/A | N/A | |||||||||||||||||||||||||||||||||||
Subordinated debt | Market Yield | Market Yield | (b) | - | |||||||||||||||||||||||||||||||||||||
Common equity and warrants & preferred equity | Enterprise Value | Revenue Multiple | (e) | - | |||||||||||||||||||||||||||||||||||||
Enterprise Value | EBITDA Multiple | (e) | - | ||||||||||||||||||||||||||||||||||||||
Transaction Precedent | Transaction Price | (c) | N/A | - | N/A | N/A | |||||||||||||||||||||||||||||||||||
Total | $ |
Asset | Fair Value | Valuation Technique | Unobservable Input | Range | Weighted Average (a) | ||||||||||||||||||||||||||||||||||||
Senior secured debt | $ | Market Yield | Market Yield | (b) | - | ||||||||||||||||||||||||||||||||||||
Broker Quotations | Broker Quoted Price | (d) | N/A | - | N/A | N/A | |||||||||||||||||||||||||||||||||||
Subordinated debt | Market Yield | Market Yield | (b) | - | |||||||||||||||||||||||||||||||||||||
Common equity and warrants & preferred equity | Enterprise Value | Revenue Multiple | (e) | - | |||||||||||||||||||||||||||||||||||||
Enterprise Value | EBITDA Multiple | (e) | - | ||||||||||||||||||||||||||||||||||||||
Transaction Precedent | Transaction Price | (c) | N/A | - | N/A | N/A | |||||||||||||||||||||||||||||||||||
Total | $ |
Common Shares | ||||||||||||||||||||||||||||||||
(Share amounts in thousands) | Shares | Par Value | Additional Paid-in-Capital | Accumulated Distributable Earnings (Loss) | Total Net Assets | |||||||||||||||||||||||||||
Balance at September 30, 2022 | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||
Issuance of Common Shares | — | |||||||||||||||||||||||||||||||
Issuance of Common Shares under dividend reinvestment plan | — | |||||||||||||||||||||||||||||||
Net investment income | — | — | — | |||||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) | — | — | — | ( | ( | |||||||||||||||||||||||||||
Net realized gains (losses) | — | — | — | ( | ( | |||||||||||||||||||||||||||
Provision for income tax (expense) benefit | — | — | — | ( | ( | |||||||||||||||||||||||||||
Distributions to shareholders | — | — | — | ( | ( | |||||||||||||||||||||||||||
Balance at December 31, 2022 | ( | |||||||||||||||||||||||||||||||
Issuance of Common Shares | — | |||||||||||||||||||||||||||||||
Issuance of Common Shares under dividend reinvestment plan | — | |||||||||||||||||||||||||||||||
Net investment income | — | — | — | |||||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) | — | — | — | |||||||||||||||||||||||||||||
Net realized gains (losses) | — | — | — | ( | ( | |||||||||||||||||||||||||||
Provision for income tax (expense) benefit | — | — | — | ( | ( | |||||||||||||||||||||||||||
Distributions to shareholders | — | — | — | ( | ( | |||||||||||||||||||||||||||
Balance at March 31, 2023 | ( | |||||||||||||||||||||||||||||||
Issuance of Common Shares | — | |||||||||||||||||||||||||||||||
Issuance of Common Shares under dividend reinvestment plan | — | |||||||||||||||||||||||||||||||
Shares repurchased, net of early repurchase deduction | ( | — | ( | — | ( | |||||||||||||||||||||||||||
Net investment income | — | — | — | |||||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) | — | — | — | |||||||||||||||||||||||||||||
Net realized gains (losses) | — | — | — | ( | ( | |||||||||||||||||||||||||||
Provision for income tax (expense) benefit | — | — | — | ( | ( | |||||||||||||||||||||||||||
Distributions to shareholders | — | — | — | ( | ( | |||||||||||||||||||||||||||
Balance at June 30, 2023 | $ | $ | $ | ( | $ |
Common Shares | ||||||||||||||||||||||||||||||||
Shares | Par Value | Additional Paid-in-Capital | Accumulated Distributable Earnings (Loss) | Total Net Assets | ||||||||||||||||||||||||||||
Capital contribution | $ | $ | $ | — | $ | |||||||||||||||||||||||||||
Net investment income | — | — | — | |||||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) | — | — | — | ( | ( | |||||||||||||||||||||||||||
Balance at December 31, 2021 | ||||||||||||||||||||||||||||||||
Capital contributions | — | |||||||||||||||||||||||||||||||
Net investment income | — | — | — | |||||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) | — | — | — | ( | ( | |||||||||||||||||||||||||||
Net realized gains (losses) | — | — | — | |||||||||||||||||||||||||||||
Provision for income tax (expense) benefit | — | — | — | ( | ( | |||||||||||||||||||||||||||
Distributions to shareholders | — | — | — | ( | ( | |||||||||||||||||||||||||||
Balance at March 31, 2022 | ||||||||||||||||||||||||||||||||
Capital contributions | — | |||||||||||||||||||||||||||||||
Net investment income | — | — | — | |||||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) | — | — | — | ( | ( | |||||||||||||||||||||||||||
Net realized gains (losses) | — | — | — | ( | ( | |||||||||||||||||||||||||||
Provision for income tax (expense) benefit | — | — | — | ( | ( | |||||||||||||||||||||||||||
Balance at June 30, 2022 | $ | $ | $ | ( | $ |
Shares | Amount | ||||||||||
Class I | |||||||||||
Issuance of Common Shares | $ | ||||||||||
Issuance of Common Shares under dividend reinvestment plan | |||||||||||
Share repurchases, net of early repurchase deduction | — | — | |||||||||
Net increase (decrease) | $ | ||||||||||
Class S | |||||||||||
Issuance of Common Shares | $ | ||||||||||
Issuance of Common Shares under dividend reinvestment plan | |||||||||||
Share repurchases, net of early repurchase deduction | ( | ( | |||||||||
Net increase (decrease) | $ | ||||||||||
Class D | |||||||||||
Issuance of Common Shares | $ | ||||||||||
Issuance of Common Shares under dividend reinvestment plan | — | — | |||||||||
Share repurchases, net of early repurchase deduction | — | — | |||||||||
Net increase (decrease) | $ | ||||||||||
Total net increase (decrease) | $ |
Class I Shares | Class S Shares | Class D Shares | |||||||||||||||
May 31, 2022 | $ | ||||||||||||||||
June 30, 2022 | $ | ||||||||||||||||
July 31, 2022 | $ | $ | |||||||||||||||
August 31, 2022 | $ | $ | |||||||||||||||
September 30, 2022 | $ | $ | |||||||||||||||
October 31, 2022 | $ | $ | |||||||||||||||
November 30, 2022 | $ | $ | |||||||||||||||
December 31, 2022 | $ | $ | |||||||||||||||
January 31, 2023 | $ | $ | |||||||||||||||
February 28, 2023 | $ | $ | |||||||||||||||
March 31, 2023 | $ | $ | |||||||||||||||
April 30, 2023 | $ | $ | |||||||||||||||
May 31, 2023 | $ | $ | |||||||||||||||
June 30, 2023 | $ | $ | $ |
Class I | ||||||||||||||||||||||||||
Date Declared | Record Date | Payment Date | Distribution Per Share | Distribution Amount | ||||||||||||||||||||||
October 26, 2022 | October 31, 2022 | November 28, 2022 | $ | $ | ||||||||||||||||||||||
November 21, 2022 | November 30, 2022 | December 28, 2022 | ||||||||||||||||||||||||
December 21, 2022 | December 31, 2022 | January 30, 2023 | ||||||||||||||||||||||||
December 21, 2022 | December 31, 2022 | January 30, 2023 | ||||||||||||||||||||||||
January 24, 2023 | January 31, 2023 | February 24, 2023 | ||||||||||||||||||||||||
February 22, 2023 | February 28, 2023 | March 29, 2023 | ||||||||||||||||||||||||
March 22, 2023 | March 31, 2023 | April 27, 2023 | ||||||||||||||||||||||||
April 25, 2023 | April 30, 2023 | May 26, 2023 | ||||||||||||||||||||||||
May 22, 2023 | May 31, 2023 | June 28, 2023 | ||||||||||||||||||||||||
June 26, 2023 | June 30, 2023 | July 27, 2023 | ||||||||||||||||||||||||
$ | $ |
Class S | ||||||||||||||||||||||||||
Date Declared | Record Date | Payment Date | Distribution Per Share | Distribution Amount | ||||||||||||||||||||||
October 26, 2022 | October 31, 2022 | November 28, 2022 | $ | $ | ||||||||||||||||||||||
November 21, 2022 | November 30, 2022 | December 28, 2022 | ||||||||||||||||||||||||
December 21, 2022 | December 31, 2022 | January 30, 2023 | ||||||||||||||||||||||||
December 21, 2022 | December 31, 2022 | January 30, 2023 | ||||||||||||||||||||||||
January 24, 2023 | January 31, 2023 | February 24, 2023 | ||||||||||||||||||||||||
February 22, 2023 | February 28, 2023 | March 29, 2023 | ||||||||||||||||||||||||
March 22, 2023 | March 31, 2023 | April 27, 2023 | ||||||||||||||||||||||||
April 25, 2023 | April 30, 2023 | May 26, 2023 | ||||||||||||||||||||||||
May 22, 2023 | May 31, 2023 | June 28, 2023 | ||||||||||||||||||||||||
June 26, 2023 | June 30, 2023 | July 27, 2023 | ||||||||||||||||||||||||
$ | $ |
Class D | ||||||||||||||||||||||||||
Date Declared | Record Date | Payment Date | Distribution Per Share | Distribution Amount | ||||||||||||||||||||||
June 26, 2023 | June 30, 2023 | July 27, 2023 | $ | $ | ||||||||||||||||||||||
$ | $ |
Class I | Class S | |||||||||||||||||||||||||
Source of Distribution | Per Share | Amount | Per Share | Amount | ||||||||||||||||||||||
Net investment income | $ | $ | $ | $ | ||||||||||||||||||||||
Distributions in excess of net investment income | ||||||||||||||||||||||||||
Total | $ | $ | $ | $ |
Three months ended June 30, 2023 | Three months ended June 30, 2022 | Nine months ended June 30, 2023 | For the period from December 10, 2021 (commencement of operations) to June 30, 2022 | |||||||||||||||||||||||
Net increase (decrease) in net assets resulting from operations | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||
Net unrealized (appreciation) depreciation | ( | ( | ||||||||||||||||||||||||
Other book/tax differences | ( | ( | ||||||||||||||||||||||||
Taxable income (1) | $ | $ | $ | $ |
Undistributed ordinary income, net | $ | ||||
Net realized capital losses | |||||
Unrealized losses, net | ( | ||||
Accumulated overdistributed earnings | $ | ( |
Shareholder Servicing and/or Distribution Fee as a % of NAV | |||||
Class I shares | % | ||||
Class S shares | % | ||||
Class D shares | % |
(Share amounts in thousands) | For the three months ended June 30, 2023 | Three months ended June 30, 2022 | For the nine months ended June 30, 2023 | For the period from December 10, 2021 (commencement of operations) to June 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||
Class I | Class S | Class D | Class I | Class I | Class S | Class D | Class I | |||||||||||||||||||||||||||||||||||||||||||
Net asset value at beginning of period | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Capital Contribution | ||||||||||||||||||||||||||||||||||||||||||||||||||
Net investment income (1) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Net unrealized appreciation (depreciation) (1)(2) | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Net realized gains (losses) (1) | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Net increase (decrease) in net assets resulting from operations | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Distributions of net investment income to shareholders | ( | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Distributions in excess of net investment income | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Net asset value at end of period | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Total return (3) | % | % | % | ( | % | % | % | % | ( | % | ||||||||||||||||||||||||||||||||||||||||
Common shares outstanding at beginning of the period or the commencement date | ||||||||||||||||||||||||||||||||||||||||||||||||||
Common shares outstanding at end of period | ||||||||||||||||||||||||||||||||||||||||||||||||||
Net assets at the beginning of the period or the commencement date | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Net assets at end of period | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Average net assets (4) | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Ratio of net investment income to average net assets (5) | % | % | % | % | % | % | % | % | ||||||||||||||||||||||||||||||||||||||||||
Ratio of total expenses to average net assets (5)(7) | % | % | % | % | % | % | % | % | ||||||||||||||||||||||||||||||||||||||||||
Ratio of net expenses to average net assets (5) | % | % | % | % | % | % | % | % | ||||||||||||||||||||||||||||||||||||||||||
Ratio of portfolio turnover to average investments at fair value (5) | % | % | % | % | % | % | % | % | ||||||||||||||||||||||||||||||||||||||||||
Weighted average outstanding debt | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Average debt per share (1) | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Asset coverage ratio (6) | % | % | % | % | % | % | % | % |
(1) | Calculated based upon weighted average shares outstanding for the period. | ||||
(2) | The amount shown may not correspond with the net unrealized appreciation on investments for the three months ended June 30, 2023 and 2022, the nine months ended June 30, 2023 and the period from December 10, 2021 (commencement of operations) to June 30, 2022 as it includes the effect of the timing of equity issuances. | ||||
(3) | Total return is calculated as the change in NAV per share during the period, plus distributions per share or capital activity, if any, divided by the beginning NAV per share, assuming a dividend reinvestment price equal to the NAV per share at the beginning of the period. | ||||
(4) | Calculated based upon the weighted average net assets for the period. | ||||
(5) | Financial results for the three months ended June 30, 2023 and 2022, the nine months ended June 30, 2023 and the period from December 10, 2021 (commencement of operations) to June 30, 2022 have not been annualized for purposes of this ratio. | ||||
(6) | Based on outstanding senior securities of $ | ||||
(7) | Total expenses to average net assets is prior to management fee waivers and expense support/reimbursements provided by the Adviser. |
June 30, 2023 | September 30, 2022 | |||||||||||||
CVAUSA Management, LLC | $ | $ | ||||||||||||
107-109 Beech OAK22 LLC | ||||||||||||||
Delta Leasing SPV II LLC | ||||||||||||||
OneOncology, LLC | ||||||||||||||
Seres Therapeutics, Inc. | ||||||||||||||
MND Holdings III Corp | ||||||||||||||
North Star Acquisitionco, LLC | ||||||||||||||
scPharmaceuticals Inc. | ||||||||||||||
BioXcel Therapeutics, Inc. | ||||||||||||||
IW Buyer LLC | ||||||||||||||
Grove Hotel Parcel Owner, LLC | ||||||||||||||
Harrow Health, Inc. | ||||||||||||||
Inventus Power, Inc. | ||||||||||||||
iCIMs, Inc. | ||||||||||||||
ADC Therapeutics SA | ||||||||||||||
Transit Buyer LLC | ||||||||||||||
SEI Holding I Corporation | ||||||||||||||
PPW Aero Buyer, Inc. | ||||||||||||||
Ardonagh Midco 3 PLC | ||||||||||||||
107 Fair Street LLC | ||||||||||||||
Establishment Labs Holdings Inc. | ||||||||||||||
HUB Pen Company, LLC | ||||||||||||||
Dukes Root Control Inc. | ||||||||||||||
Innocoll Pharmaceuticals Limited | ||||||||||||||
112-126 Van Houten Real22 LLC | ||||||||||||||
Coupa Holdings, LLC | ||||||||||||||
athenahealth Group Inc. | ||||||||||||||
Oranje Holdco, Inc. | ||||||||||||||
Avalara, Inc. | ||||||||||||||
Salus Workers' Compensation, LLC | ||||||||||||||
Galileo Parent, Inc. | ||||||||||||||
SCP Eye Care Services, LLC | ||||||||||||||
MRI Software LLC | ||||||||||||||
Mesoblast, Inc. | ||||||||||||||
LSL Holdco, LLC | ||||||||||||||
Pluralsight, LLC | ||||||||||||||
Supreme Fitness Group NY Holdings, LLC | ||||||||||||||
ASP-R-PAC Acquisition Co LLC | ||||||||||||||
Kings Buyer, LLC | ||||||||||||||
PFNY Holdings, LLC | ||||||||||||||
$ | $ |
Gross Distribution | Shareholder Servicing and/or Distribution Fee | Net Distribution | ||||||||||||||||||
Class I shares | $ | $ | $ | |||||||||||||||||
Class S shares | $ | $ | $ | |||||||||||||||||
Class D shares | $ | $ | $ |
June 30, 2023 | September 30, 2022 | |||||||||||||
Cost: | ||||||||||||||
Senior Secured Debt | 94.56 | % | 93.44 | % | ||||||||||
Subordinated Debt | 4.70 | % | 4.98 | % | ||||||||||
Preferred Equity | 0.47 | % | 1.35 | % | ||||||||||
Common Equity and Warrants | 0.27 | % | 0.23 | % | ||||||||||
Total | 100.00 | % | 100.00 | % |
June 30, 2023 | September 30, 2022 | |||||||||||||
Fair Value: | ||||||||||||||
Senior Secured Debt | 94.56 | % | 93.96 | % | ||||||||||
Subordinated Debt | 4.67 | % | 4.52 | % | ||||||||||
Preferred Equity | 0.42 | % | 1.28 | % | ||||||||||
Common Equity and Warrants | 0.35 | % | 0.24 | % | ||||||||||
Total | 100.00 | % | 100.00 | % |
June 30, 2023 | September 30, 2022 | |||||||||||||
Fair Value: | ||||||||||||||
Application Software | 9.49 | % | 10.12 | % | ||||||||||
Other Specialty Retail | 7.84 | % | — | % | ||||||||||
Electrical Components & Equipment | 5.95 | % | 0.77 | % | ||||||||||
Diversified Metals & Mining | 5.11 | % | 0.86 | % | ||||||||||
Education Services | 4.75 | % | 3.43 | % | ||||||||||
Health Care Technology | 4.69 | % | 6.92 | % | ||||||||||
Aerospace & Defense | 4.33 | % | 1.20 | % | ||||||||||
Health Care Services | 4.17 | % | 1.53 | % | ||||||||||
Distributors | 3.02 | % | 2.90 | % | ||||||||||
Integrated Telecommunication Services | 2.70 | % | 2.16 | % | ||||||||||
Auto Parts & Equipment | 2.58 | % | — | % | ||||||||||
Biotechnology | 2.55 | % | 2.81 | % | ||||||||||
Systems Software | 2.47 | % | 4.24 | % | ||||||||||
Health Care Distributors | 2.28 | % | 5.51 | % | ||||||||||
Gold | 2.16 | % | — | % | ||||||||||
Property & Casualty Insurance | 2.15 | % | 2.33 | % | ||||||||||
Trading Companies & Distributors | 1.90 | % | 1.12 | % | ||||||||||
Industrial Machinery & Supplies & Components | 1.90 | % | — | % | ||||||||||
Interactive Media & Services | 1.86 | % | — | % | ||||||||||
Diversified Support Services | 1.82 | % | 3.63 | % | ||||||||||
Multi-Sector Holdings | 1.69 | % | 1.27 | % | ||||||||||
Pharmaceuticals | 1.68 | % | 1.04 | % | ||||||||||
Diversified Financial Services | 1.67 | % | — | % | ||||||||||
Cable & Satellite | 1.57 | % | 2.04 | % | ||||||||||
Health Care Supplies | 1.57 | % | 1.96 | % | ||||||||||
Metal, Glass & Plastic Containers | 1.51 | % | — | % | ||||||||||
Environmental & Facilities Services | 1.38 | % | 1.13 | % | ||||||||||
Hotels, Resorts & Cruise Lines | 1.35 | % | 4.03 | % | ||||||||||
Personal Care Products | 1.22 | % | — | % | ||||||||||
Insurance Brokers | 1.11 | % | — | % | ||||||||||
Office Services & Supplies | 1.06 | % | 1.86 | % | ||||||||||
Specialized Finance | 1.04 | % | 0.85 | % | ||||||||||
Real Estate Development | 1.01 | % | — | % | ||||||||||
Research & Consulting Services | 0.96 | % | 1.78 | % | ||||||||||
Passenger Airlines | 0.96 | % | — | % | ||||||||||
Soft Drinks & Non-alcoholic Beverages | 0.83 | % | — | % | ||||||||||
Restaurants | 0.77 | % | 1.57 | % | ||||||||||
Leisure Facilities | 0.71 | % | 2.07 | % | ||||||||||
Advertising | 0.57 | % | 1.63 | % | ||||||||||
Electronic Components | 0.52 | % | 1.51 | % | ||||||||||
Air Freight & Logistics | 0.51 | % | 1.48 | % | ||||||||||
Consumer Finance | 0.40 | % | 1.45 | % | ||||||||||
Internet Services & Infrastructure | 0.38 | % | 0.44 | % | ||||||||||
Diversified Real Estate Activities | 0.36 | % | — | % | ||||||||||
Paper & Plastic Packaging Products & Materials | 0.36 | % | — | % | ||||||||||
Leisure Products | 0.31 | % | 2.76 | % | ||||||||||
Health Care Facilities | 0.25 | % | 2.27 | % | ||||||||||
IT Consulting & Other Services | 0.25 | % | 0.84 | % | ||||||||||
Other Specialized REITs | 0.24 | % | — | % | ||||||||||
Construction Materials | 0.04 | % | — | % | ||||||||||
Industrial Machinery | — | % | 4.20 | % | ||||||||||
Other Diversified Financial Services | — | % | 1.79 | % | ||||||||||
Metal & Glass Containers | — | % | 1.72 | % | ||||||||||
Alternative Carriers | — | % | 1.69 | % | ||||||||||
Data Processing & Outsourced Services | — | % | 1.54 | % | ||||||||||
Personal Products | — | % | 1.29 | % | ||||||||||
Paper Packaging | — | % | 1.12 | % | ||||||||||
Internet & Direct Marketing Retail | — | % | 1.11 | % | ||||||||||
Oil & Gas Refining & Marketing | — | % | 0.93 | % | ||||||||||
Airport Services | — | % | 0.69 | % | ||||||||||
Specialized REITs | — | % | 0.68 | % | ||||||||||
Paper Products | — | % | 0.66 | % | ||||||||||
Diversified Banks | — | % | 0.50 | % | ||||||||||
Specialty Stores | — | % | 0.44 | % | ||||||||||
Automotive Retail | — | % | 0.13 | % | ||||||||||
Total | 100.00 | % | 100.00 | % |
June 30, 2023 | September 30, 2022 | |||||||||||||
United States | 85.58 | % | 90.88 | % | ||||||||||
India | 3.07 | % | 0.85 | % | ||||||||||
United Kingdom | 2.66 | % | — | % | ||||||||||
Canada | 2.16 | % | — | % | ||||||||||
Luxembourg | 1.20 | % | — | % | ||||||||||
France | 1.06 | % | 0.99 | % | ||||||||||
Chile | 0.96 | % | — | % | ||||||||||
Costa Rica | 0.95 | % | 2.38 | % | ||||||||||
Netherlands | 0.83 | % | — | % | ||||||||||
Switzerland | 0.77 | % | 2.32 | % | ||||||||||
Cayman Islands | 0.76 | % | — | % | ||||||||||
Germany | — | % | 1.21 | % | ||||||||||
Ireland | — | % | 1.37 | % | ||||||||||
Total | 100.00 | % | 100.00 | % |
For the three months ended June 30, 2023 | For the three months ended June 30, 2022 | For the nine months ended June 30, 2023 | For the period from December 10, 2021 (commencement of operations) to June 30, 2022 | |||||||||||||||||||||||
Expenses: | ||||||||||||||||||||||||||
Base management fee | $ | 2,817 | $ | 286 | $ | 6,183 | $ | 286 | ||||||||||||||||||
Investment income incentive fee | 2,835 | — | 5,808 | — | ||||||||||||||||||||||
Professional fees | 401 | 212 | 1,589 | 415 | ||||||||||||||||||||||
Class S distribution and shareholder servicing fees | 589 | — | 1,116 | — | ||||||||||||||||||||||
Board of trustees fees | 66 | 90 | 198 | 150 | ||||||||||||||||||||||
Organization expenses | — | 549 | 4 | 549 | ||||||||||||||||||||||
Amortization of continuous offering costs | 725 | 255 | 2,517 | 255 | ||||||||||||||||||||||
Interest expense | 5,215 | 953 | 11,595 | 1,274 | ||||||||||||||||||||||
Administrator expense | 267 | 60 | 711 | 84 | ||||||||||||||||||||||
General and administrative expenses | 271 | 121 | 796 | 124 | ||||||||||||||||||||||
Total expenses | $ | 13,186 | $ | 2,526 | $ | 30,517 | $ | 3,137 | ||||||||||||||||||
Management and incentive fees waived | — | (286) | (1,642) | (286) | ||||||||||||||||||||||
Expense reimbursements (support) | 348 | (804) | (504) | (804) | ||||||||||||||||||||||
Net expenses | $ | 13,534 | $ | 1,436 | $ | 28,371 | $ | 2,047 |
Debt Outstanding as of September 30, 2022 | Debt Outstanding as of June 30, 2023 | Weighted average debt outstanding for the nine months ended June 30, 2023 | Maximum debt outstanding for the nine months ended June 30, 2023 | |||||||||||||||||||||||
ING Credit Agreement | $ | 75,000 | $ | 275,000 | $ | 170,512 | $ | 275,000 | ||||||||||||||||||
JPM SPV Facility | — | 50,000 | 19,744 | 50,000 | ||||||||||||||||||||||
Total debt | $ | 75,000 | $ | 325,000 | $ | 190,256 |
Payments due by period as of June 30, 2023 | ||||||||||||||||||||||||||
Total | < 1 year | 1-3 years | 3-5 years | |||||||||||||||||||||||
ING Credit Agreement | $ | 275,000 | $ | — | $ | — | $ | 275,000 | ||||||||||||||||||
Interest due on ING Credit Agreement | 101,097 | 20,219 | 40,438 | 40,440 | ||||||||||||||||||||||
JPM Loan and Security Agreement | 50,000 | — | — | 50,000 | ||||||||||||||||||||||
Interest due on JPM Loan and Security Agreement | 18,338 | 3,937 | 7,874 | 6,527 | ||||||||||||||||||||||
Total | $ | 444,435 | $ | 24,156 | $ | 48,312 | $ | 371,967 |
Shares | Amount | ||||||||||
Class I | |||||||||||
Issuance of Common Shares | 16,273,329 | $ | 381,028 | ||||||||
Issuance of Common Shares under dividend reinvestment plan | 182,183 | 4,264 | |||||||||
Share repurchases, net of early repurchase deduction | — | — | |||||||||
Net increase (decrease) | 16,455,512 | $ | 385,292 | ||||||||
Class S | |||||||||||
Issuance of Common Shares | 10,943,532 | $ | 256,304 | ||||||||
Issuance of Common Shares under dividend reinvestment plan | 192,853 | 4,506 | |||||||||
Share repurchases, net of early repurchase deduction | (1,692) | (40) | |||||||||
Net increase (decrease) | 11,134,693 | $ | 260,770 | ||||||||
Class D | |||||||||||
Issuance of Common Shares | 646 | $ | 15 | ||||||||
Issuance of Common Shares under dividend reinvestment plan | — | — | |||||||||
Share repurchases, net of early repurchase deduction | — | — | |||||||||
646 | $ | 15 | |||||||||
Total net increase (decrease) | 27,590,851 | 646,077 |
Class I Shares | Class S Shares | Class D Shares | |||||||||||||||
May 31, 2022 | $ | 24.32 | — | — | |||||||||||||
June 30, 2022 | $ | 23.71 | — | — | |||||||||||||
July 31, 2022 | $ | 23.98 | $ | 23.98 | — | ||||||||||||
August 31, 2022 | $ | 24.03 | $ | 24.03 | — | ||||||||||||
September 30, 2022 | $ | 23.47 | $ | 23.47 | — | ||||||||||||
October 31, 2022 | $ | 23.33 | $ | 23.33 | — | ||||||||||||
November 30, 2022 | $ | 23.46 | $ | 23.46 | — | ||||||||||||
December 31, 2022 | $ | 23.23 | $ | 23.23 | — | ||||||||||||
January 31, 2023 | $ | 23.64 | $ | 23.64 | — | ||||||||||||
February 28, 2023 | $ | 23.56 | $ | 23.56 | — | ||||||||||||
March 31, 2023 | $ | 23.42 | $ | 23.42 | — | ||||||||||||
April 30, 2023 | $ | 23.40 | $ | 23.40 | — | ||||||||||||
May 31, 2023 | $ | 23.23 | $ | 23.23 | — | ||||||||||||
June 30, 2023 | $ | 23.48 | $ | 23.48 | $ | 23.48 |
Class I | ||||||||||||||||||||||||||
Date Declared | Record Date | Payment Date | Net Distribution Per Share | Distribution Amount | ||||||||||||||||||||||
October 26, 2022 | October 31, 2022 | November 28, 2022 | $ | 0.1800 | $ | 2,470 | ||||||||||||||||||||
November 21, 2022 | November 30, 2022 | December 28, 2022 | 0.1900 | 2,818 | ||||||||||||||||||||||
December 21, 2022 | December 31, 2022 | January 30, 2023 | 0.1900 | 3,171 | ||||||||||||||||||||||
December 21, 2022 | December 31, 2022 | January 30, 2023 | 0.0400 | 668 | ||||||||||||||||||||||
January 24, 2023 | January 31, 2023 | February 24, 2023 | 0.1900 | 3,351 | ||||||||||||||||||||||
February 22, 2023 | February 28, 2023 | March 29, 2023 | 0.1900 | 3,834 | ||||||||||||||||||||||
March 22, 2023 | March 31, 2023 | April 27, 2023 | 0.1900 | 4,252 | ||||||||||||||||||||||
April 25, 2023 | April 30, 2023 | May 26, 2023 | 0.1900 | 4,568 | ||||||||||||||||||||||
May 22, 2023 | May 31, 2023 | June 28, 2023 | 0.1900 | 5,068 | ||||||||||||||||||||||
June 26, 2023 | June 30, 2023 | July 27, 2023 | 0.1900 | 5,605 | ||||||||||||||||||||||
$ | 1.7400 | $ | 35,805 |
Class S | ||||||||||||||||||||||||||
Date Declared | Record Date | Payment Date | Net Distribution Per Share | Distribution Amount | ||||||||||||||||||||||
October 26, 2022 | October 31, 2022 | November 28, 2022 | $ | 0.1634 | $ | 574 | ||||||||||||||||||||
November 21, 2022 | November 30, 2022 | December 28, 2022 | 0.1735 | 684 | ||||||||||||||||||||||
December 21, 2022 | December 31, 2022 | January 30, 2023 | 0.1734 | 789 | ||||||||||||||||||||||
December 21, 2022 | December 31, 2022 | January 30, 2023 | 0.0400 | 182 | ||||||||||||||||||||||
January 24, 2023 | January 31, 2023 | February 24, 2023 | 0.1735 | 916 | ||||||||||||||||||||||
February 22, 2023 | February 28, 2023 | March 29, 2023 | 0.1733 | 1,024 | ||||||||||||||||||||||
March 22, 2023 | March 31, 2023 | April 27, 2023 | 0.1733 | 1,486 | ||||||||||||||||||||||
April 25, 2023 | April 30, 2023 | May 26, 2023 | 0.1734 | 1,764 | ||||||||||||||||||||||
May 22, 2023 | May 31, 2023 | June 28, 2023 | 0.1734 | 2,036 | ||||||||||||||||||||||
June 26, 2023 | June 30, 2023 | July 27, 2023 | 0.1735 | 2,381 | ||||||||||||||||||||||
$ | 1.5907 | $ | 11,836 |
Class D | ||||||||||||||||||||||||||
Date Declared | Record Date | Payment Date | Distribution Per Share | Distribution Amount | ||||||||||||||||||||||
June 26, 2023 | June 30, 2023 | July 27, 2023 | $ | 0.1852 | $ | — | ||||||||||||||||||||
$ | 0.1852 | $ | — |
Gross Distribution | Shareholder Servicing and/or Distribution Fee | Net Distribution | ||||||||||||||||||
Class I shares | $ | 0.1900 | $ | — | $ | 0.1900 | ||||||||||||||
Class S shares | $ | 0.1900 | $ | 0.0166 | $ | 0.1734 | ||||||||||||||
Class D shares | $ | 0.1900 | $ | 0.0049 | $ | 0.1851 |
June 30, 2023 | September 30, 2022 | |||||||||||||||||||||||||
($ in thousands) | Fair Value | % of Floating Rate Portfolio | Fair Value | % of Floating Rate Portfolio | ||||||||||||||||||||||
0% | $ | 147,294 | 12.98 | % | $ | 87,955 | 23.79 | % | ||||||||||||||||||
>0% and <1% | 379,106 | 33.40 | 192,723 | 52.13 | ||||||||||||||||||||||
1% | 422,938 | 37.27 | 89,020 | 24.08 | ||||||||||||||||||||||
>1% | 185,574 | 16.35 | — | — | ||||||||||||||||||||||
Total | $ | 1,134,912 | 100.00 | % | $ | 369,698 | 100.00 | % | ||||||||||||||||||
Basis point increase ($ in thousands) | Increase in Interest Income | (Increase) in Interest Expense | Net increase in net assets resulting from operations | |||||||||||||||||
250 | $ | 29,316 | $ | (8,125) | $ | 21,191 | ||||||||||||||
200 | 23,425 | (6,500) | 16,925 | |||||||||||||||||
150 | 17,535 | (4,875) | 12,660 | |||||||||||||||||
100 | 11,644 | (3,250) | 8,394 | |||||||||||||||||
50 | 5,822 | (1,625) | 4,197 |
Basis point decrease ($ in thousands) | (Decrease) in Interest Income | Decrease in Interest Expense | Net (decrease) in net assets resulting from operations | |||||||||||||||||
50 | $ | (5,822) | $ | 1,625 | $ | (4,197) | ||||||||||||||
100 | (11,644) | 3,250 | (8,394) | |||||||||||||||||
150 | (17,466) | 4,875 | (12,591) | |||||||||||||||||
200 | (23,271) | 6,500 | (16,771) | |||||||||||||||||
250 | (29,044) | 8,125 | (20,919) |
June 30, 2023 | September 30, 2022 | |||||||||||||||||||||||||
($ in thousands) | Debt Investments | Borrowings | Debt Investments | Borrowings | ||||||||||||||||||||||
Prime rate | $ | — | $ | — | $ | — | $ | — | ||||||||||||||||||
LIBOR | ||||||||||||||||||||||||||
30 day | 24,593 | — | 137,460 | — | ||||||||||||||||||||||
90 day | 36,834 | — | 85,546 | — | ||||||||||||||||||||||
180 day | — | — | 7,592 | — | ||||||||||||||||||||||
EURIBOR | ||||||||||||||||||||||||||
30 day | — | — | — | — | ||||||||||||||||||||||
90 day | 1,091 | — | — | — | ||||||||||||||||||||||
180 day | 22,410 | — | — | — | ||||||||||||||||||||||
SOFR | ||||||||||||||||||||||||||
30 day | 410,532 | 275,000 | 48,591 | 75,000 | ||||||||||||||||||||||
90 day | 624,494 | 50,000 | 103,206 | — | ||||||||||||||||||||||
180 day | 44,003 | — | 16,177 | — | ||||||||||||||||||||||
UK LIBOR | ||||||||||||||||||||||||||
90 day | 20,451 | — | — | — | ||||||||||||||||||||||
Fixed rate | 145,908 | — | 59,856 | — |
Exhibit | Description | |||||||
Amendment No. 1, dated as of June 28, 2023, to that certain Senior Secured Credit Agreement, dated as of March 25, 2022, as amended prior to June 28, 2023, among the Company, the Subsidiary Guarantor, the lenders named therein and the Administrative Agent (incorporated by reference to Exhibit 10.1 of the Company's Current Report on Form 8-K, filed July 5, 2023).(1) | ||||||||
Amendment No. 1, dated as of July 5, 2023 to the Loan and Security Agreement dated as of February 24, 2023, among OSCF Lending SPV, the Company, the Lenders party thereto, Citibank, N.A., Virtus Group, LP and JPM.* (1) | ||||||||
Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.* | ||||||||
Certification of Chief Financial Officer (Principal Financial Officer) Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.* | ||||||||
Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.* | ||||||||
Certification of Chief Financial Officer (Principal Financial Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.* | ||||||||
101.INS* | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||||||
101.SCH* | Inline XBRL Taxonomy Extension Schema Document. | |||||||
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |||||||
101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document. | |||||||
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |||||||
104* | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
* | Filed herewith. |
(1) | Schedules and exhibits to this Exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company undertakes to furnish supplemental copies of any of the omitted schedules and exhibits to the Securities and Exchange Commission upon request. |
OAKTREE STRATEGIC CREDIT FUND | ||||||||
By: | /s/ Armen Panossian | |||||||
Armen Panossian | ||||||||
Chairman, Chief Executive Officer and Chief Investment Officer | ||||||||
By: | /s/ Christopher McKown | |||||||
Christopher McKown | ||||||||
Chief Financial Officer and Treasurer |
OSCF LENDING SPV, LLC, as Company | |||||
By: | Oaktree Strategic Credit Fund | ||||
Its: | Managing Member | ||||
By: | Oaktree Fund Advisors, LLC | ||||
Its: | Investment Advisor | ||||
By: | /s/ | ||||
Name: | Matthew Stewart | ||||
Title: | Managing Director |
By: | /s/ | ||||
Name: | Mary Gallegly | ||||
Title: | Managing Director |
Oaktree Strategic Credit Fund, as Parent | |||||
By: | Oaktree Fund Advisors, LLC | ||||
Its: | Investment Advisor | ||||
By: | /s/ | ||||
Name: | Matthew Stewart | ||||
Title: | Managing Director |
By: | /s/ | ||||
Name: | Mary Gallegly | ||||
Title: | Managing Director |
Oaktree Strategic Credit Fund, as Servicer | |||||
By: | Oaktree Fund Advisors, LLC | ||||
Its: | Investment Advisor | ||||
By: | /s/ | ||||
Name: | Matthew Stewart | ||||
Title: | Managing Director |
By: | /s/ | ||||
Name: | Mary Gallegly | ||||
Title: | Managing Director |
JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, as Administrative Agent | |||||
By: | /s/ | ||||
Name: | James Greenfield | ||||
Title: | Executive Director |
JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, as Lender | |||||
By: | /s/ | ||||
Name: | James Greenfield | ||||
Title: | Executive Director |
CITIBANK, N.A., as Collateral Agent | |||||
By: | /s/ | ||||
Name: | Veronica Rayo | ||||
Title: | Senior Trust Officer |
CITIBANK, N.A., as Securities Intermediary | |||||
By: | /s/ | ||||
Name: | Veronica Rayo | ||||
Title: | Senior Trust Officer |
VIRTUS GROUP, LP, as Collateral Administrator | |||||
By: | Rocket Partners Holdings, LLC, its General Partner | ||||
By: | /s/ | ||||
Name: | Paul Plank | ||||
Title: | Authorized Signatory |
Period Start Date | Period End Date | Minimum Funding Amount (as a percentage of aggregate Financing Commitments) | ||||||
Effective Date | May 24, 2023 | 15.0015.0% | ||||||
May 25, 2023 | Last day of the Ramp-Up PeriodJune 29, 2023 | 45.0045.0% | ||||||
First day following the Ramp-Up PeriodJune 30, 2023 | November 24July 30, 2023 | 60.0016.7% | ||||||
July 31, 2023 | September 30, 2023 | 33.3% | ||||||
October 1, 2023 | December 30, 2023 | 45.0% | ||||||
December 31, 2023 | March 30, 2024 | 60.0% | ||||||
November 25March 31, 20232024 | Last day of the Reinvestment Period | 75.0075.0% |
By: | /s/ Armen Panossian | |||||||
Armen Panossian Chief Executive Officer |
By: | /s/ Christopher McKown | |||||||
Christopher McKown Chief Financial Officer |
/s/ Armen Panossian | ||
Name: Armen Panossian | ||
Date: August 8, 2023 |
/s/ Christopher McKown | ||
Name: Christopher McKown | ||
Date: August 8, 2023 |
Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands |
Jun. 30, 2023 |
Sep. 30, 2022 |
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||||||
Investment owned, fair value | $ 1,279,166 | $ 428,556 | ||||||||||||||||||
Cash and cash equivalents | 76,603 | 58,443 | ||||||||||||||||||
Restricted cash | 3,605 | 0 | ||||||||||||||||||
Interest receivable | 9,750 | 3,297 | ||||||||||||||||||
Receivables from unsettled transactions | 24,640 | 3,920 | ||||||||||||||||||
Deferred financing costs | 10,638 | 3,295 | ||||||||||||||||||
Deferred offering costs | 402 | 2,132 | ||||||||||||||||||
Derivative asset at fair value | 255 | 13 | ||||||||||||||||||
Other assets | 585 | 438 | ||||||||||||||||||
Total assets | 1,407,549 | 501,496 | ||||||||||||||||||
Liabilities: | ||||||||||||||||||||
Accounts payable, accrued expenses and other liabilities | 2,240 | 1,107 | ||||||||||||||||||
Dividends payable | 7,994 | 3,657 | ||||||||||||||||||
Base management fee and incentive fee payable | 3,881 | 0 | ||||||||||||||||||
Payable for share repurchases | 40 | 0 | ||||||||||||||||||
Interest payable | 1,625 | 469 | ||||||||||||||||||
Payables from unsettled transactions | 45,089 | 51,566 | ||||||||||||||||||
Deferred tax liability | 1 | 44 | ||||||||||||||||||
Credit facilities payable | 325,000 | 75,000 | ||||||||||||||||||
Total liabilities | 392,635 | 134,769 | ||||||||||||||||||
Commitments and contingencies (Note 11) | ||||||||||||||||||||
Net assets: | ||||||||||||||||||||
Common shares, $0.01 par value per share; unlimited shares authorized, 43,219 and 15,628 shares issued and outstanding as of June 30, 2023 and September 30, 2022, respectively | 432 | 156 | ||||||||||||||||||
Additional paid-in-capital | 1,026,447 | 380,646 | ||||||||||||||||||
Accumulated distributable earnings (loss) | (11,965) | (14,075) | ||||||||||||||||||
Total net assets (equivalent to $23.48 and $23.47 per common share as of June 30, 2023 and September 30, 2022, respectively) (Note 10) | 1,014,914 | 366,727 | ||||||||||||||||||
Total liabilities and net assets | 1,407,549 | 501,496 | ||||||||||||||||||
Affiliated Entity | ||||||||||||||||||||
Assets: | ||||||||||||||||||||
Due from affiliates | 1,905 | 1,402 | ||||||||||||||||||
Liabilities: | ||||||||||||||||||||
Due to affiliates | 6,765 | 2,926 | ||||||||||||||||||
Non-control/Non-affiliate | ||||||||||||||||||||
Assets: | ||||||||||||||||||||
Investment owned, fair value | $ 1,279,166 | [1],[2],[3],[4] | $ 428,556 | [5],[6],[7],[8] | ||||||||||||||||
|
Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($) $ in Thousands |
Jun. 30, 2023 |
May 31, 2023 |
Apr. 30, 2023 |
Mar. 31, 2023 |
Feb. 28, 2023 |
Jan. 31, 2023 |
Dec. 31, 2022 |
Nov. 30, 2022 |
Oct. 31, 2022 |
Sep. 30, 2022 |
Aug. 31, 2022 |
Jul. 31, 2022 |
Jun. 30, 2022 |
May 31, 2022 |
Mar. 31, 2022 |
Feb. 03, 2022 |
Dec. 10, 2021 |
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Investment owned, at cost | $ 1,282,585 | $ 444,725 | |||||||||||||||||||||||||||||||||
Common stock, par value, (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 | ||||||||||||||||||||||||||||||||
Common stock, shares issued (in shares) | 43,219,000 | 15,628,000 | |||||||||||||||||||||||||||||||||
Common stock, shares outstanding (in shares) | 43,219,000 | 15,628,000 | 11,301,000 | ||||||||||||||||||||||||||||||||
Net asset value per common share (dollars per share) | $ 23.48 | $ 23.47 | $ 23.71 | ||||||||||||||||||||||||||||||||
Common Class I | |||||||||||||||||||||||||||||||||||
Common stock, par value, (in dollars per share) | $ 0.01 | $ 0.01 | |||||||||||||||||||||||||||||||||
Common stock, shares outstanding (in shares) | 29,495,000 | 22,379,000 | 13,040,000 | 11,301,000 | 4,000,000 | 1,000,000 | |||||||||||||||||||||||||||||
Net asset value per common share (dollars per share) | $ 23.48 | $ 23.23 | $ 23.40 | $ 23.42 | $ 23.56 | $ 23.64 | $ 23.23 | $ 23.46 | $ 23.33 | $ 23.47 | $ 24.03 | $ 23.98 | $ 23.71 | $ 24.32 | $ 25.04 | $ 0 | |||||||||||||||||||
Common Class S | |||||||||||||||||||||||||||||||||||
Common stock, par value, (in dollars per share) | $ 0.01 | $ 0.01 | |||||||||||||||||||||||||||||||||
Common stock, shares outstanding (in shares) | 13,723,000 | 8,572,000 | 2,588,000 | ||||||||||||||||||||||||||||||||
Net asset value per common share (dollars per share) | $ 23.48 | $ 23.23 | $ 23.40 | $ 23.42 | $ 23.56 | $ 23.64 | $ 23.23 | $ 23.46 | $ 23.33 | $ 23.47 | $ 24.03 | $ 23.98 | $ 0 | $ 0 | |||||||||||||||||||||
Non-control/Non-affiliate | |||||||||||||||||||||||||||||||||||
Investment owned, at cost | $ 1,282,585 | [1],[2],[3],[4] | $ 444,725 | [5],[6],[7],[8] | |||||||||||||||||||||||||||||||
|
Consolidated Statements of Assets and Liabilities - Supplemental Information - USD ($) $ in Thousands |
Jun. 30, 2023 |
May 31, 2023 |
Apr. 30, 2023 |
Mar. 31, 2023 |
Feb. 28, 2023 |
Jan. 31, 2023 |
Dec. 31, 2022 |
Nov. 30, 2022 |
Oct. 31, 2022 |
Sep. 30, 2022 |
Aug. 31, 2022 |
Jul. 31, 2022 |
Jun. 30, 2022 |
May 31, 2022 |
Mar. 31, 2022 |
Dec. 10, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common shares outstanding at end of period (shares) | 43,219,000 | 15,628,000 | 11,301,000 | |||||||||||||
Net asset value per common share (dollars per share) | $ 23.48 | $ 23.47 | $ 23.71 | |||||||||||||
Common Class I | ||||||||||||||||
Net assets | $ 692,668 | $ 524,123 | $ 305,989 | $ 267,967 | $ 100,172 | $ 25,000 | ||||||||||
Common shares outstanding at end of period (shares) | 29,495,000 | 22,379,000 | 13,040,000 | 11,301,000 | 4,000,000 | 1,000,000 | ||||||||||
Net asset value per common share (dollars per share) | $ 23.48 | $ 23.23 | $ 23.40 | $ 23.42 | $ 23.56 | $ 23.64 | $ 23.23 | $ 23.46 | $ 23.33 | $ 23.47 | $ 24.03 | $ 23.98 | $ 23.71 | $ 24.32 | $ 25.04 | $ 0 |
Common Class S | ||||||||||||||||
Net assets | $ 322,231 | $ 200,737 | $ 60,738 | |||||||||||||
Common shares outstanding at end of period (shares) | 13,723,000 | 8,572,000 | 2,588,000 | |||||||||||||
Net asset value per common share (dollars per share) | $ 23.48 | 23.23 | 23.40 | $ 23.42 | 23.56 | 23.64 | 23.23 | 23.46 | 23.33 | $ 23.47 | 24.03 | 23.98 | 0 | 0 | ||
Common Class D | ||||||||||||||||
Net assets | $ 15 | $ 0 | $ 0 | |||||||||||||
Common shares outstanding at end of period (shares) | 1,000 | 0 | 0 | |||||||||||||
Net asset value per common share (dollars per share) | $ 23.48 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 |
Consolidated Statements of Operations - USD ($) |
3 Months Ended | 7 Months Ended | 9 Months Ended | |
---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2022 |
Jun. 30, 2023 |
|
Revenues [Abstract] | ||||
Interest on cash and cash equivalents | $ 453,000 | $ 48,000 | $ 48,000 | $ 829,000 |
Total interest income | 30,681,000 | 3,571,000 | 5,107,000 | 66,103,000 |
Interest income, PIK | 1,107,000 | 10,000 | 20,000 | 2,195,000 |
Fee income | 654,000 | 93,000 | 113,000 | 882,000 |
Total investment income | 32,442,000 | 3,674,000 | 5,240,000 | 69,180,000 |
Expenses: | ||||
Base management fee | 2,817,000 | 286,000 | 286,000 | 6,183,000 |
Investment income incentive fee | 2,835,000 | 0 | 0 | 5,808,000 |
Professional fees | 401,000 | 212,000 | 415,000 | 1,589,000 |
Class S distribution and shareholder servicing fees | 589,000 | 0 | 0 | 1,116,000 |
Board of trustees fees | 66,000 | 90,000 | 150,000 | 198,000 |
Organization expenses | 0 | 549,000 | 549,000 | 4,000 |
Amortization of continuous offering costs | 725,000 | 255,000 | 255,000 | 2,517,000 |
Interest expense | 5,215,000 | 953,000 | 1,274,000 | 11,595,000 |
Administrator expense | 267,000 | 60,000 | 84,000 | 711,000 |
General and administrative expenses | 271,000 | 121,000 | 124,000 | 796,000 |
Total expenses | 13,186,000 | 2,526,000 | 3,137,000 | 30,517,000 |
Management and incentive fees waived | 0 | (286,000) | (286,000) | (1,642,000) |
Expense reimbursements (support) | 348,000 | (804,000) | (804,000) | (504,000) |
Net expenses | 13,534,000 | 1,436,000 | 2,047,000 | 28,371,000 |
Net investment income | 18,908,000 | 2,238,000 | 3,193,000 | 40,809,000 |
Unrealized appreciation (depreciation): | ||||
Foreign currency forward contracts | 757,000 | 0 | 0 | 242,000 |
Net unrealized appreciation (depreciation) | 6,783,000 | (11,946,000) | (11,968,000) | 11,995,000 |
Realized gains (losses): | ||||
Foreign currency forward contracts | (731,000) | 0 | 0 | (1,239,000) |
Net realized gains (losses) | (476,000) | (51,000) | (43,000) | (2,877,000) |
Provision for income tax (expense) benefit | (71,000) | (15,000) | (16,000) | (176,000) |
Net realized and unrealized gains (losses), net of taxes | 6,236,000 | (12,012,000) | (12,027,000) | 8,942,000 |
Net increase (decrease) in net assets resulting from operations | 25,144,000 | (9,774,000) | (8,834,000) | 49,751,000 |
Non-control/Non-affiliate | ||||
Revenues [Abstract] | ||||
Interest income | 30,228,000 | 3,523,000 | 5,059,000 | 65,274,000 |
Interest income, PIK | 1,107,000 | 10,000 | 20,000 | 2,195,000 |
Unrealized appreciation (depreciation): | ||||
Net unrealized appreciation (depreciation) | 6,026,000 | (11,946,000) | (11,968,000) | 11,753,000 |
Realized gains (losses): | ||||
Realized gain (loss) | $ 255,000 | $ (51,000) | $ (43,000) | $ (1,638,000) |
Consolidated Schedule of Investments € in Thousands, £ in Thousands, $ in Thousands |
Jun. 30, 2023
USD ($)
shares
|
Jun. 30, 2023
EUR (€)
shares
|
Jun. 30, 2023
GBP (£)
shares
|
Sep. 30, 2022
USD ($)
shares
|
Sep. 30, 2022
EUR (€)
shares
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Investment owned, at cost | $ 1,282,585 | $ 444,725 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | 1,279,166 | 428,556 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Money market funds, at carrying value | [1],[2],[3],[4] | 58,443 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total investment owned, at cost and money market funds, at carrying value | 1,362,793 | [5],[6],[7],[8] | 503,168 | [1],[2],[3],[4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Total investment owned, at fair value and money market funds, at carrying value | $ 1,359,374 | [5],[6],[7],[8] | $ 486,999 | [1],[2],[3],[4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
% of Net Assets | 126.03% | 126.03% | 126.03% | 116.86% | 116.86% | |||||||||||||||||||||||||||||||||||||||||||||||||||
Money market funds, percent of net assets | 7.90% | 7.90% | 7.90% | 15.90% | 15.90% | |||||||||||||||||||||||||||||||||||||||||||||||||||
Total portfolio investments, percent of net assets | 133.90% | 133.90% | 133.90% | 132.80% | 132.80% | |||||||||||||||||||||||||||||||||||||||||||||||||||
Non-control/Non-affiliate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | $ 1,282,585 | [5],[6],[7],[8] | $ 444,725 | [1],[2],[3],[4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | 1,279,166 | [5],[6],[7],[8] | $ 428,556 | [1],[2],[3],[4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Money market funds, at carrying value | $ 80,208 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
% of Net Assets | 126.00% | 126.00% | 126.00% | 116.90% | 116.90% | |||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: 107 Fair Street LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[12] | 12.50% | 12.50% | 12.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[12],[13] | $ 953 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[12] | 920 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[12] | $ 903 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: 107-109 Beech OAK22 LLC, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.00% | 11.00% | 11.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[13] | $ 9,393 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9] | 9,301 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9] | $ 9,125 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: 112-126 Van Houten Real22 LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[12] | 12.00% | 12.00% | 12.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[12],[13] | $ 2,996 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[12] | 2,959 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[12] | $ 2,944 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: AB BSL CLO 4, CLO Notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 5.50% | 5.50% | 5.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 10.46% | 10.46% | 10.46% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13],[14] | $ 3,800 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | 3,800 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 3,843 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 7.50% | [5],[6],[7],[8],[9],[10],[14] | 7.50% | [5],[6],[7],[8],[9],[10],[14] | 7.50% | [5],[6],[7],[8],[9],[10],[14] | 7.50% | [1],[2],[3],[4],[15],[16],[17] | 7.50% | [1],[2],[3],[4],[15],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 12.89% | [5],[6],[7],[8],[9],[10],[11],[14] | 12.89% | [5],[6],[7],[8],[9],[10],[11],[14] | 12.89% | [5],[6],[7],[8],[9],[10],[11],[14] | 11.20% | [1],[2],[3],[4],[15],[16],[17],[18] | 11.20% | [1],[2],[3],[4],[15],[16],[17],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 10,406 | [5],[6],[7],[8],[9],[10],[13],[14] | $ 10,406 | [1],[2],[3],[4],[15],[16],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 9,938 | [5],[6],[7],[8],[9],[10],[14] | 9,881 | [1],[2],[3],[4],[15],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 9,899 | [5],[6],[7],[8],[9],[10],[14] | $ 9,890 | [1],[2],[3],[4],[15],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 7.50% | [5],[6],[7],[8],[9],[10],[14] | 7.50% | [5],[6],[7],[8],[9],[10],[14] | 7.50% | [5],[6],[7],[8],[9],[10],[14] | 7.50% | [1],[2],[3],[4],[15],[16],[17],[20] | 7.50% | [1],[2],[3],[4],[15],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 0 | [5],[6],[7],[8],[9],[10],[13],[14] | $ 0 | [1],[2],[3],[4],[15],[16],[17],[19],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | (60) | [5],[6],[7],[8],[9],[10],[14] | (60) | [1],[2],[3],[4],[15],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | (60) | [5],[6],[7],[8],[9],[10],[14] | (58) | [1],[2],[3],[4],[15],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: ADC Therapeutics SA, Warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 275 | [5],[6],[7],[8],[9],[14] | 275 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 29 | [5],[6],[7],[8],[9],[14] | $ 115 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | 45,727 | [5],[6],[7],[8],[9],[14] | 45,727 | [5],[6],[7],[8],[9],[14] | 45,727 | [5],[6],[7],[8],[9],[14] | 45,727 | [1],[2],[3],[4],[16],[17] | 45,727 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp. Common Stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[16] | $ 428 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[16] | $ 409 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [1],[2],[3],[4],[16] | 4,560 | 4,560 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Common Stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9] | $ 428 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9] | $ 658 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [5],[6],[7],[8],[9] | 4,560 | 4,560 | 4,560 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: AIP RD Buyer Corp., Second Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 7.75% | [5],[6],[7],[8],[9],[10] | 7.75% | [5],[6],[7],[8],[9],[10] | 7.75% | [5],[6],[7],[8],[9],[10] | 7.75% | [1],[2],[3],[4],[15],[16] | 7.75% | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 12.95% | [5],[6],[7],[8],[9],[10],[11] | 12.95% | [5],[6],[7],[8],[9],[10],[11] | 12.95% | [5],[6],[7],[8],[9],[10],[11] | 10.88% | [1],[2],[3],[4],[15],[16],[18] | 10.88% | [1],[2],[3],[4],[15],[16],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 4,563 | [5],[6],[7],[8],[9],[10],[13] | $ 4,563 | [1],[2],[3],[4],[15],[16],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 4,489 | [5],[6],[7],[8],[9],[10] | 4,481 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 4,476 | [5],[6],[7],[8],[9],[10] | $ 4,403 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: APX Group Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[17] | 3.50% | 3.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 6.24% | 6.24% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[17],[19] | $ 1,995 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[17] | 1,881 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[17] | $ 1,891 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: APX Group Inc., Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 5.75% | 5.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[17],[19] | $ 275 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[17] | 229 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[17] | $ 218 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: ARES LXIV CLO, Multi-Sector Holdings, CLO Notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 3.75% | 3.75% | 3.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 8.74% | 8.74% | 8.74% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13],[14] | $ 2,200 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | 2,050 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 2,043 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 3.75% | 3.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 7.42% | 7.42% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 4,098 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 3,951 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 3,797 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Fixed Rate Bond 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 7.50% | 7.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[19] | $ 1,200 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4] | 1,158 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4] | $ 794 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: ASP Unifrax Holdings, Inc., Fixed Rate Bond 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 5.25% | 5.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[19] | $ 250 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4] | 222 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4] | $ 193 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 6.00% | [5],[6],[7],[8],[9],[10],[14] | 6.00% | [5],[6],[7],[8],[9],[10],[14] | 6.00% | [5],[6],[7],[8],[9],[10],[14] | 6.00% | [1],[2],[3],[4],[15],[16],[17],[20] | 6.00% | [1],[2],[3],[4],[15],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 0 | [5],[6],[7],[8],[9],[10],[13],[14] | $ 0 | [1],[2],[3],[4],[15],[16],[17],[19],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | (9) | [5],[6],[7],[8],[9],[10],[14] | (10) | [1],[2],[3],[4],[15],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ (29) | [5],[6],[7],[8],[9],[10],[14] | $ (14) | [1],[2],[3],[4],[15],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: ASP-R-PAC Acquisition Co LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 6.00% | [5],[6],[7],[8],[9],[10],[14] | 6.00% | [5],[6],[7],[8],[9],[10],[14] | 6.00% | [5],[6],[7],[8],[9],[10],[14] | 6.00% | [1],[2],[3],[4],[15],[16],[17] | 6.00% | [1],[2],[3],[4],[15],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 11.31% | [5],[6],[7],[8],[9],[10],[11],[14] | 11.31% | [5],[6],[7],[8],[9],[10],[11],[14] | 11.31% | [5],[6],[7],[8],[9],[10],[11],[14] | 9.67% | [1],[2],[3],[4],[15],[16],[17],[18] | 9.67% | [1],[2],[3],[4],[15],[16],[17],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 4,874 | [5],[6],[7],[8],[9],[10],[13],[14] | $ 4,911 | [1],[2],[3],[4],[15],[16],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 4,801 | [5],[6],[7],[8],[9],[10],[14] | 4,825 | [1],[2],[3],[4],[15],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 4,630 | [5],[6],[7],[8],[9],[10],[14] | $ 4,798 | [1],[2],[3],[4],[15],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Access CIG, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 3.75% | [5],[6],[7],[8],[10] | 3.75% | [5],[6],[7],[8],[10] | 3.75% | [5],[6],[7],[8],[10] | 3.75% | [1],[2],[3],[4],[15] | 3.75% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 8.94% | [5],[6],[7],[8],[10],[11] | 8.94% | [5],[6],[7],[8],[10],[11] | 8.94% | [5],[6],[7],[8],[10],[11] | 6.82% | [1],[2],[3],[4],[15],[18] | 6.82% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 3,312 | [5],[6],[7],[8],[10],[13] | $ 3,984 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 3,285 | [5],[6],[7],[8],[10] | 3,870 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 3,282 | [5],[6],[7],[8],[10] | $ 3,826 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Access CIG, LLC, Second Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 7.75% | [5],[6],[7],[8],[9],[10] | 7.75% | [5],[6],[7],[8],[9],[10] | 7.75% | [5],[6],[7],[8],[9],[10] | 7.75% | [1],[2],[3],[4],[15] | 7.75% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 12.94% | [5],[6],[7],[8],[9],[10],[11] | 12.94% | [5],[6],[7],[8],[9],[10],[11] | 12.94% | [5],[6],[7],[8],[9],[10],[11] | 10.82% | [1],[2],[3],[4],[15],[18] | 10.82% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 4,000 | [5],[6],[7],[8],[9],[10],[13] | $ 4,000 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 3,986 | [5],[6],[7],[8],[9],[10] | 3,982 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 3,777 | [5],[6],[7],[8],[9],[10] | $ 3,815 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Altice France S.A., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 4.00% | [5],[6],[7],[8],[10],[14] | 4.00% | [5],[6],[7],[8],[10],[14] | 4.00% | [5],[6],[7],[8],[10],[14] | 4.00% | [1],[2],[3],[4],[15],[17] | 4.00% | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.32% | [5],[6],[7],[8],[10],[11],[14] | 9.32% | [5],[6],[7],[8],[10],[11],[14] | 9.32% | [5],[6],[7],[8],[10],[11],[14] | 6.91% | [1],[2],[3],[4],[15],[17],[18] | 6.91% | [1],[2],[3],[4],[15],[17],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 8,962 | [5],[6],[7],[8],[10],[13],[14] | $ 1,995 | [1],[2],[3],[4],[15],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 8,732 | [5],[6],[7],[8],[10],[14] | 1,905 | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 8,452 | [5],[6],[7],[8],[10],[14] | $ 1,815 | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Altice France S.A., Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 5.50% | [5],[6],[7],[8],[10],[11],[14] | 5.50% | [5],[6],[7],[8],[10],[11],[14] | 5.50% | [5],[6],[7],[8],[10],[11],[14] | 5.50% | [1],[2],[3],[4],[15],[17],[18] | 5.50% | [1],[2],[3],[4],[15],[17],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 7,200 | [5],[6],[7],[8],[13],[14] | $ 3,200 | [1],[2],[3],[4],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 5,971 | [5],[6],[7],[8],[14] | 2,685 | [1],[2],[3],[4],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 5,156 | [5],[6],[7],[8],[14] | $ 2,416 | [1],[2],[3],[4],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 8.00% | 8.00% | 8.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 13.34% | 13.34% | 13.34% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 12,913 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 11,942 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 11,764 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | [5],[6],[7],[8],[9],[10] | 3.50% | 3.50% | 3.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Alto Pharmacy Holdings, Inc., Warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9] | $ 943 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9] | $ 760 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [5],[6],[7],[8],[9] | 244,370 | 244,370 | 244,370 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: American Auto Auction Group, LLC, Second Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 8.75% | [5],[6],[7],[8],[9],[10] | 8.75% | [5],[6],[7],[8],[9],[10] | 8.75% | [5],[6],[7],[8],[9],[10] | 8.75% | [1],[2],[3],[4],[15],[16] | 8.75% | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 13.99% | [5],[6],[7],[8],[9],[10],[11] | 13.99% | [5],[6],[7],[8],[9],[10],[11] | 13.99% | [5],[6],[7],[8],[9],[10],[11] | 12.30% | [1],[2],[3],[4],[15],[16],[18] | 12.30% | [1],[2],[3],[4],[15],[16],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 6,901 | [5],[6],[7],[8],[9],[10],[13] | $ 6,901 | [1],[2],[3],[4],[15],[16],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 6,791 | [5],[6],[7],[8],[9],[10] | 6,776 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 5,107 | [5],[6],[7],[8],[9],[10] | $ 6,211 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: American Rock Salt Company LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 4.00% | [5],[6],[7],[8],[10] | 4.00% | [5],[6],[7],[8],[10] | 4.00% | [5],[6],[7],[8],[10] | 4.00% | [1],[2],[3],[4],[15] | 4.00% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.22% | [5],[6],[7],[8],[10],[11] | 9.22% | [5],[6],[7],[8],[10],[11] | 9.22% | [5],[6],[7],[8],[10],[11] | 7.12% | [1],[2],[3],[4],[15],[18] | 7.12% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 17,376 | [5],[6],[7],[8],[10],[13] | $ 3,990 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 16,624 | [5],[6],[7],[8],[10] | 3,817 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 16,406 | [5],[6],[7],[8],[10] | $ 3,706 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: American Tire Distributors, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 6.25% | [5],[6],[7],[8],[10] | 6.25% | [5],[6],[7],[8],[10] | 6.25% | [5],[6],[7],[8],[10] | 6.25% | [1],[2],[3],[4],[15] | 6.25% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 11.49% | [5],[6],[7],[8],[10],[11] | 11.49% | [5],[6],[7],[8],[10],[11] | 11.49% | [5],[6],[7],[8],[10],[11] | 9.03% | [1],[2],[3],[4],[15],[18] | 9.03% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 7,660 | [5],[6],[7],[8],[10],[13] | $ 3,980 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 7,070 | [5],[6],[7],[8],[10] | 3,960 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 6,682 | [5],[6],[7],[8],[10] | $ 3,738 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Amynta Agency Borrower Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 5.00% | 5.00% | 5.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 10.20% | 10.20% | 10.20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 12,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | 11,662 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | $ 11,700 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Anastasia Parent, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 3.75% | [5],[6],[7],[8],[10] | 3.75% | [5],[6],[7],[8],[10] | 3.75% | [5],[6],[7],[8],[10] | 3.75% | [1],[2],[3],[4],[15] | 3.75% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.25% | [5],[6],[7],[8],[10],[11] | 9.25% | [5],[6],[7],[8],[10],[11] | 9.25% | [5],[6],[7],[8],[10],[11] | 7.42% | [1],[2],[3],[4],[15],[18] | 7.42% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 6,858 | [5],[6],[7],[8],[10],[13] | $ 6,912 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 5,757 | [5],[6],[7],[8],[10] | 5,802 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 5,293 | [5],[6],[7],[8],[10] | $ 5,530 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Apex Group Treasury LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[17] | 5.00% | 5.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 9.13% | 9.13% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[17],[19] | $ 6,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[17] | 5,610 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[17] | $ 5,865 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[16],[17],[20] | 6.50% | 6.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | € | [1],[2],[3],[4],[15],[16],[17],[19],[20] | € 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[16],[17],[20] | $ (280) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[16],[17],[20] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[14] | 6.75% | 6.75% | 6.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14] | 9.57% | 9.57% | 9.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | € | [5],[6],[7],[8],[9],[10],[13],[14] | € 9,600 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[14] | $ 9,608 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[14] | $ 10,568 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Ardonagh Midco 3 PLC, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[14],[21] | 7.00% | 7.00% | 7.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14],[21] | 12.22% | 12.22% | 12.22% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[14],[21] | $ 3,520 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[14],[21] | 3,338 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[14],[21] | $ 3,584 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Ares LXVIII CLO, Multi-Sector Holdings, CLO Notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 5.75% | 5.75% | 5.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 10.83% | 10.83% | 10.83% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13],[14] | $ 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 5,087 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Astra Acquisition Corp., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 5.25% | [5],[6],[7],[8],[10] | 5.25% | [5],[6],[7],[8],[10] | 5.25% | [5],[6],[7],[8],[10] | 5.25% | [1],[2],[3],[4],[15] | 5.25% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 10.44% | [5],[6],[7],[8],[10],[11] | 10.44% | [5],[6],[7],[8],[10],[11] | 10.44% | [5],[6],[7],[8],[10],[11] | 8.37% | [1],[2],[3],[4],[15],[18] | 8.37% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 4,848 | [5],[6],[7],[8],[10],[13] | $ 4,848 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 4,609 | [5],[6],[7],[8],[10] | 4,577 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 3,417 | [5],[6],[7],[8],[10] | $ 4,145 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 4.00% | 4.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 7.65% | 7.65% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 4,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 3,803 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 3,423 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 4.00% | 4.00% | 4.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 9.20% | 9.20% | 9.20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 3,970 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | 3,799 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | $ 3,768 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, First Lien Term Loan 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 4.25% | 4.25% | 4.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 9.47% | 9.47% | 9.47% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 5,985 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | 5,653 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | $ 5,706 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Asurion, LLC, Second Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 5.25% | [5],[6],[7],[8],[10] | 5.25% | [5],[6],[7],[8],[10] | 5.25% | [5],[6],[7],[8],[10] | 5.25% | [1],[2],[3],[4],[15] | 5.25% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 10.47% | [5],[6],[7],[8],[10],[11] | 10.47% | [5],[6],[7],[8],[10],[11] | 10.47% | [5],[6],[7],[8],[10],[11] | 8.37% | [1],[2],[3],[4],[15],[18] | 8.37% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 7,500 | [5],[6],[7],[8],[10],[13] | $ 8,500 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 6,854 | [5],[6],[7],[8],[10] | 7,628 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 6,311 | [5],[6],[7],[8],[10] | $ 6,545 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Avalara, Inc., First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 7.25% | 7.25% | 7.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (42) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (38) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Avalara, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 7.25% | 7.25% | 7.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 12.49% | 12.49% | 12.49% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 19,029 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 18,609 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 18,648 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: BYJU's Alpha, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[17] | 6.00% | 6.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 8.98% | 8.98% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[17],[19] | $ 4,975 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[17] | 4,925 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[17] | $ 3,646 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Battery Park CLO II Ltd, CLO Notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[17] | 8.36% | 8.36% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 12.41% | 12.41% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[17],[19] | $ 1,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[17] | 1,326 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[17] | 1,326 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., First Lien Term Loan 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[16],[17],[19],[20] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[16],[17],[20] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[16],[17],[20] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 8.00% | [5],[6],[7],[8],[9],[10],[11],[14] | 8.00% | [5],[6],[7],[8],[9],[10],[11],[14] | 8.00% | [5],[6],[7],[8],[9],[10],[11],[14] | 10.25% | [1],[2],[3],[4],[15],[16],[17],[18],[20] | 10.25% | [1],[2],[3],[4],[15],[16],[17],[18],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 3,202 | [5],[6],[7],[8],[9],[13],[14] | $ 3,130 | [1],[2],[3],[4],[16],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 3,098 | [5],[6],[7],[8],[9],[14] | 3,005 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 2,994 | [5],[6],[7],[8],[9],[14] | 3,007 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | [5],[6],[7],[8],[9],[14] | 2.25% | 2.25% | 2.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 1,530 | [5],[6],[7],[8],[9],[13],[14],[22] | 0 | [1],[2],[3],[4],[16],[17],[19],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 1,530 | [5],[6],[7],[8],[9],[14],[22] | 0 | [1],[2],[3],[4],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 1,492 | [5],[6],[7],[8],[9],[14],[22] | 0 | [1],[2],[3],[4],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., First Lien Term Loan 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14],[21] | 8.00% | 8.00% | 8.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 0 | [5],[6],[7],[8],[9],[13],[14],[21] | 1,384 | [1],[2],[3],[4],[16],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 0 | [5],[6],[7],[8],[9],[14],[21] | 1,384 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 0 | [5],[6],[7],[8],[9],[14],[21] | 1,384 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | [5],[6],[7],[8],[9],[14],[21] | 2.25% | 2.25% | 2.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., First Lien Term Loan 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[13],[14],[21],[22] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14],[21],[22] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14],[21],[22] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., First Lien Term Loan 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14],[21] | 8.00% | 8.00% | 8.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[13],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14],[21] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | [5],[6],[7],[8],[9],[14],[21] | 2.25% | 2.25% | 2.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., First Lien Term Loan 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[13],[14],[21],[22] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14],[21],[22] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14],[21],[22] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: BioXcel Therapeutics, Inc., Warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 74 | [5],[6],[7],[8],[9],[14] | 74 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 16 | [5],[6],[7],[8],[9],[14] | $ 58 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | 12,453 | [5],[6],[7],[8],[9],[14] | 12,453 | [5],[6],[7],[8],[9],[14] | 12,453 | [5],[6],[7],[8],[9],[14] | 12,453 | [1],[2],[3],[4],[16],[17] | 12,453 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Blackhawk Network Holdings, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 3.00% | 3.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 6.03% | 6.03% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 7,020 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 6,780 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 6,581 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Boxer Parent Company Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 3.75% | 3.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 6.87% | 6.87% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 7,965 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 7,644 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 7,570 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Boxer Parent Company Inc., Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 7.13% | 7.13% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[19] | $ 500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4] | 483 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4] | $ 491 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: CCO Holdings LLC, Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 4.50% | [5],[6],[7],[8],[10],[11],[14] | 4.50% | [5],[6],[7],[8],[10],[11],[14] | 4.50% | [5],[6],[7],[8],[10],[11],[14] | 4.50% | [1],[2],[3],[4],[15],[17],[18] | 4.50% | [1],[2],[3],[4],[15],[17],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 6,281 | [5],[6],[7],[8],[13],[14] | $ 1,281 | [1],[2],[3],[4],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 5,127 | [5],[6],[7],[8],[14] | 1,064 | [1],[2],[3],[4],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 5,021 | [5],[6],[7],[8],[14] | $ 979 | [1],[2],[3],[4],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: CD&R Firefly Bidco Limited, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 6.00% | 6.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 10.18% | 10.18% | 10.18% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | £ | [5],[6],[7],[8],[10],[13],[14] | £ 16,086 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | $ 19,150 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 19,863 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: CITGO Petroleum Corp., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 6.25% | 6.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 9.37% | 9.37% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 3,979 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 3,950 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 3,990 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: CVAUSA Management, LLC, Health Care Services, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (75) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (73) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: CVAUSA Management, LLC, Health Care Services, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.59% | 11.59% | 11.59% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 13,658 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 13,254 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 13,264 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: CVAUSA Management, LLC, Health Care Services, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (202) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (197) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: CVAUSA Management, LLC, Health Care Services, First Lien Term Loan 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (86) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (82) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Carvana Co., Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 5.63% | 5.63% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[17],[19] | $ 800 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[17] | 696 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[17] | $ 564 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Cengage Learning, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 4.75% | 4.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 7.81% | 7.81% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 7,592 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 7,265 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 6,893 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 3.50% | 3.50% | 3.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 8.81% | 8.81% | 8.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13],[14] | $ 6,915 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | 6,489 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 6,618 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[17] | 3.50% | 3.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 6.31% | 6.31% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[17],[19] | $ 6,969 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[17] | 6,438 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[17] | $ 6,246 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 5.13% | 5.13% | 5.13% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[13],[14] | $ 726 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[14] | 640 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[14] | $ 660 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Fixed Rate Bond 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 5.13% | 5.13% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[17],[19] | $ 726 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[17] | 627 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[17] | $ 614 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Clear Channel Outdoor Holdings, Inc., Fixed Rate Bond 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 7.75% | 7.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[17],[19] | $ 174 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[17] | 167 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[17] | $ 132 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Colony Holding Corporation, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.65% | 11.65% | 11.65% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 12,148 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 11,826 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 11,820 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Colony Holding Corporation, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.75% | 11.75% | 11.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 3,950 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 3,875 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 3,843 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Condor Merger Sub Inc., Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 7.38% | [5],[6],[7],[8],[10],[11] | 7.38% | [5],[6],[7],[8],[10],[11] | 7.38% | [5],[6],[7],[8],[10],[11] | 7.38% | [1],[2],[3],[4],[15],[18] | 7.38% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 4,527 | [5],[6],[7],[8],[13] | $ 4,527 | [1],[2],[3],[4],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 4,504 | [5],[6],[7],[8] | 4,502 | [1],[2],[3],[4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 3,941 | [5],[6],[7],[8] | $ 3,710 | [1],[2],[3],[4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Convergeone Holdings, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 5.00% | [5],[6],[7],[8],[10] | 5.00% | [5],[6],[7],[8],[10] | 5.00% | [5],[6],[7],[8],[10] | 5.00% | [1],[2],[3],[4],[15] | 5.00% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 10.37% | [5],[6],[7],[8],[10],[11] | 10.37% | [5],[6],[7],[8],[10],[11] | 10.37% | [5],[6],[7],[8],[10],[11] | 8.12% | [1],[2],[3],[4],[15],[18] | 8.12% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 4,936 | [5],[6],[7],[8],[10],[13] | $ 4,974 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 4,599 | [5],[6],[7],[8],[10] | 4,534 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 3,151 | [5],[6],[7],[8],[10] | $ 3,589 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 7.50% | 7.50% | 7.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (22) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (21) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 7.50% | 7.50% | 7.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 12.60% | 12.60% | 12.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 13,464 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 13,143 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 13,152 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Coupa Holdings, LLC, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 7.50% | 7.50% | 7.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (15) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (14) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Covetrus, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 5.00% | [5],[6],[7],[8],[10] | 5.00% | [5],[6],[7],[8],[10] | 5.00% | [5],[6],[7],[8],[10] | 5.00% | [1],[2],[3],[4],[15] | 5.00% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 10.24% | [5],[6],[7],[8],[10],[11] | 10.24% | [5],[6],[7],[8],[10],[11] | 10.24% | [5],[6],[7],[8],[10],[11] | 7.65% | [1],[2],[3],[4],[15],[18] | 7.65% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 21,036 | [5],[6],[7],[8],[10],[13] | $ 7,589 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 19,933 | [5],[6],[7],[8],[10] | 7,134 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 19,643 | [5],[6],[7],[8],[10] | $ 7,108 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Cuppa Bidco BV, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 4.75% | 4.75% | 4.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 8.68% | 8.68% | 8.68% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | € | [5],[6],[7],[8],[10],[13],[14] | € 10,940 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | $ 9,499 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 10,649 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 4.00% | 4.00% | 4.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 9.54% | 9.54% | 9.54% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13],[14] | $ 1,985 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | 1,945 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 1,977 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Curium Bidco S.à.r.l., First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 4.25% | 4.25% | 4.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 9.79% | 9.79% | 9.79% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13],[14] | $ 2,982 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | 2,926 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 2,966 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: DTI Holdco, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 4.75% | [5],[6],[7],[8],[10] | 4.75% | [5],[6],[7],[8],[10] | 4.75% | [5],[6],[7],[8],[10] | 4.75% | [1],[2],[3],[4],[15] | 4.75% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.80% | [5],[6],[7],[8],[10],[11] | 9.80% | [5],[6],[7],[8],[10],[11] | 9.80% | [5],[6],[7],[8],[10],[11] | 7.33% | [1],[2],[3],[4],[15],[18] | 7.33% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 13,176 | [5],[6],[7],[8],[10],[13] | $ 8,000 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 12,587 | [5],[6],[7],[8],[10] | 7,739 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 12,299 | [5],[6],[7],[8],[10] | $ 7,616 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Dealer Tire Financial, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 4.50% | 4.50% | 4.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 9.60% | 9.60% | 9.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 11,151 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | 11,075 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | 11,123 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Dealer Tire, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 4.25% | 4.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 7.37% | 7.37% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 3,985 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 3,833 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 3,893 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Delivery Hero FinCo LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[17] | 5.75% | 5.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 8.49% | 8.49% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[17],[19] | $ 4,988 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[17] | 4,890 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[17] | 4,757 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Common Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[16],[17] | 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[16],[17] | $ 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [1],[2],[3],[4],[16],[17] | 2 | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Common Stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14] | 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14] | $ 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [5],[6],[7],[8],[9],[14] | 2 | 2 | 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Preferred Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | $ 330 | [5],[6],[7],[8],[9],[14] | $ 330 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 330 | [5],[6],[7],[8],[9],[14] | $ 330 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | 330 | [5],[6],[7],[8],[9],[14] | 330 | [5],[6],[7],[8],[9],[14] | 330 | [5],[6],[7],[8],[9],[14] | 330 | [1],[2],[3],[4],[16],[17] | 330 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Subordinated Debt Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14],[21] | 3.00% | 3.00% | 3.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[13],[14],[21] | $ 10,300 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14],[21] | 10,300 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14],[21] | $ 10,300 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | [5],[6],[7],[8],[9],[14],[21] | 7.00% | 7.00% | 7.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Subordinated Draw Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[16],[17],[18],[20] | 10.00% | 10.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[16],[17],[19],[20] | $ 3,303 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[16],[17],[20] | 3,303 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[16],[17],[20] | 3,303 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Delta Leasing SPV II LLC, Warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | $ 0 | [5],[6],[7],[8],[9],[14] | 0 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 0 | [5],[6],[7],[8],[9],[14] | $ 0 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | 25 | [5],[6],[7],[8],[9],[14] | 25 | [5],[6],[7],[8],[9],[14] | 25 | [5],[6],[7],[8],[9],[14] | 25 | [1],[2],[3],[4],[16],[17] | 25 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 5.00% | [5],[6],[7],[8],[10] | 5.00% | [5],[6],[7],[8],[10] | 5.00% | [5],[6],[7],[8],[10] | 5.00% | [1],[2],[3],[4],[15] | 5.00% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 10.22% | [5],[6],[7],[8],[10],[11] | 10.22% | [5],[6],[7],[8],[10],[11] | 10.22% | [5],[6],[7],[8],[10],[11] | 8.12% | [1],[2],[3],[4],[15],[18] | 8.12% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 13,801 | [5],[6],[7],[8],[10],[13] | $ 7,623 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 13,383 | [5],[6],[7],[8],[10] | 7,321 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 13,523 | [5],[6],[7],[8],[10] | $ 7,120 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: DirecTV Financing, LLC, Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 5.88% | [5],[6],[7],[8],[10],[11] | 5.88% | [5],[6],[7],[8],[10],[11] | 5.88% | [5],[6],[7],[8],[10],[11] | 5.88% | [1],[2],[3],[4],[15],[18] | 5.88% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 1,750 | [5],[6],[7],[8],[13] | $ 750 | [1],[2],[3],[4],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 1,585 | [5],[6],[7],[8] | 670 | [1],[2],[3],[4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 1,587 | [5],[6],[7],[8] | $ 648 | [1],[2],[3],[4] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Domtar Corp, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 5.50% | 5.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 8.26% | 8.26% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 2,977 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 2,953 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 2,847 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Dukes Root Control Inc., First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[21] | 11.72% | 11.72% | 11.72% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 580 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 551 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ 551 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Dukes Root Control Inc., First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.56% | 11.56% | 11.56% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 11,834 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 11,593 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 11,596 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Dukes Root Control Inc., First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[21] | 11.84% | 11.84% | 11.84% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 667 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 635 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ 609 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Eagle Parent Corp., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 4.25% | 4.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 7.80% | 7.80% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 2,985 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 2,916 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 2,912 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 3.00% | [5],[6],[7],[8],[9],[10],[11],[14] | 3.00% | [5],[6],[7],[8],[9],[10],[11],[14] | 3.00% | [5],[6],[7],[8],[9],[10],[11],[14] | 3.00% | [1],[2],[3],[4],[15],[16],[17],[18],[20] | 3.00% | [1],[2],[3],[4],[15],[16],[17],[18],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 10,883 | [5],[6],[7],[8],[9],[13],[14] | $ 10,403 | [1],[2],[3],[4],[16],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 10,764 | [5],[6],[7],[8],[9],[14] | 10,260 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 10,448 | [5],[6],[7],[8],[9],[14] | $ 10,216 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | 6.00% | [5],[6],[7],[8],[9],[14] | 6.00% | [5],[6],[7],[8],[9],[14] | 6.00% | [5],[6],[7],[8],[9],[14] | 6.00% | [1],[2],[3],[4],[16],[17],[20] | 6.00% | [1],[2],[3],[4],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14] | 3.00% | 3.00% | 3.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 1,743 | [5],[6],[7],[8],[9],[13],[14] | $ 0 | [1],[2],[3],[4],[16],[17],[19],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 1,717 | [5],[6],[7],[8],[9],[14] | 3 | [1],[2],[3],[4],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 1,673 | [5],[6],[7],[8],[9],[14] | $ 0 | [1],[2],[3],[4],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | [5],[6],[7],[8],[9],[14] | 6.00% | 6.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., First Lien Term Loan 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14],[21] | 3.00% | 3.00% | 3.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[13],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14],[21] | 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | [5],[6],[7],[8],[9],[14],[21] | 6.00% | 6.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Establishment Labs Holdings Inc., First Lien Term Loan 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14],[21] | 3.00% | 3.00% | 3.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[13],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14],[21] | 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | [5],[6],[7],[8],[9],[14],[21] | 6.00% | 6.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 3.75% | [5],[6],[7],[8],[10],[14] | 3.75% | [5],[6],[7],[8],[10],[14] | 3.75% | [5],[6],[7],[8],[10],[14] | 3.75% | [1],[2],[3],[4],[15],[17] | 3.75% | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.00% | [5],[6],[7],[8],[10],[11],[14] | 9.00% | [5],[6],[7],[8],[10],[11],[14] | 9.00% | [5],[6],[7],[8],[10],[11],[14] | 7.44% | [1],[2],[3],[4],[15],[17],[18] | 7.44% | [1],[2],[3],[4],[15],[17],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 15,906 | [5],[6],[7],[8],[10],[13],[14] | $ 1,995 | [1],[2],[3],[4],[15],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 15,462 | [5],[6],[7],[8],[10],[14] | 1,953 | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 15,456 | [5],[6],[7],[8],[10],[14] | $ 1,864 | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Frontier Communications Holdings, LLC, Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 6.00% | [5],[6],[7],[8],[10],[11],[14] | 6.00% | [5],[6],[7],[8],[10],[11],[14] | 6.00% | [5],[6],[7],[8],[10],[11],[14] | 6.00% | [1],[2],[3],[4],[15],[17],[18] | 6.00% | [1],[2],[3],[4],[15],[17],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 7,517 | [5],[6],[7],[8],[13],[14] | $ 4,017 | [1],[2],[3],[4],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 6,276 | [5],[6],[7],[8],[14] | 3,493 | [1],[2],[3],[4],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 5,536 | [5],[6],[7],[8],[14] | $ 3,164 | [1],[2],[3],[4],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 7.25% | 7.25% | 7.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[21] | 12.34% | 12.34% | 12.34% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 1,397 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 1,305 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ 1,307 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Galileo Parent, Inc., Aerospace & Defense, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 7.25% | 7.25% | 7.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 12.34% | 12.34% | 12.34% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 20,277 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 19,685 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 19,697 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Gibson Brands, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 5.00% | [5],[6],[7],[8],[9],[10] | 5.00% | [5],[6],[7],[8],[9],[10] | 5.00% | [5],[6],[7],[8],[9],[10] | 5.00% | [1],[2],[3],[4],[15],[16] | 5.00% | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 10.25% | [5],[6],[7],[8],[9],[10],[11] | 10.25% | [5],[6],[7],[8],[9],[10],[11] | 10.25% | [5],[6],[7],[8],[9],[10],[11] | 7.94% | [1],[2],[3],[4],[15],[16],[18] | 7.94% | [1],[2],[3],[4],[15],[16],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 4,930 | [5],[6],[7],[8],[9],[10],[13] | $ 4,967 | [1],[2],[3],[4],[15],[16],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 4,777 | [5],[6],[7],[8],[9],[10] | 4,793 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 3,993 | [5],[6],[7],[8],[9],[10] | $ 4,024 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Global Aircraft Leasing Co Ltd, Trading Companies & Distributors, Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[13],[14] | $ 7,645 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[14] | 6,954 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[14] | $ 7,007 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: GoldenTree Loan Management EUR CLO 2 DAC, CLO Notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 2.85% | 2.85% | 2.85% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 6.05% | 6.05% | 6.05% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | € | [5],[6],[7],[8],[10],[13],[14] | € 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | $ 872 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 970 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 8.00% | [5],[6],[7],[8],[9],[10],[21] | 8.00% | [5],[6],[7],[8],[9],[10],[21] | 8.00% | [5],[6],[7],[8],[9],[10],[21] | 8.00% | [1],[2],[3],[4],[15],[16],[20] | 8.00% | [1],[2],[3],[4],[15],[16],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 0 | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | [1],[2],[3],[4],[15],[16],[19],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | (28) | [5],[6],[7],[8],[9],[10],[21] | (33) | [1],[2],[3],[4],[15],[16],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ (18) | [5],[6],[7],[8],[9],[10],[21] | $ (31) | [1],[2],[3],[4],[15],[16],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 8.00% | [5],[6],[7],[8],[9],[10] | 8.00% | [5],[6],[7],[8],[9],[10] | 8.00% | [5],[6],[7],[8],[9],[10] | 8.00% | [1],[2],[3],[4],[15],[16] | 8.00% | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 13.39% | [5],[6],[7],[8],[9],[10],[11] | 13.39% | [5],[6],[7],[8],[9],[10],[11] | 13.39% | [5],[6],[7],[8],[9],[10],[11] | 11.04% | [1],[2],[3],[4],[15],[16],[18] | 11.04% | [1],[2],[3],[4],[15],[16],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 17,551 | [5],[6],[7],[8],[9],[10],[13] | $ 17,684 | [1],[2],[3],[4],[15],[16],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 17,272 | [5],[6],[7],[8],[9],[10] | 17,350 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 17,376 | [5],[6],[7],[8],[9],[10] | $ 17,374 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Grove Hotel Parcel Owner, LLC, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 8.00% | [5],[6],[7],[8],[9],[10],[21] | 8.00% | [5],[6],[7],[8],[9],[10],[21] | 8.00% | [5],[6],[7],[8],[9],[10],[21] | 8.00% | [1],[2],[3],[4],[15],[16],[20] | 8.00% | [1],[2],[3],[4],[15],[16],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 0 | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | [1],[2],[3],[4],[15],[16],[19],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | (56) | [5],[6],[7],[8],[9],[10],[21] | (67) | [1],[2],[3],[4],[15],[16],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ (35) | [5],[6],[7],[8],[9],[10],[21] | $ (62) | [1],[2],[3],[4],[15],[16],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: HUB Pen Company, LLC, Other Specialty Retail, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[21] | 11.76% | 11.76% | 11.76% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 108 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ 24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: HUB Pen Company, LLC, Other Specialty Retail, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.76% | 11.76% | 11.76% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 27,404 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 26,680 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 26,708 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Harbor Purchaser Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 5.25% | [5],[6],[7],[8],[10] | 5.25% | [5],[6],[7],[8],[10] | 5.25% | [5],[6],[7],[8],[10] | 5.25% | [1],[2],[3],[4],[15] | 5.25% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 10.45% | [5],[6],[7],[8],[10],[11] | 10.45% | [5],[6],[7],[8],[10],[11] | 10.45% | [5],[6],[7],[8],[10],[11] | 8.38% | [1],[2],[3],[4],[15],[18] | 8.38% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 10,471 | [5],[6],[7],[8],[10],[13] | $ 8,550 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 10,064 | [5],[6],[7],[8],[10] | 8,197 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 8,992 | [5],[6],[7],[8],[10] | 7,813 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Harrow Health, Inc., First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[14] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14] | 11.74% | 11.74% | 11.74% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[14] | $ 9,319 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[14] | 9,108 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[14] | $ 9,127 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Harrow Health, Inc., First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[14],[21] | 6.50% | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[14],[21] | (114) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[14],[21] | $ (103) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Horizon Aircraft Finance I Ltd., CLO Notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 4.46% | 4.46% | 4.46% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[13],[14] | $ 3,081 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[14] | 2,479 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[14] | $ 2,667 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: IAMGOLD Corporation, Gold, Second Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[14] | 8.25% | 8.25% | 8.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14] | 13.30% | 13.30% | 13.30% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[14] | $ 28,394 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[14] | 27,564 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[14] | $ 27,585 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: IW Buyer LLC, Electrical Components & Equipment, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.75% | 6.75% | 6.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[21] | 11.80% | 11.80% | 11.80% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 459 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 267 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ 267 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: IW Buyer LLC, Electrical Components & Equipment, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.75% | 6.75% | 6.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.80% | 11.80% | 11.80% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 34,461 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 33,428 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | 33,428 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Impel Neuropharma, Inc., First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | 5,565 | [5],[6],[7],[8],[9],[13],[22] | 5,129 | [1],[2],[3],[4],[16],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 5,565 | [5],[6],[7],[8],[9],[22] | 5,129 | [1],[2],[3],[4],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 5,189 | [5],[6],[7],[8],[9],[22] | $ 5,129 | [1],[2],[3],[4],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Impel Neuropharma, Inc., First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 8.75% | [5],[6],[7],[8],[9],[10] | 8.75% | [5],[6],[7],[8],[9],[10] | 8.75% | [5],[6],[7],[8],[9],[10] | 8.75% | [1],[2],[3],[4],[15],[16] | 8.75% | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 14.14% | [5],[6],[7],[8],[9],[10],[11] | 14.14% | [5],[6],[7],[8],[9],[10],[11] | 14.14% | [5],[6],[7],[8],[9],[10],[11] | 12.45% | [1],[2],[3],[4],[15],[16],[18] | 12.45% | [1],[2],[3],[4],[15],[16],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 4,768 | [5],[6],[7],[8],[9],[10],[13] | $ 4,768 | [1],[2],[3],[4],[15],[16],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 4,697 | [5],[6],[7],[8],[9],[10] | 4,682 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 4,589 | [5],[6],[7],[8],[9],[10] | $ 4,682 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 11.00% | [5],[6],[7],[8],[9],[10],[11],[14] | 11.00% | [5],[6],[7],[8],[9],[10],[11],[14] | 11.00% | [5],[6],[7],[8],[9],[10],[11],[14] | 11.00% | [1],[2],[3],[4],[15],[16],[17],[18],[20] | 11.00% | [1],[2],[3],[4],[15],[16],[17],[18],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 4,316 | [5],[6],[7],[8],[9],[13],[14] | $ 4,316 | [1],[2],[3],[4],[16],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 4,178 | [5],[6],[7],[8],[9],[14] | 4,149 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 3,947 | [5],[6],[7],[8],[9],[14] | 4,057 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14],[21] | 11.00% | 11.00% | 11.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 0 | [5],[6],[7],[8],[9],[13],[14],[21] | 0 | [1],[2],[3],[4],[16],[17],[19],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 0 | [5],[6],[7],[8],[9],[14],[21] | 0 | [1],[2],[3],[4],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 0 | [5],[6],[7],[8],[9],[14],[21] | 0 | [1],[2],[3],[4],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, First Lien Term Loan 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14],[21] | 11.00% | 11.00% | 11.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[13],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14],[21] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14],[21] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Innocoll Pharmaceuticals Limited, Warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 85 | [5],[6],[7],[8],[9],[14] | 85 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 88 | [5],[6],[7],[8],[9],[14] | $ 385 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | 36,087 | [5],[6],[7],[8],[9],[14] | 36,087 | [5],[6],[7],[8],[9],[14] | 36,087 | [5],[6],[7],[8],[9],[14] | 36,087 | [1],[2],[3],[4],[16],[17] | 36,087 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 7.50% | 7.50% | 7.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (149) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (149) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Inventus Power, Inc., Electrical Components & Equipment, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 7.50% | 7.50% | 7.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 12.72% | 12.72% | 12.72% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 43,875 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 42,560 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 42,558 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Iris Holding, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 4.75% | [5],[6],[7],[8],[10],[14] | 4.75% | [5],[6],[7],[8],[10],[14] | 4.75% | [5],[6],[7],[8],[10],[14] | 4.75% | [1],[2],[3],[4],[15],[17] | 4.75% | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.90% | [5],[6],[7],[8],[10],[11],[14] | 9.90% | [5],[6],[7],[8],[10],[11],[14] | 9.90% | [5],[6],[7],[8],[10],[11],[14] | 7.89% | [1],[2],[3],[4],[15],[17],[18] | 7.89% | [1],[2],[3],[4],[15],[17],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 10,918 | [5],[6],[7],[8],[10],[13],[14] | $ 8,000 | [1],[2],[3],[4],[15],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 10,255 | [5],[6],[7],[8],[10],[14] | 7,478 | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 9,297 | [5],[6],[7],[8],[10],[14] | $ 7,376 | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Jamestown CLO XII Ltd., CLO Notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[17] | 7.00% | 7.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 9.71% | 9.71% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[17],[19] | $ 500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[17] | 389 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[17] | $ 410 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: KKR Apple Bidco, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 4.00% | 4.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 7.06% | 7.06% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 3,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 2,970 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 2,949 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Kindercare Learning Centers Kindercare Portfolio, Diversified Real Estate Activities, CLO Notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 2.41% | 2.41% | 2.41% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 7.56% | 7.56% | 7.56% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13],[14] | $ 4,964 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | 4,617 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 4,633 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 6.50% | [5],[6],[7],[8],[9],[10],[21] | 6.50% | [5],[6],[7],[8],[9],[10],[21] | 6.50% | [5],[6],[7],[8],[9],[10],[21] | 6.50% | [1],[2],[3],[4],[15],[16],[20] | 6.50% | [1],[2],[3],[4],[15],[16],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 11.84% | [5],[6],[7],[8],[9],[10],[11],[21] | 11.84% | [5],[6],[7],[8],[9],[10],[11],[21] | 11.84% | [5],[6],[7],[8],[9],[10],[11],[21] | 10.17% | [1],[2],[3],[4],[15],[16],[18],[20] | 10.17% | [1],[2],[3],[4],[15],[16],[18],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 156 | [5],[6],[7],[8],[9],[10],[13],[21] | $ 117 | [1],[2],[3],[4],[15],[16],[19],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 150 | [5],[6],[7],[8],[9],[10],[21] | 111 | [1],[2],[3],[4],[15],[16],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 146 | [5],[6],[7],[8],[9],[10],[21] | $ 104 | [1],[2],[3],[4],[15],[16],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Kings Buyer, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 6.50% | [5],[6],[7],[8],[9],[10] | 6.50% | [5],[6],[7],[8],[9],[10] | 6.50% | [5],[6],[7],[8],[9],[10] | 6.50% | [1],[2],[3],[4],[15],[16] | 6.50% | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 11.84% | [5],[6],[7],[8],[9],[10],[11] | 11.84% | [5],[6],[7],[8],[9],[10],[11] | 11.84% | [5],[6],[7],[8],[9],[10],[11] | 10.17% | [1],[2],[3],[4],[15],[16],[18] | 10.17% | [1],[2],[3],[4],[15],[16],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 4,815 | [5],[6],[7],[8],[9],[10],[13] | $ 4,852 | [1],[2],[3],[4],[15],[16],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 4,767 | [5],[6],[7],[8],[9],[10] | 4,803 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 4,742 | [5],[6],[7],[8],[9],[10] | $ 4,755 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: LABL Inc, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 5.00% | [5],[6],[7],[8],[10] | 5.00% | [5],[6],[7],[8],[10] | 5.00% | [5],[6],[7],[8],[10] | 5.00% | [1],[2],[3],[4],[15] | 5.00% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 10.20% | [5],[6],[7],[8],[10],[11] | 10.20% | [5],[6],[7],[8],[10],[11] | 10.20% | [5],[6],[7],[8],[10],[11] | 8.12% | [1],[2],[3],[4],[15],[18] | 8.12% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 13,682 | [5],[6],[7],[8],[10],[13] | $ 8,786 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 13,222 | [5],[6],[7],[8],[10] | 8,366 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 13,570 | [5],[6],[7],[8],[10] | $ 7,971 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 6.00% | [5],[6],[7],[8],[9],[10],[21] | 6.00% | [5],[6],[7],[8],[9],[10],[21] | 6.00% | [5],[6],[7],[8],[9],[10],[21] | 6.00% | [1],[2],[3],[4],[15],[16],[20] | 6.00% | [1],[2],[3],[4],[15],[16],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[16],[18],[20] | 9.12% | 9.12% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 0 | [5],[6],[7],[8],[9],[10],[13],[21] | $ 812 | [1],[2],[3],[4],[15],[16],[19],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | (16) | [5],[6],[7],[8],[9],[10],[21] | 794 | [1],[2],[3],[4],[15],[16],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ (56) | [5],[6],[7],[8],[9],[10],[21] | $ 784 | [1],[2],[3],[4],[15],[16],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[16] | 6.00% | 6.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[16],[18] | 9.12% | 9.12% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[16],[19] | $ 9,134 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[16] | 8,972 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[16] | $ 8,883 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.00% | 6.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.20% | 11.20% | 11.20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 9,020 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 8,882 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 8,524 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: LSL Holdco, LLC, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.00% | 6.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.20% | 11.20% | 11.20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 1,050 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 985 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 992 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: LTI Holdings, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 3.50% | [5],[6],[7],[8],[10] | 3.50% | [5],[6],[7],[8],[10] | 3.50% | [5],[6],[7],[8],[10] | 3.25% | [1],[2],[3],[4],[15] | 3.25% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 8.72% | [5],[6],[7],[8],[10],[11] | 8.72% | [5],[6],[7],[8],[10],[11] | 8.72% | [5],[6],[7],[8],[10],[11] | 6.37% | [1],[2],[3],[4],[15],[18] | 6.37% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 6,909 | [5],[6],[7],[8],[10],[13] | $ 6,964 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 6,677 | [5],[6],[7],[8],[10] | 6,650 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 6,653 | [5],[6],[7],[8],[10] | $ 6,462 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Latam Airlines Group S.A., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 9.50% | 9.50% | 9.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 14.61% | 14.61% | 14.61% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13],[14] | $ 12,063 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | 11,166 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 12,289 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[16] | 6.25% | 6.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[16],[18] | 9.75% | 9.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[16],[19] | $ 8,197 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[16] | 8,006 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[16] | $ 7,911 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.25% | 6.25% | 6.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.45% | 11.45% | 11.45% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 2,836 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 2,765 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 2,785 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: MHE Intermediate Holdings, LLC, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.00% | 6.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.20% | 11.20% | 11.20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 5,299 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 5,193 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 5,161 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 7.50% | 7.50% | 7.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[21] | 12.58% | 12.58% | 12.58% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 2,166 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 1,895 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ 1,895 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: MND Holdings III Corp, Other Specialty Retail, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 7.50% | 7.50% | 7.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 12.74% | 12.74% | 12.74% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 41,587 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 40,867 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 40,867 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 5.50% | 5.50% | 5.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 10.84% | 10.84% | 10.84% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 4,609 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 4,460 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 4,482 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 5.50% | 5.50% | 5.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 10.84% | 10.84% | 10.84% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 4,966 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 4,958 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 4,830 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, Application Software, First Lien Term Loan 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 5.50% | 5.50% | 5.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[21] | 10.83% | 10.83% | 10.83% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 798 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 790 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ 736 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[16] | 5.50% | 5.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[16],[18] | 9.17% | 9.17% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[16],[19] | $ 4,149 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[16] | 4,076 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[16] | $ 4,033 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: MRI Software LLC, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[16],[20] | 5.50% | 5.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[16],[19],[20] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[16],[20] | (13) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[16],[20] | $ (134) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Madison Park Funding LXIII, CLO Notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 5.50% | 5.50% | 5.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 10.58% | 10.58% | 10.58% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13],[14] | $ 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 5,064 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Mauser Packaging Solutions Holding Company, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 4.00% | 4.00% | 4.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 9.16% | 9.16% | 9.16% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 8,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | 7,886 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | $ 7,987 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Mauser Packaging Solutions Holding Company, Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 7.88% | 7.88% | 7.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[13] | $ 2,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8] | 2,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8] | $ 1,989 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: McAfee Corp., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 3.75% | [5],[6],[7],[8],[10] | 3.75% | [5],[6],[7],[8],[10] | 3.75% | [5],[6],[7],[8],[10] | 3.75% | [1],[2],[3],[4],[15] | 3.75% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.01% | [5],[6],[7],[8],[10],[11] | 9.01% | [5],[6],[7],[8],[10],[11] | 9.01% | [5],[6],[7],[8],[10],[11] | 6.36% | [1],[2],[3],[4],[15],[18] | 6.36% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 12,902 | [5],[6],[7],[8],[10],[13] | $ 6,983 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 12,241 | [5],[6],[7],[8],[10] | 6,561 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 12,377 | [5],[6],[7],[8],[10] | 6,388 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Medline Borrower, LP, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 3.25% | 3.25% | 3.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 8.47% | 8.47% | 8.47% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 11,945 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | 11,526 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | $ 11,821 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc, Warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[16],[17] | 152 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[16],[17] | $ 54 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [1],[2],[3],[4],[16],[17] | 66,347 | 66,347 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 8.00% | [5],[6],[7],[8],[9],[10],[11],[14] | 8.00% | [5],[6],[7],[8],[9],[10],[11],[14] | 8.00% | [5],[6],[7],[8],[9],[10],[11],[14] | 8.00% | [1],[2],[3],[4],[15],[16],[17],[18],[20] | 8.00% | [1],[2],[3],[4],[15],[16],[17],[18],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 2,315 | [5],[6],[7],[8],[9],[13],[14] | $ 2,284 | [1],[2],[3],[4],[16],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 2,168 | [5],[6],[7],[8],[9],[14] | 2,105 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 2,072 | [5],[6],[7],[8],[9],[14] | $ 2,039 | [1],[2],[3],[4],[16],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | 1.75% | [5],[6],[7],[8],[9],[14] | 1.75% | [5],[6],[7],[8],[9],[14] | 1.75% | [5],[6],[7],[8],[9],[14] | 1.75% | [1],[2],[3],[4],[16],[17],[20] | 1.75% | [1],[2],[3],[4],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14],[21] | 8.00% | 8.00% | 8.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 0 | [5],[6],[7],[8],[9],[13],[14],[21] | $ 0 | [1],[2],[3],[4],[16],[17],[19],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 0 | [5],[6],[7],[8],[9],[14],[21] | 0 | [1],[2],[3],[4],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 0 | [5],[6],[7],[8],[9],[14],[21] | $ 0 | [1],[2],[3],[4],[16],[17],[20] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | [5],[6],[7],[8],[9],[14],[21] | 1.75% | 1.75% | 1.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., First Lien Term Loan 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14],[21] | 8.00% | 8.00% | 8.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[13],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14],[21] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | [5],[6],[7],[8],[9],[14],[21] | 1.75% | 1.75% | 1.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Warrants 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14] | $ 152 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14] | $ 111 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [5],[6],[7],[8],[9],[14] | 66,347 | 66,347 | 66,347 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Mesoblast, Inc., Warrants 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14] | $ 39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [5],[6],[7],[8],[9],[14] | 17,058 | 17,058 | 17,058 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Mitchell International, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 3.75% | 3.75% | 3.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 8.94% | 8.94% | 8.94% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 9,451 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | 8,973 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | $ 9,259 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Mitchell International, Inc., Second Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 6.50% | [5],[6],[7],[8],[10] | 6.50% | [5],[6],[7],[8],[10] | 6.50% | [5],[6],[7],[8],[10] | 6.50% | [1],[2],[3],[4],[15] | 6.50% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 11.69% | [5],[6],[7],[8],[10],[11] | 11.69% | [5],[6],[7],[8],[10],[11] | 11.69% | [5],[6],[7],[8],[10],[11] | 9.57% | [1],[2],[3],[4],[15],[18] | 9.57% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 4,000 | [5],[6],[7],[8],[10],[13] | $ 4,000 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 3,809 | [5],[6],[7],[8],[10] | 3,786 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 3,550 | [5],[6],[7],[8],[10] | $ 3,690 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: NFP Corp., Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 6.88% | 6.88% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[19] | $ 2,284 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4] | 2,155 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4] | $ 1,785 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: NFP Corp., Fixed Rate Bond 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 4.88% | 4.88% | 4.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[13] | $ 2,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8] | 1,768 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8] | $ 1,789 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: NFP Corp., Fixed Rate Bond 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 6.88% | 6.88% | 6.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[13] | $ 3,784 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8] | 3,461 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8] | $ 3,290 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: New Enterprise Stone & Lime Co Inc, Construction Materials, Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[11] | 5.25% | 5.25% | 5.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[13] | $ 500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8] | 453 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8] | $ 456 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Nidda BondCo GmbH, Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 3.50% | 3.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | € | [1],[2],[3],[4],[17],[19] | € 500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[17] | $ 462 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[17] | $ 446 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: North Star Acquisitionco, LLC, Education Services, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.00% | 6.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | € | [5],[6],[7],[8],[9],[10],[13],[21] | € 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | $ (86) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (83) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: North Star Acquisitionco, LLC, Education Services, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.00% | 6.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 10.81% | 10.81% | 10.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | € | [5],[6],[7],[8],[9],[10],[13] | € 36,717 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | $ 36,002 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 36,023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: North Star Acquisitionco, LLC, Education Services, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.00% | 6.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | € | [5],[6],[7],[8],[9],[10],[13],[21] | € 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | $ (33) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (32) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: OEConnection LLC, Second Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 7.00% | [5],[6],[7],[8],[9],[10] | 7.00% | [5],[6],[7],[8],[9],[10] | 7.00% | [5],[6],[7],[8],[9],[10] | 7.00% | [1],[2],[3],[4],[15],[16] | 7.00% | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 12.34% | [5],[6],[7],[8],[9],[10],[11] | 12.34% | [5],[6],[7],[8],[9],[10],[11] | 12.34% | [5],[6],[7],[8],[9],[10],[11] | 10.05% | [1],[2],[3],[4],[15],[16],[18] | 10.05% | [1],[2],[3],[4],[15],[16],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 5,355 | [5],[6],[7],[8],[9],[10],[13] | $ 5,355 | [1],[2],[3],[4],[15],[16],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 5,276 | [5],[6],[7],[8],[9],[10] | 5,263 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 5,221 | [5],[6],[7],[8],[9],[10] | $ 5,154 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: OFSI BSL CLO XI, Ltd., CLO Notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 7.60% | [5],[6],[7],[8],[10],[14] | 7.60% | [5],[6],[7],[8],[10],[14] | 7.60% | [5],[6],[7],[8],[10],[14] | 7.60% | [1],[2],[3],[4],[15],[17] | 7.60% | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 12.58% | [5],[6],[7],[8],[10],[11],[14] | 12.58% | [5],[6],[7],[8],[10],[11],[14] | 12.58% | [5],[6],[7],[8],[10],[11],[14] | 9.12% | [1],[2],[3],[4],[15],[17],[18] | 9.12% | [1],[2],[3],[4],[15],[17],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 2,500 | [5],[6],[7],[8],[10],[13],[14] | $ 2,500 | [1],[2],[3],[4],[15],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 2,173 | [5],[6],[7],[8],[10],[14] | 2,156 | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 2,250 | [5],[6],[7],[8],[10],[14] | $ 2,265 | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: OneOncology, LLC, Health Care Services, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.25% | 6.25% | 6.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (113) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (113) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: OneOncology, LLC, Health Care Services, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.25% | 6.25% | 6.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.49% | 11.49% | 11.49% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10] | $ 22,885 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 22,318 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 22,322 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: OneOncology, LLC, Health Care Services, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.25% | 6.25% | 6.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (107) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (106) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 7.75% | 7.75% | 7.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (46) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (45) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Oranje Holdco, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 7.75% | 7.75% | 7.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 12.79% | 12.79% | 12.79% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 15,746 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 15,379 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 15,385 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[16],[20] | 7.00% | 7.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[16],[19],[20] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[16],[20] | (7) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[16],[20] | $ (4) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[16] | 7.00% | 7.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[16],[18] | 9.28% | 9.28% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[16],[19] | $ 8,279 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[16] | 8,139 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[16] | $ 8,196 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: PFNY Holdings, LLC, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[16],[20] | 7.00% | 7.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[16],[18],[20] | 9.25% | 9.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[16],[19],[20] | $ 705 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[16],[20] | 692 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[16],[20] | $ 697 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 7.00% | 7.00% | 7.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (135) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (141) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: PPW Aero Buyer, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 7.00% | 7.00% | 7.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 12.10% | 12.10% | 12.10% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 26,825 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 25,818 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 25,779 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Park Place Technologies, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 5.00% | 5.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 8.13% | 8.13% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 1,995 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 1,936 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 1,899 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Park Place Technologies, LLC, Internet Services & Infrastructure, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 5.00% | 5.00% | 5.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 10.20% | 10.20% | 10.20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 4,957 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | 4,752 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | $ 4,833 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Peloton Interactive, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 6.50% | 6.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 8.35% | 8.35% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[17],[19] | $ 7,980 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[17] | 7,674 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[17] | $ 7,813 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: PetSmart LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 3.75% | 3.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 6.87% | 6.87% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 1,995 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 1,875 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 1,895 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: PetSmart LLC, Other Specialty Retail, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 3.75% | 3.75% | 3.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 8.95% | 8.95% | 8.95% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 10,929 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | 10,706 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | $ 10,927 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 8.00% | 8.00% | 8.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[21] | 13.04% | 13.04% | 13.04% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 820 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 574 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ 759 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Pluralsight, LLC, Application Software, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 8.00% | 8.00% | 8.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 13.04% | 13.04% | 13.04% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 26,144 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 22,222 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 25,177 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[16] | 8.50% | 8.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[16],[18] | 10.01% | 10.01% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[16],[19] | $ 6,387 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[16] | 6,235 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[16] | $ 6,259 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 7.25% | 7.25% | 7.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 12.42% | 12.42% | 12.42% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 5,457 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 5,365 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 5,348 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Profrac Holdings II, LLC, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 7.25% | 7.25% | 7.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 12.42% | 12.42% | 12.42% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 628 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 619 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 615 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: RP Escrow Issuer LLC, Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 5.25% | 5.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[19] | $ 333 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4] | 306 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4] | $ 276 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Radiology Partners Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 4.25% | 4.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 7.33% | 7.33% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 6,253 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 5,873 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 5,297 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Radiology Partners Inc., Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 9.25% | 9.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[19] | $ 1,950 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4] | 1,938 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4] | $ 1,275 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Renaissance Holding Corp., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 4.75% | [5],[6],[7],[8],[10] | 4.75% | [5],[6],[7],[8],[10] | 4.75% | [5],[6],[7],[8],[10] | 3.25% | [1],[2],[3],[4],[15] | 3.25% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.99% | [5],[6],[7],[8],[10],[11] | 9.99% | [5],[6],[7],[8],[10],[11] | 9.99% | [5],[6],[7],[8],[10],[11] | 6.37% | [1],[2],[3],[4],[15],[18] | 6.37% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 16,000 | [5],[6],[7],[8],[10],[13] | $ 2,238 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 15,535 | [5],[6],[7],[8],[10] | 2,134 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 15,834 | [5],[6],[7],[8],[10] | $ 2,135 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Metals & Mining, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 4.00% | 4.00% | 4.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 9.19% | 9.19% | 9.19% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 7,975 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | 7,806 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | $ 7,870 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: SCIH Salt Holdings Inc., Diversified Metals & Mining, Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 4.88% | 4.88% | 4.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[13] | $ 2,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8] | 1,804 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8] | 1,789 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Common Stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9] | 761 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9] | $ 752 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [5],[6],[7],[8],[9] | 761 | 761 | 761 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Second Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 8.75% | 8.75% | 8.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 14.00% | 14.00% | 14.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 5,881 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 5,721 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 5,705 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: SCP Eye Care Services, LLC, Second Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 8.75% | 8.75% | 8.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (26) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (52) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: SEI Holding I Corporation, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.75% | 6.75% | 6.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (43) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (41) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: SEI Holding I Corporation, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.75% | 6.75% | 6.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.99% | 11.99% | 11.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 17,463 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 16,967 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 16,992 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: SEI Holding I Corporation, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.75% | 6.75% | 6.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[21] | 11.99% | 11.99% | 11.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 391 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 350 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ 357 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: SM Wellness Holdings, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 4.75% | [5],[6],[7],[8],[9],[10] | 4.75% | [5],[6],[7],[8],[9],[10] | 4.75% | [5],[6],[7],[8],[9],[10] | 4.75% | [1],[2],[3],[4],[15],[16] | 4.75% | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.97% | [5],[6],[7],[8],[9],[10],[11] | 9.97% | [5],[6],[7],[8],[9],[10],[11] | 9.97% | [5],[6],[7],[8],[9],[10],[11] | 7.49% | [1],[2],[3],[4],[15],[16],[18] | 7.49% | [1],[2],[3],[4],[15],[16],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 12,851 | [5],[6],[7],[8],[9],[10],[13] | $ 6,430 | [1],[2],[3],[4],[15],[16],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 11,963 | [5],[6],[7],[8],[9],[10] | 6,223 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 11,919 | [5],[6],[7],[8],[9],[10] | $ 6,108 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: SPX Flow, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 4.50% | [5],[6],[7],[8],[10] | 4.50% | [5],[6],[7],[8],[10] | 4.50% | [5],[6],[7],[8],[10] | 4.50% | [1],[2],[3],[4],[15] | 4.50% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.70% | [5],[6],[7],[8],[10],[11] | 9.70% | [5],[6],[7],[8],[10],[11] | 9.70% | [5],[6],[7],[8],[10],[11] | 7.63% | [1],[2],[3],[4],[15],[18] | 7.63% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 18,496 | [5],[6],[7],[8],[10],[13] | $ 9,500 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 17,705 | [5],[6],[7],[8],[10] | 9,105 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 18,303 | [5],[6],[7],[8],[10] | $ 8,823 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 10.00% | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (63) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (57) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 10.00% | 10.00% | 10.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 15.24% | 15.24% | 15.24% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 15,638 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 15,120 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | 15,169 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Salus Workers' Compensation, LLC, Warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9] | 200 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9] | $ 1,152 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [5],[6],[7],[8],[9] | 606,357 | 606,357 | 606,357 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[14] | 7.88% | 7.88% | 7.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14] | 12.95% | 12.95% | 12.95% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[14] | $ 11,547 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[14] | 11,116 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[14] | $ 11,129 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[14] | 7.88% | 7.88% | 7.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14] | 12.88% | 12.88% | 12.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[14] | $ 4,330 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[14] | 4,169 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[14] | $ 4,173 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[14] | 7.88% | 7.88% | 7.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[14],[21] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, First Lien Term Loan 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[14] | 7.88% | 7.88% | 7.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[14],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[14],[21] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[14],[21] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Seres Therapeutics, Inc., Biotechnology, Warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14] | 293 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14] | $ 324 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [5],[6],[7],[8],[9],[14] | 93,470 | 93,470 | 93,470 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Southern Veterinary Partners, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 4.00% | [5],[6],[7],[8],[10] | 4.00% | [5],[6],[7],[8],[10] | 4.00% | [5],[6],[7],[8],[10] | 4.00% | [1],[2],[3],[4],[15] | 4.00% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.22% | [5],[6],[7],[8],[10],[11] | 9.22% | [5],[6],[7],[8],[10],[11] | 9.22% | [5],[6],[7],[8],[10],[11] | 7.12% | [1],[2],[3],[4],[15],[18] | 7.12% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 3,217 | [5],[6],[7],[8],[10],[13] | $ 3,242 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 3,089 | [5],[6],[7],[8],[10] | 3,096 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 3,170 | [5],[6],[7],[8],[10] | $ 3,076 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Sunshine Luxembourg VII Sarl, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 3.75% | 3.75% | 3.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 9.09% | 9.09% | 9.09% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13],[14] | $ 10,386 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | 10,113 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 10,347 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Superior Industries International, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 7.75% | 7.75% | 7.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 12.85% | 12.85% | 12.85% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 33,395 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 32,483 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 33,048 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[23] | 7.00% | 7.00% | 7.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[23] | 12.18% | 12.18% | 12.18% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[23] | $ 396 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[23] | 391 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[23] | $ 375 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[23] | 7.00% | 7.00% | 7.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[23] | 12.18% | 12.18% | 12.18% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[23] | $ 8,217 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[23] | 8,102 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[23] | $ 7,785 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21],[23] | 7.00% | 7.00% | 7.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[21],[23] | 12.18% | 12.18% | 12.18% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21],[23] | $ 704 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21],[23] | 693 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21],[23] | $ 662 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Supreme Fitness Group NY Holdings, LLC, Leisure Facilities, First Lien Term Loan 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21],[23] | 7.00% | 7.00% | 7.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[23] | 12.18% | 12.18% | 12.18% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21],[23] | $ 281 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21],[23] | 270 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21],[23] | $ 236 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Surgery Center Holdings, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 3.75% | 3.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 6.51% | 6.51% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 6,977 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 6,724 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 6,639 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: THL Zinc Ventures Ltd, Diversified Metals & Mining, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[14] | 13.00% | 13.00% | 13.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[13],[14] | $ 39,751 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[14] | 39,253 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[14] | $ 39,270 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: TIBCO Software Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 4.50% | [5],[6],[7],[8],[10] | 4.50% | [5],[6],[7],[8],[10] | 4.50% | [5],[6],[7],[8],[10] | 4.50% | [1],[2],[3],[4],[15] | 4.50% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.84% | [5],[6],[7],[8],[10],[11] | 9.84% | [5],[6],[7],[8],[10],[11] | 9.84% | [5],[6],[7],[8],[10],[11] | 8.15% | [1],[2],[3],[4],[15],[18] | 8.15% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 15,794 | [5],[6],[7],[8],[10],[13] | $ 8,834 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 14,573 | [5],[6],[7],[8],[10] | 8,039 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 14,811 | [5],[6],[7],[8],[10] | $ 7,949 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Tacala, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 3.50% | 3.50% | 3.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 8.69% | 8.69% | 8.69% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 2,984 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | 2,865 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | $ 2,942 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Tacala, LLC, Second Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 7.50% | [5],[6],[7],[8],[10] | 7.50% | [5],[6],[7],[8],[10] | 7.50% | [5],[6],[7],[8],[10] | 7.50% | [1],[2],[3],[4],[15] | 7.50% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 12.69% | [5],[6],[7],[8],[10],[11] | 12.69% | [5],[6],[7],[8],[10],[11] | 12.69% | [5],[6],[7],[8],[10],[11] | 10.62% | [1],[2],[3],[4],[15],[18] | 10.62% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 7,310 | [5],[6],[7],[8],[10],[13] | $ 7,310 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 7,119 | [5],[6],[7],[8],[10] | 7,090 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 6,926 | [5],[6],[7],[8],[10] | $ 6,725 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Ten-X LLC, Interactive Media & Services, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.00% | 6.00% | 6.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.09% | 11.09% | 11.09% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 24,934 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 23,703 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 23,750 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Touchstone Acquisition, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 6.00% | [5],[6],[7],[8],[9],[10] | 6.00% | [5],[6],[7],[8],[9],[10] | 6.00% | [5],[6],[7],[8],[9],[10] | 6.00% | [1],[2],[3],[4],[15],[16] | 6.00% | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 11.20% | [5],[6],[7],[8],[9],[10],[11] | 11.20% | [5],[6],[7],[8],[9],[10],[11] | 11.20% | [5],[6],[7],[8],[9],[10],[11] | 9.12% | [1],[2],[3],[4],[15],[16],[18] | 9.12% | [1],[2],[3],[4],[15],[16],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 8,506 | [5],[6],[7],[8],[9],[10],[13] | $ 8,571 | [1],[2],[3],[4],[15],[16],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 8,372 | [5],[6],[7],[8],[9],[10] | 8,417 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 8,294 | [5],[6],[7],[8],[9],[10] | $ 8,400 | [1],[2],[3],[4],[15],[16] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Transit Buyer LLC, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 6.25% | 6.25% | 6.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.07% | 11.07% | 11.07% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 8,448 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 8,290 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 8,304 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Transit Buyer LLC, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.25% | 6.25% | 6.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | (72) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ (65) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Trinitas CLO XV DAC, CLO Notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10],[14] | 7.45% | 7.45% | 7.45% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11],[14] | 12.72% | 12.72% | 12.72% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13],[14] | $ 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10],[14] | 814 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10],[14] | $ 929 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Fixed Rate Bond 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 6.50% | [5],[6],[7],[8],[10],[11],[14] | 6.50% | [5],[6],[7],[8],[10],[11],[14] | 6.50% | [5],[6],[7],[8],[10],[11],[14] | 6.50% | [1],[2],[3],[4],[15],[17],[18] | 6.50% | [1],[2],[3],[4],[15],[17],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 1,750 | [5],[6],[7],[8],[13],[14] | $ 1,750 | [1],[2],[3],[4],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 1,626 | [5],[6],[7],[8],[14] | 1,613 | [1],[2],[3],[4],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 1,240 | [5],[6],[7],[8],[14] | $ 1,177 | [1],[2],[3],[4],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Uniti Group LP, Fixed Rate Bond 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 4.75% | [5],[6],[7],[8],[10],[11],[14] | 4.75% | [5],[6],[7],[8],[10],[11],[14] | 4.75% | [5],[6],[7],[8],[10],[11],[14] | 4.75% | [1],[2],[3],[4],[15],[17],[18] | 4.75% | [1],[2],[3],[4],[15],[17],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 2,200 | [5],[6],[7],[8],[13],[14] | $ 2,200 | [1],[2],[3],[4],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 1,933 | [5],[6],[7],[8],[14] | 1,899 | [1],[2],[3],[4],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 1,828 | [5],[6],[7],[8],[14] | $ 1,743 | [1],[2],[3],[4],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Vertiv Group Corporation, Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[17],[18] | 4.13% | 4.13% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[17],[19] | $ 1,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[17] | 1,258 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[17] | $ 1,210 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: WP CPP Holdings, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 3.75% | [5],[6],[7],[8],[10] | 3.75% | [5],[6],[7],[8],[10] | 3.75% | [5],[6],[7],[8],[10] | 3.75% | [1],[2],[3],[4],[15] | 3.75% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.03% | [5],[6],[7],[8],[10],[11] | 9.03% | [5],[6],[7],[8],[10],[11] | 9.03% | [5],[6],[7],[8],[10],[11] | 6.56% | [1],[2],[3],[4],[15],[18] | 6.56% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 9,657 | [5],[6],[7],[8],[10],[13] | $ 5,730 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 9,047 | [5],[6],[7],[8],[10] | 5,388 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 8,776 | [5],[6],[7],[8],[10] | $ 5,147 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: WWEX Uni Topco Holdings, LLC, First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 4.00% | [5],[6],[7],[8],[10] | 4.00% | [5],[6],[7],[8],[10] | 4.00% | [5],[6],[7],[8],[10] | 4.00% | [1],[2],[3],[4],[15] | 4.00% | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 9.50% | [5],[6],[7],[8],[10],[11] | 9.50% | [5],[6],[7],[8],[10],[11] | 9.50% | [5],[6],[7],[8],[10],[11] | 7.67% | [1],[2],[3],[4],[15],[18] | 7.67% | [1],[2],[3],[4],[15],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 6,912 | [5],[6],[7],[8],[10],[13] | $ 6,965 | [1],[2],[3],[4],[15],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 6,581 | [5],[6],[7],[8],[10] | 6,585 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 6,580 | [5],[6],[7],[8],[10] | $ 6,363 | [1],[2],[3],[4],[15] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Wellfleet CLO 2022-2, Ltd., CLO Notes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | 8.56% | [5],[6],[7],[8],[10],[14] | 8.56% | [5],[6],[7],[8],[10],[14] | 8.56% | [5],[6],[7],[8],[10],[14] | 8.56% | [1],[2],[3],[4],[15],[17] | 8.56% | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | 13.54% | [5],[6],[7],[8],[10],[11],[14] | 13.54% | [5],[6],[7],[8],[10],[11],[14] | 13.54% | [5],[6],[7],[8],[10],[11],[14] | 12.17% | [1],[2],[3],[4],[15],[17],[18] | 12.17% | [1],[2],[3],[4],[15],[17],[18] | ||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | $ 1,500 | [5],[6],[7],[8],[10],[13],[14] | $ 1,500 | [1],[2],[3],[4],[15],[17],[19] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | 1,444 | [5],[6],[7],[8],[10],[14] | 1,440 | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | $ 1,454 | [5],[6],[7],[8],[10],[14] | $ 1,440 | [1],[2],[3],[4],[15],[17] | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., First Lien Term Loan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15] | 3.00% | 3.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 6.12% | 6.12% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[19] | $ 7,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15] | 6,467 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15] | $ 5,882 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: Zayo Group Holdings, Inc., Fixed Rate Bond | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[18] | 4.00% | 4.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[19] | $ 1,700 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4] | 1,427 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4] | 1,368 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Preferred Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[16] | 5,693 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[16] | $ 5,167 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [1],[2],[3],[4],[16] | 5,809 | 5,809 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 3.50% | 3.50% | 3.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[10],[11] | 8.59% | 8.59% | 8.59% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 17,179 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | 16,123 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | $ 16,577 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[10] | 3.50% | 3.50% | 3.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[10],[13] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[10] | (134) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[10] | (74) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: athenahealth Group Inc., Preferred Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9] | 5,693 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9] | $ 5,080 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [5],[6],[7],[8],[9] | 5,809 | 5,809 | 5,809 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 6.75% | 6.75% | 6.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11],[21] | 11.99% | 11.99% | 11.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 241 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 220 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ 184 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 3.38% | 3.38% | 3.38% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 8.50% | 8.50% | 8.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 15,468 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 15,243 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 14,858 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, interest rate, paid in kind | [5],[6],[7],[8],[9],[10] | 3.88% | 3.88% | 3.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 7.25% | 7.25% | 7.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 12.38% | 12.38% | 12.38% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 2,325 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 2,289 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 2,279 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., Application Software, First Lien Term Loan 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 7.25% | 7.25% | 7.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., First Lien Revolver | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[16],[20] | 6.75% | 6.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[16],[19],[20] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[16],[20] | (25) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[16],[20] | $ (25) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[16] | 6.75% | 6.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [1],[2],[3],[4],[15],[16],[18] | 9.49% | 9.49% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[16],[19] | $ 15,164 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[16] | 14,904 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[16] | $ 14,899 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: iCIMs, Inc., First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [1],[2],[3],[4],[15],[16],[20] | 6.75% | 6.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [1],[2],[3],[4],[15],[16],[19],[20] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [1],[2],[3],[4],[15],[16],[20] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [1],[2],[3],[4],[15],[16],[20] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., First Lien Term Loan 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10] | 8.75% | 8.75% | 8.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment interest rate | [5],[6],[7],[8],[9],[10],[11] | 11.75% | 11.75% | 11.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13] | $ 7,654 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10] | 7,302 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10] | $ 7,392 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., First Lien Term Loan 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 8.75% | 8.75% | 8.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., First Lien Term Loan 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, basis spread, variable rate | [5],[6],[7],[8],[9],[10],[21] | 8.75% | 8.75% | 8.75% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, principal | [5],[6],[7],[8],[9],[10],[13],[21] | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9],[10],[21] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9],[10],[21] | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment, Identifier [Axis]: scPharmaceuticals Inc., Warrants | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, at cost | [5],[6],[7],[8],[9] | 258 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, fair value | [5],[6],[7],[8],[9] | $ 600 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment owned, balance (in shares) | shares | [5],[6],[7],[8],[9] | 79,075 | 79,075 | 79,075 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Consolidated Schedule of Investments - Derivatives € in Thousands, £ in Thousands, $ in Thousands |
Jun. 30, 2023
USD ($)
|
Jun. 30, 2023
EUR (€)
|
Jun. 30, 2023
GBP (£)
|
Sep. 30, 2022
USD ($)
|
---|---|---|---|---|
Schedule of Investments [Line Items] | ||||
Derivative asset at fair value | $ 255 | $ 13 | ||
Foreign currency forward contract | ||||
Schedule of Investments [Line Items] | ||||
Notional Amount to be Purchased | 187 | |||
Notional Amount to be Sold | 178 | |||
Derivative asset at fair value | 255 | $ 13 | ||
Foreign Exchange Forward, 1 | ||||
Schedule of Investments [Line Items] | ||||
Notional Amount to be Purchased | 25,568 | |||
Notional Amount to be Sold | € | € 23,044 | |||
Derivative asset at fair value | 376 | |||
Foreign Exchange Forward, 2 | ||||
Schedule of Investments [Line Items] | ||||
Notional Amount to be Purchased | 19,619 | |||
Notional Amount to be Sold | £ | £ 15,523 | |||
Derivative liablity | $ (121) |
Consolidated Schedule of Investments - Parenthetical |
Jun. 30, 2023 |
Sep. 30, 2022 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Percentage of total assets representing qualifying assets | 78.00% | 80.00% |
Percentage of total assets representing non-qualifying assets | 22.00% | 20.00% |
Organization |
9 Months Ended |
---|---|
Jun. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization | Note 1. Organization Oaktree Strategic Credit Fund (the “Company”) is a Delaware statutory trust formed on November 24, 2021 and is structured as a non-diversified, closed-end management investment company. On February 3, 2022, the Company elected to be regulated as a business development company (a “BDC”) under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company intends to elect to be treated, and intends to qualify annually thereafter, as a registered investment company (a “RIC”) under the Internal Revenue Code of 1986, as amended (the “Code”). Effective as of February 3, 2022, the Company is externally managed by Oaktree Fund Advisors, LLC (the "Adviser") pursuant to an investment advisory agreement (as amended and restated, the “Investment Advisory Agreement”), between the Company and the Adviser. The Adviser is an entity under common control with Oaktree Capital Group, LLC ("OCG"). In 2019, Brookfield Corporation (formerly known as Brookfield Asset Management, Inc., collectively with its affiliates, "Brookfield") acquired a majority economic interest in OCG. OCG operates as an independent business within Brookfield, with its own product offerings and investment, marketing and support teams. The Company’s investment objective is to generate stable current income and long-term capital appreciation. The Company seeks to meet its investment objective by primarily investing in private debt opportunities. In connection with its formation, the Company has the authority to issue an unlimited number of common shares of beneficial interest, par value $0.01 per share (“Common Shares”). The Company offers on a continuous basis up to $5.0 billion aggregate offering price of Common Shares (the “Maximum Offering Amount”) pursuant to an offering registered with the Securities and Exchange Commission. The Company offers to sell any combination of three classes of Common Shares, Class S shares, Class D shares and Class I shares, with a dollar value up to the Maximum Offering Amount. The share classes have different ongoing distribution and/or shareholder servicing fees. The Company accepted purchase orders and held investors’ funds in an interest-bearing escrow account until the Company received purchase orders for Common Shares of at least $100.0 million, excluding subscriptions by Oaktree Fund GP I, L.P. in respect of the Class I shares purchased by Oaktree Fund GP I, L.P. prior to March 31, 2022, in any combination of purchases of Class S shares, Class D shares and Class I shares. As of June 1, 2022, the Company had satisfied the minimum offering requirement and the Board had authorized the release of proceeds from escrow. As of June 30, 2023, the Company has issued and sold 29,292,019 Class I shares for an aggregate purchase price of $699.6 million of which $100.0 million was purchased by an affiliate of the Adviser. As of June 30, 2023, the Company has issued and sold 13,523,516 Class S shares for an aggregate purchase price of $317.9 million. As of June 30, 2023, the Company has issued and sold 646 Class D shares for an aggregate purchase price of less than $0.1 million.
|
Significant Accounting Policies |
9 Months Ended |
---|---|
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Note 2. Significant Accounting Policies Basis of Presentation: The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the consolidated financial statements have been made. The Company is an investment company following the accounting and reporting guidance in FASB ASC Topic 946, Financial Services - Investment Companies ("ASC 946"). Use of Estimates: The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions affecting amounts reported in the consolidated financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition. Consolidation: The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. The consolidated subsidiaries are wholly-owned and, as such, consolidated into the consolidated financial statements. The assets of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of the Company. As an investment company, portfolio investments held by the Company are not consolidated into the consolidated financial statements but rather are included on the Consolidated Statement of Assets and Liabilities as investments at fair value. Fair Value Measurements: Our Adviser, as the valuation designee of our Board pursuant to Rule 2a-5 under the Investment Company Act, determines the fair value of our assets on at least a quarterly basis in accordance with ASC 820. ASC 820 defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: •Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. •Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. •Level 3 — Unobservable inputs that reflect the Adviser's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. The Adviser's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, the Adviser obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. The Adviser seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If the Adviser is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within the Adviser's set threshold, the Adviser seeks to obtain a quote directly from a broker making a market for the asset. The Adviser evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. The Adviser also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, the Adviser performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, the Adviser does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined not to be reliable or are not readily available, the Adviser values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, the Adviser analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. the Adviser also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. The Adviser may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and the Adviser considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, the Adviser depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. The Adviser estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. In December 2020, the SEC adopted Rule 2a-5 under the Investment Company Act. Rule 2a-5 permits boards of registered investment companies and Business Development Companies to either (i) choose to continue to determine fair value in good faith, or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Trustees has designated the Adviser to serve as its valuation designee effective September 8, 2022. The Adviser undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: •The quarterly valuation process begins with each portfolio company or investment being initially valued by the Adviser's valuation team; •Preliminary valuations are then reviewed and discussed with management of the Adviser; •Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to the Adviser; •The Adviser compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; •The Audit Committee reviews the valuation report with the Adviser, and the Adviser responds and supplements the valuation report to reflect any discussions between the Adviser and the Audit Committee; and •The Adviser, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of June 30, 2023 and September 30, 2022 was determined by the Adviser, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms each quarter to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. When the Company determines its net asset value as of the last day of a month that is not also the last day of a calendar quarter, the Company intends to update the value of securities with reliable market quotations to the most recent market quotation. For securities without reliable market quotations, pursuant to the Company's valuation policy, the Adviser’s valuation team will generally value such assets at the most recent quarterly valuation or, in the case of securities acquired after such date, cost, unless, in either case, the Adviser determines that since the most recent quarter end or the date of acquisition for securities acquired after quarter end, as the case may be, a significant observable change has occurred with respect to the investment (which determination may be as a result of a material event at a portfolio company, material change in market spreads, secondary market transaction in the securities of an investment or otherwise). If the Adviser determines such a change has occurred with respect to one or more investments, the Adviser will determine whether to update the value for each relevant investment using a range of values from an independent valuation firm, where applicable, in accordance with the Company's valuation policy. Additionally, the Adviser may otherwise determine to update the most recent quarter end valuation of an investment without reliable market quotations that the Adviser considers to be material to the Company using a range of values from an independent valuation firm. With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax liability," and "credit facilities payable," which are reported at amortized cost, all assets and liabilities on the Consolidated Statements of Assets and Liabilities approximate fair value. The carrying value of the line items titled "due from affiliates," "interest receivable," "receivables from unsettled transactions," "accounts payable, accrued expenses and other liabilities," "dividends payable," "base management fee and incentive fee payable," "interest payable," "payables from unsettled transactions" and "due to affiliates" approximate fair value due to their short maturities. Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company. Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statement of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statement of Operations. Secured Borrowings: Securities sold and simultaneously repurchased at a premium are reported as financing transactions in accordance with FASB ASC Topic 860, Transfers and Servicing ("ASC 860"). Amounts payable to the counterparty are due on the repurchase settlement date and, excluding accrued interest, such amounts are presented in the accompanying Consolidated Statement of Assets and Liabilities as secured borrowings. Premiums payable are separately reported as accrued interest. Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash, and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of June 30, 2023 and September 30, 2022, there were no investments on non-accrual status. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. For the Company's secured borrowings, the interest earned on the entire loan balance is recorded within interest income and the interest earned by the counterparty is recorded within interest expense in the Consolidated Statements of Operations. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost bases of these investments in the consolidated financial statements including for purposes of computing the capital gains incentive fee payable by the Company to the Adviser. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s shareholders, even though the Company has not yet collected the cash and may never do so. Fee Income The Adviser or its affiliates may provide financial advisory services to portfolio companies in connection with structuring a transaction and in return the Company may receive fees for capital structuring services. These fees are generally nonrecurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment. Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less, when acquired. The Company places its cash and cash equivalents with financial institutions and, at times, cash held in bank accounts may exceed the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets. As of June 30, 2023, included in restricted cash was $3.6 million that was held at Citibank, N.A. in connection with the Company’s JPM Agreements (defined below). Pursuant to the terms of the JPM Agreements, the Company was restricted in terms of access to the $3.6 million until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the JPM Agreements. Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date. Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities. Deferred financing costs incurred in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs incurred in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Company's Consolidated Statement of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. Organization and Offering Costs: Costs associated with the organization of the Company will be expensed as incurred. Costs associated with the offering of Common Shares of the Company are capitalized as "deferred offering costs" on the Consolidated Statements of Assets and Liabilities and amortized over a twelve-month period from incurrence. For the three and nine months ended June 30, 2023, the Company incurred organization costs of zero and $4, respectively. For each of the three months ended June 30, 2022 and the period from December 10, 2021 (commencement of operations) to June 30, 2022, the Company expensed organization costs of $549. As of June 30, 2023 and September 30, 2022, $402 and $2,132, respectively, of offering costs were capitalized on the Consolidated Statements of Assets and Liabilities. For the three and nine months ended June 30, 2023, the Company amortized offering costs of $725 and $2,517, respectively. For each of the three months ended June 30, 2022 and the period from December 10, 2021 (commencement of operations) to June 30, 2022, the Company amortized offering costs of $255. Allocation of Income, Expenses, Gains and Losses: Income, expenses (other than those attributable to a specific class), gains and losses are allocated to each class of shares based upon the relative proportion of net assets represented by such class. Operating expenses directly attributable to a specific class are charged against the operations of that class. Distributions: To the extent that the Company has taxable income available, the Company intends to make monthly distributions to its shareholders. Distributions to shareholders are recorded on the record date. All distributions will be paid at the discretion of the Board and will depend on the Company’s earnings, financial condition, maintenance of our tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time. Although the gross distribution per share is generally equivalent for each share class, the net distribution for each share class is reduced for any class specific expenses, including distribution and shareholder servicing fees, if any. Income Taxes: On February 3, 2022, the Company elected to be regulated as a BDC under the Investment Company Act. The Company also intends to elect to be treated as a RIC under the Code as soon as reasonably practicable. So long as the Company maintains its status as a RIC, it generally will not pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that it distributes at least annually to its shareholders as dividends. Rather, any tax liability related to income earned and distributed by the Company would represent obligations of the Company’s investors and would not be reflected in the consolidated financial statements of the Company. The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax year 2022. To qualify for and maintain qualification as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to qualify for RIC tax treatment, the Company must distribute to its shareholders, for each taxable year, at least 90% of its “investment company taxable income” for that year, which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses. In addition, based on the excise tax distribution requirements, the Company is subject to a 4% nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner in each taxable year an amount at least equal to the sum of (1) 98% of its ordinary income for the calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income realized, but not distributed, in prior years. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to corporate income tax is considered to have been distributed. The Company did not incur a U.S. federal excise tax for calendar year 2022 and does not expect to incur a U.S. federal excise tax for calendar year 2023. The Company holds certain portfolio investments through a taxable subsidiary. The purpose of the Company's taxable subsidiary is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiary is consolidated for financial reporting purposes, and portfolio investments held by it are included in the Company’s consolidated financial statements as portfolio investments and recorded at fair value. The taxable subsidiary is not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statement of Operations. The Company uses the liability method to account for its taxable subsidiary's income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.
|
Portfolio Investments |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Portfolio Investments | Note 3. Portfolio Investments Portfolio Composition As of June 30, 2023, the fair value of the Company's investment portfolio was $1,279.2 million and was composed of investments in 108 portfolio companies. As of September 30, 2022, the fair value of the Company's investment portfolio was $428.6 million and was composed of investments in 81 portfolio companies. As of June 30, 2023 and September 30, 2022, the Company's investment portfolio consisted of the following:
The composition of the Company's debt investments as of June 30, 2023 and September 30, 2022 by floating rates and fixed rates was as follows:
The geographic composition of the Company's portfolio is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the portfolio composition by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets:
The composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of June 30, 2023 and September 30, 2022 was as follows:
Fair Value Measurements The following table presents the financial instruments carried at fair value as of June 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:
The following table presents the financial instruments carried at fair value as of September 30, 2022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:
When a determination is made to classify a financial instrument within Level 3 of the valuation hierarchy, the determination is based upon the fact that the unobservable factors are significant to the overall fair value measurement. However, Level 3 financial instruments typically have both unobservable or Level 3 components and observable components (i.e. components that are actively quoted and can be validated by external sources). Accordingly, the appreciation (depreciation) in the tables below includes changes in fair value due in part to observable factors that are part of the valuation methodology. The principal value of the borrowings outstanding under the ING Credit Agreement (as defined below) and the JPM Loan and Security Agreement (as defined below) approximates fair value due to its variable rate and is included in Level 3 of the hierarchy. The following table provides a roll-forward of the changes in fair value from March 31, 2023 to June 30, 2023, for all investments for which the Company determined fair value using unobservable (Level 3) factors:
(a) There were transfers out of Level 3 to Level 2 for certain investments during the three months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity. The following table provides a roll-forward of the changes in fair value from March 31, 2022 to June 30, 2022, for all investments for which the Company determined fair value using unobservable (Level 3) factors:
__________ (a) There were transfers into Level 3 from Level 2 for certain investments during the three months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity. The following table provides a roll-forward of the changes in fair value from September 30, 2022 to June 30, 2023, for all investments for which the Company determined fair value using unobservable (Level 3) factors:
(a) There were transfers into Level 3 from Level 2 for certain investments during the nine months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity. The following table provides a roll-forward of the changes in fair value from December 10, 2021 (commencement of operations) to June 30, 2022, for all investments for which the Company determined fair value using unobservable (Level 3) factors:
Significant Unobservable Inputs for Level 3 Investments The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which were carried at fair value as of June 30, 2023:
_____________________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participant would take into account market yield when pricing the investment. (c) Used when there is an observable transaction or pending event for the investment. (d) The Adviser generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. The Adviser evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (e) Used when market participant would use such multiple when pricing the investment. The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which were carried at fair value as of September 30, 2022:
_____________________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participant would take into account market yield when pricing the investment. (c) Used when there is an observable transaction or pending event for the investment. (d) The Adviser generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. The Adviser evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (e) Used when market participant would use such multiple when pricing the investment.
|
Fee Income |
9 Months Ended |
---|---|
Jun. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Fee Income | Fee Income For the three and nine months ended June 30, 2023, the Company recorded total fee income of $654 and $882, respectively, of which $27 and $188, respectively, was recurring in nature. For the three months ended June 30, 2022 and the period from December 10, 2021 (commencement of operations) to June 30, 2022, the Company recorded total fee income of $93 and $113, respectively, of which $20 and $40, respectively, was recurring in nature. Recurring fee income consisted of servicing fees and certain exit fees. |
Share Data and Net Assets |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share Data and Net Assets | Share Data and Distributions Changes in Net Assets The following table presents the changes in net assets for the three and nine months ended June 30, 2023:
The following table presents the changes in net assets for the three months ended June 30, 2022 and the period from December 10, 2021 (commencement of operations) to June 30, 2022:
Capital Activity In connection with its formation, the Company has the authority to issue an unlimited number of Class I, Class S and Class D common shares of beneficial interest at $0.01 per share par value. As of June 30, 2023, the Company has issued and sold 29,292,019 Class I shares for an aggregate purchase price of $699.6 million. As of June 30, 2023, the Company has issued and sold 13,523,516 Class S shares for an aggregate purchase price of $317.9 million. As of June 30, 2023, the Company has issued and sold 646 Class D shares for an aggregate purchase price of less than $0.1 million. As of June 30, 2023, the Company has issued 203,519 Class I shares and 201,271 Class S shares pursuant to its distribution reinvestment plan. The following table summarizes transactions in common shares of beneficial interest for the nine months ended June 30, 2023:
On December 10, 2021, an affiliate of the Adviser purchased 1,000,000 Class I shares for $25.0 million, or $25.00 per share, to provide the necessary capital to commence investing activities prior to the release of proceeds from escrow and the initial public offering. Net Asset Value per Share and Offering Price The Company determines NAV per share for each class of shares as of the last calendar day of each month. Share issuances pursuant to accepted monthly subscriptions are effective the first calendar day of each month. Shares are issued and sold at a purchase price equivalent to the most recent NAV per share available for each share class, which will be the prior calendar day NAV per share (i.e. the prior month-end NAV). The following table summarizes each month-end NAV per share for Class I, Class S and Class D shares utilized as the purchase price for shares issued and sold after the Company broke escrow:
Distributions The Board authorizes and declares monthly distribution amounts per share of outstanding Common Shares. The following table presents distributions that were declared during the nine months ended June 30, 2023:
Distribution Reinvestment Plan The Company has adopted a distribution reinvestment plan, pursuant to which the Company will reinvest all cash dividends declared by the Board on behalf of its shareholders who do not elect to receive their dividends in cash as provided below. As a result, if the Board authorizes, and the Company declares, a cash dividend or other distribution, then shareholders who have not opted out of the Company's distribution reinvestment plan will have their cash distributions automatically reinvested in additional shares, rather than receiving the cash dividend or other distribution. Distributions on fractional shares will be credited to each participating shareholder’s account to three decimal places. Character of Distributions The Company may fund its cash distributions to shareholders from any source of funds available to the Company, including but not limited to offering proceeds, net investment income from operations, capital gains proceeds from the sale of assets, dividends or other distributions paid to it on account of preferred and common equity investments in portfolio companies and expense support from the Adviser, which is subject to recoupment. Through June 30, 2023, a portion of the Company’s distributions resulted from expense support from the Adviser, and future distributions may result from expense support from the Adviser, each of which is subject to repayment by the Company within three years from the date of payment. The purpose of this arrangement is to avoid distributions being characterized as a return of capital for U.S. federal income tax purposes. Shareholders should understand that any such distribution is not based solely on the Company’s investment performance, and can only be sustained if the Company achieves positive investment performance in future periods and/or the Adviser continues to provide expense support. Shareholders should also understand that the Company’s future repayments of expense support will reduce the distributions that they would otherwise receive. There can be no assurance that the Company will achieve the performance necessary to sustain these distributions, or be able to pay distributions at all. Sources of distributions, other than net investment income and realized gains on a U.S. GAAP basis, include required adjustments to U.S. GAAP net investment income in the current period to determine taxable income available for distributions. The following tables reflect the sources of cash distributions on a U.S. GAAP basis that the Company has declared on its Common Shares for the nine months ended June 30, 2023:
Share Repurchase Program At the discretion of the Board of Trustees, during the quarter ended September 30, 2022 the Company commenced a share repurchase program pursuant to which the Company intends to offer to repurchase, in each quarter, up to 5% of Common Shares outstanding (either by number of shares or aggregate NAV) as of the close of the previous calendar quarter. The Board may amend or suspend the share repurchase program at any time if it deems such action to be in the best interest of shareholders. As a result, share repurchases may not be available each quarter. The Company intends to conduct such repurchase offers pursuant to tender offers in accordance with the requirements of Rule 13e-4 promulgated under the Securities Exchange Act of 1934, as amended, and the Investment Company Act. All shares purchased pursuant to the terms of each tender offer will be retired and thereafter will be authorized and unissued shares. Under the share repurchase program, to the extent the Company offers to repurchase shares in any particular quarter, it is expected to repurchase shares at the expiration of the tender offer at a purchase price equal to the NAV per share as of the last calendar day of the applicable quarter, except that shares that have not been outstanding for at least one year will be subject to an early repurchase deduction of 2% of such NAV (an “Early Repurchase Deduction”). The one-year holding period will be deemed satisfied if the shares to be repurchased would have been outstanding for one year or longer as of the subscription closing date immediately following the prospective repurchase date. The Early Repurchase Deduction may be waived in the case of repurchase requests arising from the death, divorce or qualified disability of the holder. The Early Repurchase Deduction will be retained by the Company for the benefit of remaining shareholders. On September 12, 2022, the Company’s initial tender offer under its share repurchase program expired, on December 13, 2022, the Company's tender offer conducted during the quarter ended December 31, 2022 under its share repurchase program expired, on March 15, 2023, the Company’s tender offer conducted during the quarter ended March 31, 2023 under its share repurchase program expired, and on June 12, 2023, the Company’s tender offer conducted during the quarter ended June 30, 2023 under its share repurchase program expired. There were 1,692 Class S shares repurchased during the three and nine months ended June 30, 2023 for a repurchase price equal to 98% of the Company's net asset value per share as of June 30, 2023, which was $23.48 per share.
|
Borrowings |
9 Months Ended |
---|---|
Jun. 30, 2023 | |
Debt Disclosure [Abstract] | |
Borrowings | Borrowings ING Credit Agreement On March 25, 2022 (the “ING Closing Date”), the Company entered into a senior secured revolving credit agreement (the “ING Credit Agreement”) among the Company, as borrower, the lenders party thereto, and ING Capital LLC (“ING”), as administrative agent. Effective on and as of May 25, 2022, the Company entered into an incremental commitment and assumption agreement (the “Incremental Commitment and Assumption Agreement”) among the Company, as borrower, the subsidiary guarantor party thereto (the “Subsidiary Guarantor”), ING, as administrative agent and issuing bank, Sumitomo Mitsui Banking Corporation and MUFG Bank, LTD, (together with Sumitomo Mitsui Banking Corporation, the “Assuming Lenders”). Pursuant to the Incremental Commitment and Assumption Agreement, among other things, each Assuming Lender (i) became a Lender (as defined in the ING Credit Agreement) under the ING Credit Agreement and (ii) agreed to make a Commitment (as defined in the ING Credit Agreement) to the Company in the amount of $150 million. The Incremental Commitment and Assumption Agreement increased the aggregate amount of Commitments under the ING Credit Agreement from $150 million to $450 million (the "Maximum Commitment"), subject to the lesser of (i) a borrowing base and (ii) the Maximum Commitment, and provided that, with respect to any lender, its individual commitment is not exceeded. The revolving credit facility has a four year availability period (the “Availability Period”) during which loans may be made and the ING Credit Agreement has a stated maturity dated that is five years from the ING Closing Date (the “Maturity Date”). Following the Availability Period the Company will be required in certain circumstances to prepay loans prior to the Maturity Date. The ING Credit Agreement provides for the issuance of letters of credit during the Availability Period in an aggregate amount of $25 million. Borrowing under the ING Credit Agreement may be used for general corporate purposes, including making investments and permitted distributions. Effective on and as of October 6, 2022, the Company entered into a subsequent incremental commitment and assumption agreement (the “Subsequent Incremental Commitment and Assumption Agreement”) among the Company, as borrower, the Subsidiary Guarantor, ING, as administrative agent and issuing bank, and Apple Bank For Savings, as an Assuming Lender. Pursuant to the Subsequent Incremental Commitment and Assumption Agreement, Apple Bank For Savings (i) became a Lender under the ING Credit Agreement and (ii) agreed to make a Commitment to the Company in the amount of $40 million. The Subsequent Incremental Commitment and Assumption Agreement increased the aggregate amount of Commitments under the ING Credit Agreement from $450 million to $490 million. Effective on and as of June 28, 2023 (the “New Effective Date”), the Company entered into Amendment No. 1 (the “ING Credit Agreement Amendment”) to the ING Credit Agreement. As a result of the ING Credit Agreement Amendment, the ING Credit Agreement provides for a senior secured revolving credit facility of up to $1,110 million (the “Increased Maximum Commitment”), increased from $490 million, subject to the lesser of (i) a borrowing base and (ii) the Increased Maximum Commitment, and provided that, with respect to any lender, its individual commitment is not exceeded. The revolving credit facility has a four year availability period (the “New Availability Period”) commencing from the New Effective Date during which loans may be made and a stated maturity date that is five years from the New Effective Date (the “New Maturity Date”). Following the New Availability Period, the Company will be required in certain circumstances to prepay loans prior to the New Maturity Date. The ING Credit Agreement provides for the issuance of letters of credit during the New Availability Period in an aggregate amount of $25 million. Borrowing under the ING Credit Agreement may be used for general corporate purposes, including making investments and permitted distributions. All obligations under the ING Credit Agreement are secured by a first-priority security interest (subject to certain exceptions) in substantially all of the present and future property and assets of the Company and of the sole current and certain future subsidiaries of the Company and guaranteed by such subsidiaries. Borrowings under the ING Credit Agreement shall be denominated in U.S. Dollars and bore, prior to the New Effective Date, interest at a rate per annum equal to either (1) SOFR, as adjusted, plus 1.875% per annum or (2) the alternative base rate (which is the greatest of the (a) prime rate, (b) the federal funds effective rate plus ½ of 1%, (c) the overnight bank funding rate plus ½ of 1%, (d) certain rates based on SOFR and (e) 0) (“ABR”) plus 0.875% per annum. On and after the New Effective Date, borrowings under the ING Credit Agreement bear interest at a rate per annum equal to either (1) the SOFR, as adjusted, plus 2.15% per annum, or, following the first year after the New Effective Date, plus 2.05% per annum if the Company has and maintains an investment grade credit rating or (2) the alternative base rate (which is the greatest of the (a) prime rate, (b) the federal funds effective rate plus ½ of 1%, (c) the overnight bank funding rate plus ½ of 1%, (d) certain rates based on SOFR and (e) 0) (“ABR”) plus 1.15% per annum or, following the first year after the New Effective Date, plus 1.05% per annum if the Company has and maintains investment grade credit rating. The Company may elect either an ABR or SOFR borrowing at each drawdown request, and loans may be converted from one rate to another at any time at the Company’s option, subject to certain conditions. Prior to the New Effective Date, the Company paid a commitment fee at a rate of 0.375% per annum on the daily unused portion of the aggregate commitments under the ING Credit Agreement. On and after the New Effective Date, the Company will pay a commitment fee at a rate of 0.375% per annum on the daily unused portion of the aggregate commitments under the ING Credit Agreement, subject to increase to 1.00% per annum on the daily unused amount if the daily unused amount is greater than or equal to 65% of the aggregate commitments under the ING Credit Agreement. At any time during the New Availability Period, the Company may propose an increase in the Increased Maximum Commitment to an amount not to exceed the greater of (a) $1,250.0 million and (b) 150% of shareholders’ equity as of the date on which such increased amount is to be effective, subject to certain conditions, including the consent of the lenders to increase their commitments and of ING. The Company has made customary representations and warranties and is required to comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar credit facilities. Borrowings under the ING Credit Agreement are subject to the leverage restrictions contained in the Investment Company Act. The ING Credit Agreement contains customary events of default for similar financing transactions. Upon the occurrence and during the continuation of an event of default, ING may terminate the commitments and declare the outstanding loans and all other obligations under the ING Credit Agreement immediately due and payable. As of June 30, 2023 and September 30, 2022, the Company had $275.0 million and $75.0 million outstanding under the ING Credit Agreement. For the nine months ended June 30, 2023, the Company’s borrowings under the ING Credit Agreement bore interest at a weighted average rate of 6.55%. For the period from December 10, 2021 (commencement of operations) to June 30, 2022, the Company’s borrowings under the ING Facility bore interest at a weighted average rate of 3.38%. The Company recorded $3,999 and $10,018 of interest expense (inclusive of fees), respectively, related to the ING Credit Agreement for the three and nine months ended June 30, 2023. The Company recorded $953 and $1,018 of interest expense (inclusive of fees) related to the ING Facility for the three months ended June 30, 2022 and the period from December 10, 2021 (commencement of operations) to June 30, 2022. JPM SPV Facility On February 24, 2023 (the “JPM Closing Date”), the Company entered into a loan and security agreement (as amended, the “JPM Loan and Security Agreement”) among OSCF Lending SPV, LLC (“OSCF Lending SPV”), a wholly owned subsidiary of the Company, as borrower, the Company, as parent and servicer, Citibank, N.A., as collateral agent and securities intermediary, Virtus Group, LP, as collateral administrator, the lenders party thereto, and JPMorgan Chase Bank, National Association (“JPM”), as administrative agent, pursuant to which JPM agreed to extend credit to OSCF Lending SPV in an aggregate principal amount up to $150 million at any one time outstanding. Effective on and as of July 5, 2023, the Company entered into Amendment No. 1 (the “JPM Loan and Security Agreement Amendment”) to the JPM Loan and Security Agreement, pursuant to which JPM has increased its commitment to extend credit to OSCF Lending SPV to an aggregate principal amount up to $300 million (the “JPM Maximum Commitment”). The JPM Loan and Security Agreement provides for a senior secured revolving credit facility that has a three-year reinvestment period (the “JPM Availability Period”) and a stated maturity date that is five years after the JPM Closing Date. Subject to certain conditions, including consent of the lenders and JPM, as administrative agent, at any time during the JPM Availability Period, OSCF Lending SPV may propose one or more increases in the JPM Maximum Commitment up to an amount not to exceed $500 million. Borrowings under the JPM Loan and Security Agreement shall be denominated in U.S. Dollars and bear interest at a rate per annum equal to the forward-looking term rate with a three-month tenor, based on the secured overnight financing rate as administered by the Federal Reserve Bank of New York (or a successor administrator), and as published by CME Group Benchmark Administration Limited (or a successor administrator), plus 2.95%. The obligations of OSCF Lending SPV under the JPM Loan and Security Agreement are secured by all of the assets held by OSCF Lending SPV, including certain loans sold or to be sold or transferred or to be transferred by the Company to OSCF Lending SPV (such loans, the “Loans”) pursuant to the terms of the Sale and Participation Agreement, dated as of the JPM Closing Date (the “JPM Sale Agreement” and, together with the JPM Loan and Security Agreement, the “JPM Agreements”), between OSCF Lending SPV, as buyer, and the Company, as seller, pursuant to which the Company will sell Loans to OSCF Lending SPV from time to time. Under the Agreements, the Company and OSCF Lending SPV, as applicable, have made representations and warranties regarding the Loans, as well as their businesses, and are required to comply with various covenants, servicing procedures, limitations on the disposition of Loans, reporting requirements and other customary requirements for similar revolving funding facilities. Borrowings under the JPM Loan and Security Agreement are subject to various covenants under the JPM Agreements as well as the asset coverage requirement contained in the Investment Company Act of 1940, as amended. As of June 30, 2023, OSCF Lending SPV had $50.0 million outstanding under the JPM Loan and Security Agreement. For the nine months ended June 30, 2023, OSCF Lending SPV’s borrowings under the JPM Loan and Security Agreement bore interest at a weighted average rate of 7.97%. The Company recorded $1,216 and $1,577 of interest expense (inclusive of fees), respectively, related to the JPM Loan and Security Agreement for the three and nine months ended June 30, 2023. Secured Borrowings As of June 30, 2023 and September 30, 2022, there were no secured borrowings outstanding. The Company did not record any interest expense in connection with secured borrowings for the three and nine months ended June 30, 2023. The Company recorded $256 of interest expense in connection with secured borrowings for the period from December 10, 2021 (commencement of operations) to June 30, 2022. There was no interest expense for the three months ended June 30, 2022. The Company's secured borrowings bore interest at a weighted average rate of 3.00% for the period from December 10, 2021 (commencement of operations) to June 30, 2022.
|
Taxable/Distributable Income |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taxable/Distributable Income | Taxable/Distributable Income Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to unrealized appreciation (depreciation) on investments and foreign currency, as gains and losses are not included in taxable income until they are realized. Presented below is a reconciliation of net increase (decrease) in net assets resulting from operations to taxable income for three months ended June 30, 2023 and 2022, nine months ended June 30, 2023 and the period from December 10, 2021 (commencement of operations) to June 30, 2022:
__________________ (1)The Company's taxable income for the three and nine months ended June 30, 2023 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2023. The final taxable income may be different than the estimate. For the three months ended June 30, 2023, the Company recognized a total provision for income tax expense of $71, which was comprised of a current tax expense of $97 and a deferred income tax benefit of $26 that resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries. For the nine months ended June 30, 2023, the Company recognized a total provision for income tax expense of $176, which was comprised of a current tax expense of $219 and a deferred income tax benefit of $43 that resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries. As of September 30, 2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows:
The aggregate cost of investments for U.S. federal income tax purposes was $444.5 million as of September 30, 2022. As of September 30, 2022, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $1.8 million. As of September 30, 2022, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was $17.7 million. Net unrealized depreciation based on the aggregate cost of investments for U.S. federal income tax purposes was $15.9 million.
|
Concentration of Credit Risk |
9 Months Ended |
---|---|
Jun. 30, 2023 | |
Risks and Uncertainties [Abstract] | |
Concentration of Credit Risk | Concentration of Credit RisksThe Company deposits its cash with financial institutions and at times such balances may be in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability. |
Related Party Transactions |
9 Months Ended | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||
Related Party Transactions [Abstract] | |||||||||||||||||||||||||||||||
Related Party Transactions | Related Party Transactions Investment Advisory Agreement Effective as of February 3, 2022, the Company has entered into the Investment Advisory Agreement with the Adviser. The Company will pay the Adviser a fee for its services consisting of two components: a management fee and an incentive fee. Management Fee Under the Investment Advisory Agreement, the management fee is payable monthly in arrears at an annual rate of 1.25% of the value of the Company's net assets as of the beginning of the first calendar day of the applicable month. For purposes of calculating the management fee, net assets means the Company's total net assets determined on a consolidated basis in accordance with GAAP. For the first calendar month in which the Company had operations, net assets were measured as of June 1, 2022, the date on which the Company broke escrow. In addition, the Adviser waived its management fee through November 2022, the first six months following June 1, 2022, the date on which the Company broke escrow for its continuous offering. For the three months ended June 30, 2023, base management fees were $2,817. For the nine months ended June 30, 2023, base management fees were $6,183, of which $877 was waived. For each of the three months ended June 30, 2022 and the period from December 10, 2021 (commencement of operations) to June 30, 2022, base management fees representing $286 were fully waived. Incentive Fee The Incentive Fee consists of two parts: the Investment Income Incentive Fee and the Capital Gains Incentive Fee (each defined below) (collectively referred to as the "Incentive Fee"). Investment Income Incentive Fee The Investment Income Incentive Fee is calculated based on the Company’s Pre-Incentive Fee Net Investment Income, which means consolidated interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies) accrued during the calendar quarter, minus the Company's operating expenses accrued for the quarter (including the management fee, expenses payable under the Administration Agreement entered into between the Company and the Administrator, and any interest expense or fees on any credit facilities or outstanding debt and dividends paid on any issued and outstanding preferred shares, but excluding the Incentive Fee and any distribution and/or shareholder servicing fees). Pre-Incentive Fee Net Investment Income includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with payment-in-kind interest and zero-coupon securities), accrued income that has not yet been received in cash. For the avoidance of doubt, Pre-Incentive Fee Net Investment Income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The impact of any expense support payments and recoupments are also excluded from Pre-Incentive Fee Net Investment Income. Pre-Incentive Fee Net Investment Income, expressed as a rate of return on the value of the Company's net assets at the end of the immediately preceding quarter, is compared to a hurdle of 1.25% per quarter (5.0% annualized) (the “Hurdle Rate”). The Company will pay the Adviser an incentive fee quarterly in arrears with respect to the Company's Pre-Incentive Fee Net Investment Income in each calendar quarter as follows: •Hurdle Rate Return: No incentive fee based on Pre-Incentive Fee Net Investment Income in any calendar quarter in which the Company's Pre-Incentive Fee Net Investment Income does not exceed the Hurdle Rate; •Catch-Up: 100% of the Pre-Incentive Fee Net Investment Income, if any, that exceeds the Hurdle Rate but is less than a 1.4286% (5.714% annualized) rate of return in any such calendar quarter (the “Catch-Up”), which is intended to provide the Adviser with approximately 12.5% of the Pre-Incentive Fee Net Investment Income as if the Hurdle Rate did not apply, if the Pre-Incentive Fee Net Investment Income exceeds the Hurdle Rate in any calendar quarter; and •87.5/12.5 Split: 12.5% of the Pre-Incentive Fee Net Investment Income, if any, that exceeds a 1.4286% (5.714% annualized) rate of return in such calendar quarter so that once the Hurdle Rate is reached and the Catch-Up is achieved, 12.5% of the Pre-Incentive Fee Net Investment Income thereafter is allocated to the Adviser. The Adviser waived the Investment Income Incentive Fee through November 2022, the first six months following June 1, 2022, the date on which the Company broke escrow for its continuous offering. For the three months ended June 30, 2023, the Investment Income Incentive Fee was $2,835. For the nine months ended June 30, 2023, the Investment Income Incentive Fee was $5,808, of which $765 was waived. Capital Gains Incentive Fee In addition to the Investment Income Incentive Fee described above, commencing on September 30, 2022, the Adviser is entitled to receive a Capital Gains Incentive Fee (as defined below). The Capital Gains Incentive Fee is determined and payable in arrears as of the end of each fiscal year. The Capital Gains Incentive Fee is equal to 12.5% of the realized capital gains, if any, on a cumulative basis from inception through the end of each fiscal year, computed net of all realized capital losses on a cumulative basis and unrealized capital depreciation, less the aggregate amount of any previously paid Capital Gains Incentive Fee, provided, that the Capital Gains Incentive Fee determined as of September 30, 2022 is calculated for a period of shorter than 12 calendar months to take into account any realized capital gains computed net of all realized capital losses and unrealized capital depreciation from the date of inception through the end of the fiscal year 2022 (the “Capital Gains Incentive Fee”). The payment obligation with respect to the Capital Gains Incentive Fee is allocated in the same manner across the Class S shares, Class D shares and Class I shares. Although the Capital Gains Incentive Fee due to the Adviser is not payable until it is contractually due based on the Investment Advisory Agreement, the Company accrues this component at the end of each reporting period based on the Company’s realized capital gains, if any, on a cumulative basis from inception through the end of each reporting period, computed net of all realized capital losses on a cumulative basis and unrealized capital depreciation, less the aggregate amount of any previously paid Capital Gains Incentive Fee, as contractually included in the calculation of the Capital Gains Incentive Fee, plus the cumulative amount of unrealized capital appreciation. If such amount is positive at the end of a period, then the Company will accrue an incentive fee equal to 12.5% of such amount. If such amount is negative, then there will be no accrual for such period or an appropriate reduction in any amount previously accrued. U.S. GAAP requires that the Capital Gains Incentive Fee accrual consider cumulative unrealized capital appreciation in the calculation, as a Capital Gains Incentive Fee would be payable if such unrealized capital appreciation were realized. There can be no assurance that such unrealized capital appreciation will be realized in the future. For the three and nine months ended June 30, 2023, there was no accrued Capital Gains Incentive Fee. Administration Agreement Effective as of February 3, 2022, the Company has entered into an Administration Agreement (as amended and restated, the “Administration Agreement”) with Oaktree Fund Administration, LLC (the “Administrator”), an affiliate of the Adviser. Pursuant to the Administration Agreement, the Administrator furnishes the Company with office facilities (certain of which are located in buildings owned by a Brookfield affiliate), equipment and clerical, bookkeeping and recordkeeping services at such facilities. Under the Administration Agreement, the Administrator performs, or oversees the performance of, the Company’s required administrative services, which include, among other things, providing assistance in accounting, legal, compliance, operations, technology and investor relations, and being responsible for the financial records that the Company is required to maintain and preparing reports to shareholders and reports filed with the SEC. In addition, the Administrator assists the Company in determining and publishing the NAV, overseeing the preparation and filing of tax returns and the printing and dissemination of reports to the Company’s shareholders, and generally overseeing the payment of expenses and the performance of administrative and professional services rendered to the Company by others. Payments under the Administration Agreement are equal to an amount that reimburses the Administrator for its costs and expenses incurred in performing its obligations under the Administration Agreement and providing personnel and facilities. The Company bears all of the costs and expenses of any sub-administration agreements that the Administrator enters into. For the avoidance of doubt, the Company bears its allocable portion of the costs of the compensation, benefits, and related administrative expenses (including travel expenses) of the Company’s officers who provide operational and administrative services under the Administration Agreement, their respective staffs and other professionals who provide services to the Company (including, in each case, employees of the Administrator or an affiliate) who assist with the preparation, coordination, and administration of the foregoing or provide other “back office” or “middle office” financial or operational services to the Company. The Company reimburses the Administrator (or its affiliates) for an allocable portion of the compensation paid by the Administrator (or its affiliates) to such individuals (based on a percentage of time such individuals devote, on an estimated basis, to the Company’s business and affairs and to acting on the Company’s behalf). The Company's Board reviews the fees payable under the Administration Agreement to determine that these fees are reasonable and comparable to administrative services charged by unaffiliated third parties. For the three and nine months ended June 30, 2023, the Company incurred $349 and $889, respectively, of expenses under the Administration Agreement, of which $267 and $711, respectively, was included in administrator expense, $58 and $146, respectively, was included in general and administrative expenses and $24 and $32, respectively, was included in organization expenses and amortization of continuous offering costs on the Consolidated Statements of Operations. For the three months ended June 30, 2022 and the period from December 10, 2021 (commencement of operations) to June 30, 2022, the Company incurred $115 and $145 of expenses under the Administration Agreement, of which $60 and $84, respectively, was included in administrator expense, $13 and $19, respectively, was included in general and administrative expenses and $42 and $42, respectively, was included in organization expenses and amortization of offering costs on the Consolidated Statements of Operations. Certain Terms of the Investment Advisory Agreement and Administration Agreement Each of the Investment Advisory Agreement and the Administration Agreement is effective as of February 3, 2022. Unless earlier terminated as described below, each of the Investment Advisory Agreement and the Administration Agreement will remain in effect for a period of two years from the date it first becomes effective and will remain in effect from year-to-year thereafter if approved annually by a majority of the Board or by the holders of a majority of the Company’s outstanding voting securities and, in each case, a majority of the independent Trustees. The Company may terminate the Investment Advisory Agreement or the Administration Agreement, without payment of any penalty, upon 60 days’ written notice. In addition, without payment of any penalty, the Adviser may terminate the Investment Advisory Agreement upon 120 days’ written notice and the Administrator may terminate the Administration Agreement upon 60 days’ written notice. The Investment Advisory Agreement will automatically terminate in the event of its assignment within the meaning of the Investment Company Act and related SEC guidance and interpretations. Distribution Manager Agreement Effective as of February 3, 2022, the Company has entered into a Distribution Manager Agreement (as amended and restated, the “Distribution Manager Agreement”) with Brookfield Oaktree Wealth Solutions LLC (the “Distribution Manager”), an affiliate of the Adviser. Under the terms of the Distribution Manager Agreement, the Distribution Manager serves as the distribution manager for the Company’s initial offering of Common Shares. The Distribution Manager is entitled to receive distribution and/or shareholder servicing fees monthly in arrears at an annual rate of 0.85% of the value of the Company’s net assets attributable to Class S shares as of the beginning of the first calendar day of the month. The Distribution Manager is entitled to receive distribution and/or shareholder servicing fees monthly in arrears at an annual rate of 0.25% of the value of the Company’s net assets attributable to Class D shares as of the beginning of the first calendar day of the month. No distribution and/or shareholding servicing fees are paid with respect to Class I shares. The distribution and/or shareholder servicing fees are payable to the Distribution Manager, but the Distribution Manager anticipates that all or a portion of the shareholder servicing fees will be retained by, or reallowed (paid) to, participating broker-dealers. The Company will cease paying the shareholder servicing and/or distribution fee on the Class S shares and Class D shares on the earlier to occur of the following: (i) a listing of Class I shares, (ii) a merger or consolidation with or into another entity, or the sale or other disposition of all or substantially all of the Company's assets or (iii) the date following the completion of the primary portion of the initial offering on which, in the aggregate, underwriting compensation from all sources in connection with the initial offering, including the shareholder servicing and/or distribution fee and other underwriting compensation, is equal to 10% of the gross proceeds from the initial offering. In addition, consistent with the exemptive relief allowing the Company to offer multiple classes of shares, at the end of the month in which the Distribution Manager in conjunction with the transfer agent determines that total transaction or other fees, including upfront placement fees or brokerage commissions, and shareholder servicing and/or distribution fees paid with respect to the shares held in a shareholder’s account would exceed, in the aggregate, 10% of the gross proceeds from the sale of such shares (or a lower limit as determined by the Distribution Manager or the applicable selling agent), the Company will cease paying the shareholder servicing and/or distribution fee on the Class S shares and Class D shares in such shareholder’s account. Compensation paid with respect to the shares in a shareholder’s account will be allocated among each share such that the compensation paid with respect to each individual share will not exceed 10% of the offering price of such share. The Company may modify this requirement in a manner that is consistent with applicable exemptive relief. At the end of such month, the applicable Class S shares or Class D shares in such shareholder’s account will convert into a number of Class I shares (including any fractional shares), with an equivalent aggregate NAV as such Class S or Class D shares. The Distribution Manager is a broker-dealer registered with the SEC and is a member of the Financial Industry Regulatory Authority (“FINRA”). Either party may terminate the Distribution Manager Agreement upon 60 days’ written notice to the other party or immediately upon notice to the other party in the event such other party failed to comply with a material provision of the Distribution Manager Agreement. The Company's obligations under the Distribution Manager Agreement to pay the shareholder servicing and/or distribution fees with respect to the Class S and Class D shares will survive termination of the agreement until such shares are no longer outstanding (including such shares that have been converted into Class I shares, as described above). Distribution and Servicing Plan Effective as of February 3, 2022, the Company established a distribution and servicing plan (the “Distribution and Servicing Plan”). The following table shows the shareholder servicing and/or distribution fees the Company pays the Distribution Manager with respect to the Class S, Class D and Class I on an annualized basis as a percentage of the Company’s NAV for such class.
The shareholder servicing and/or distribution fees is paid monthly in arrears, calculated using the NAV of the applicable class as of the beginning of the first calendar day of the month and subject to FINRA and other limitations on underwriting compensation. The Distribution Manager will reallow (pay) all or a portion of the shareholder servicing and/or distribution fees to participating brokers and servicing brokers for ongoing shareholder services performed by such brokers, and will waive shareholder servicing and/or distribution fees to the extent a broker is not eligible to receive it for failure to provide such services. Because the shareholder servicing and/or distribution fees with respect to Class S shares and Class D shares are calculated based on the aggregate NAV for all of the outstanding shares of each such class, it reduces the NAV with respect to all shares of each such class, including shares issued under the Company’s distribution reinvestment plan. Broker eligibility to receive the shareholder servicing and/or distribution fee is conditioned on a broker providing the following ongoing services with respect to the Class S or Class D shares: assistance with recordkeeping, answering investor inquiries regarding the Company, including regarding distribution payments and reinvestments, helping investors understand their investments upon their request, and assistance with share repurchase requests. The shareholder servicing and/or distribution fees are ongoing fees that are not paid at the time of purchase. For the three and nine months ended June 30, 2023, the Company recorded distribution and shareholder servicing fees of $589 and $1,116, respectively, primarily all of which were attributable to Class S shares. The Company did not record any distribution and shareholder servicing fees for the three and nine months ended June 30, 2022. Expense Support and Conditional Reimbursement Agreement Effective as of February 3, 2022, the Company has entered into an Expense Support and Conditional Reimbursement Agreement (the “Expense Support Agreement”) with the Adviser. The Adviser may elect to pay certain expenses (each, an “Expense Payment”), provided that no portion of the payment will be used to pay any interest or distribution and/or shareholder servicing fees of the Company. Any Expense Payment that the Adviser has committed to pay must be paid by the Adviser to the Company in any combination of cash or other immediately available funds no later than forty-five days after such commitment was made in writing, and/or offset against amounts due from the Company to the Adviser or its affiliates. Following any calendar month in which Available Operating Funds (as defined below) exceed the cumulative distributions accrued to the Company’s shareholders based on distributions declared with respect to record dates occurring in such calendar month (the amount of such excess being hereinafter referred to as “Excess Operating Funds”), the Company shall pay such Excess Operating Funds, or a portion thereof, to the Adviser until such time as all Expense Payments made by the Adviser to the Company within three years prior to the last business day of such calendar month have been reimbursed. Any payments required to be made by the Company shall be referred to herein as a “Reimbursement Payment.” “Available Operating Funds” means the sum of (i) net investment company taxable income (including net short-term capital gains reduced by net long-term capital losses), (ii) net capital gains (including the excess of net long-term capital gains over net short-term capital losses) and (iii) dividends and other distributions paid to the Company on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above). The Company’s obligation to make a Reimbursement Payment shall automatically become a liability of the Company on the last business day of the applicable calendar month, except to the extent the Adviser has waived its right to receive such payment for the applicable month. For the nine months ended June 30, 2023, the Adviser made Expense Payments in the amount of $852. For the three and nine months ended June 30, 2023, the Company made reimbursement payments of $348 to the Adviser.
|
Financial Highlights |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment Company [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Highlights | Note 10. Financial Highlights
|
Commitments and Contingencies |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies | Note 11. Commitments and Contingencies Off-Balance Sheet Arrangements The Company is a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As indicated in the table below, as of June 30, 2023, off-balance sheet arrangements consisted of $196,628 of unfunded commitments to provide debt financing to certain of the Company's portfolio companies. As of September 30, 2022, off-balance sheet arrangements consisted of $68,962 of unfunded commitments to provide debt financing to certain of the Company's portfolio companies. Such commitments are subject to the portfolio company's satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities. A list of unfunded commitments by investment as of June 30, 2023 and September 30, 2022 is shown in the table below:
|
Subsequent Events |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subsequent Events [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subsequent Events | Subsequent Events The Company's management evaluated subsequent events through the date of issuance of the consolidated financial statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of and for the three months ended June 30, 2023, except as discussed below. Share Issuance On July 3, 2023, the Company issued and sold pursuant to its continuous public offering 7,791,302 Class I shares for proceeds of $182.9 million, 2,162,785 Class S shares for proceeds of $50.8 million and 3,407 Class D shares for proceeds of $0.1 million. Distributions On July 24, 2023, the Board of Trustees of the Company declared a regular distribution on its outstanding common shares of beneficial interest in the amount per share set forth below:
The distribution is payable to shareholders of record as of July 31, 2023 and will be paid on or about August 29, 2023. The distribution will be paid in cash or reinvested in Common Shares for shareholders participating in the Company’s distribution reinvestment plan. JPM SPV Facility Amendment Effective on and as of July 5, 2023, the Company entered into the JPM Loan and Security Agreement Amendment. As a result of the JPM Loan and Security Agreement Amendment, the JPM Maximum Commitment was increased to $300 million.
|
N-2 - USD ($) $ / shares in Units, $ in Millions |
9 Months Ended | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
May 31, 2023 |
Apr. 30, 2023 |
Mar. 31, 2023 |
Feb. 28, 2023 |
Jan. 31, 2023 |
Dec. 31, 2022 |
Nov. 30, 2022 |
Oct. 31, 2022 |
Sep. 30, 2022 |
Aug. 31, 2022 |
Jul. 31, 2022 |
May 31, 2022 |
Mar. 31, 2022 |
Dec. 10, 2021 |
|
Cover [Abstract] | ||||||||||||||||
Entity Central Index Key | 0001872371 | |||||||||||||||
Amendment Flag | false | |||||||||||||||
Securities Act File Number | 814-01471 | |||||||||||||||
Document Type | 10-Q | |||||||||||||||
Entity Registrant Name | Oaktree Strategic Credit Fund | |||||||||||||||
Entity Address, Address Line One | 333 South Grand Avenue | |||||||||||||||
Entity Address, Address Line Two | 28th Floor | |||||||||||||||
Entity Address, City or Town | Los Angeles | |||||||||||||||
Entity Address, State or Province | CA | |||||||||||||||
Entity Address, Postal Zip Code | 90071 | |||||||||||||||
City Area Code | 213 | |||||||||||||||
Local Phone Number | 830-6300 | |||||||||||||||
Entity Emerging Growth Company | true | |||||||||||||||
Entity Ex Transition Period | true | |||||||||||||||
Financial Highlights [Abstract] | ||||||||||||||||
Senior Securities Amount (Deprecated 2023-01-31) | $ 325.0 | $ 90.0 | ||||||||||||||
General Description of Registrant [Abstract] | ||||||||||||||||
Investment Objectives and Practices [Text Block] | Our investment objective is to generate stable current income and long-term capital appreciation. We seek to meet our investment objective by primarily investing in private debt opportunities. We have the authority to issue an unlimited number of common shares of beneficial interest, par value $0.01 per share (“Common Shares”). We are offering on a best efforts, continuous basis up to $5.0 billion aggregate offering price of Common Shares (the “Maximum Offering Amount”) pursuant to an offering registered with the SEC. We offer to sell any combination of three classes of Common Shares, Class S shares, Class D shares and Class I shares, with a dollar value up to the Maximum Offering Amount. The share classes have different ongoing distribution and/or shareholder servicing fees. We accepted purchase orders and held investors’ funds in an interest-bearing escrow account until we received purchase orders for Common Shares of at least $100.0 million, excluding subscriptions by Oaktree Fund GP I, L.P. in respect of the Class I shares purchased by Oaktree Fund GP I, L.P. prior to March 31, 2022, in any combination of purchases of Class S shares, Class D shares and Class I shares.
|
|||||||||||||||
NAV Per Share | $ 23.48 | $ 23.71 | $ 23.47 | |||||||||||||
ING Credit Agreement [Member] | ||||||||||||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||||||||||||
Long Term Debt, Title [Text Block] | ING Credit Agreement | |||||||||||||||
Long Term Debt, Structuring [Text Block] | On March 25, 2022 (the “ING Closing Date”), the Company entered into a senior secured revolving credit agreement (the “ING Credit Agreement”) among the Company, as borrower, the lenders party thereto, and ING Capital LLC (“ING”), as administrative agent. Effective on and as of May 25, 2022, the Company entered into an incremental commitment and assumption agreement (the “Incremental Commitment and Assumption Agreement”) among the Company, as borrower, the subsidiary guarantor party thereto (the “Subsidiary Guarantor”), ING, as administrative agent and issuing bank, Sumitomo Mitsui Banking Corporation and MUFG Bank, LTD, (together with Sumitomo Mitsui Banking Corporation, the “Assuming Lenders”). Pursuant to the Incremental Commitment and Assumption Agreement, among other things, each Assuming Lender (i) became a Lender (as defined in the ING Credit Agreement) under the ING Credit Agreement and (ii) agreed to make a Commitment (as defined in the ING Credit Agreement) to the Company in the amount of $150 million. The Incremental Commitment and Assumption Agreement increased the aggregate amount of Commitments under the ING Credit Agreement from $150 million to $450 million (the "Maximum Commitment"), subject to the lesser of (i) a borrowing base and (ii) the Maximum Commitment, and provided that, with respect to any lender, its individual commitment is not exceeded. The revolving credit facility has a four year availability period (the “Availability Period”) during which loans may be made and the ING Credit Agreement has a stated maturity dated that is five years from the ING Closing Date (the “Maturity Date”). Following the Availability Period the Company will be required in certain circumstances to prepay loans prior to the Maturity Date. The ING Credit Agreement provides for the issuance of letters of credit during the Availability Period in an aggregate amount of $25 million. Borrowing under the ING Credit Agreement may be used for general corporate purposes, including making investments and permitted distributions. Effective on and as of October 6, 2022, the Company entered into a subsequent incremental commitment and assumption agreement (the “Subsequent Incremental Commitment and Assumption Agreement”) among the Company, as borrower, the Subsidiary Guarantor, ING, as administrative agent and issuing bank, and Apple Bank For Savings, as an Assuming Lender. Pursuant to the Subsequent Incremental Commitment and Assumption Agreement, Apple Bank For Savings (i) became a Lender under the ING Credit Agreement and (ii) agreed to make a Commitment to the Company in the amount of $40 million. The Subsequent Incremental Commitment and Assumption Agreement increased the aggregate amount of Commitments under the ING Credit Agreement from $450 million to $490 million. Effective on and as of June 28, 2023 (the “New Effective Date”), the Company entered into Amendment No. 1 (the “ING Credit Agreement Amendment”) to the ING Credit Agreement. As a result of the ING Credit Agreement Amendment, the ING Credit Agreement provides for a senior secured revolving credit facility of up to $1,110 million (the “Increased Maximum Commitment”), increased from $490 million, subject to the lesser of (i) a borrowing base and (ii) the Increased Maximum Commitment, and provided that, with respect to any lender, its individual commitment is not exceeded. The revolving credit facility has a four year availability period (the “New Availability Period”) commencing from the New Effective Date during which loans may be made and a stated maturity date that is five years from the New Effective Date (the “New Maturity Date”). Following the New Availability Period, the Company will be required in certain circumstances to prepay loans prior to the New Maturity Date. The ING Credit Agreement provides for the issuance of letters of credit during the New Availability Period in an aggregate amount of $25 million. Borrowing under the ING Credit Agreement may be used for general corporate purposes, including making investments and permitted distributions.
|
|||||||||||||||
Long Term Debt, Dividends and Covenants [Text Block] | All obligations under the ING Credit Agreement are secured by a first-priority security interest (subject to certain exceptions) in substantially all of the present and future property and assets of the Company and of the sole current and certain future subsidiaries of the Company and guaranteed by such subsidiaries. Borrowings under the ING Credit Agreement shall be denominated in U.S. Dollars and bore, prior to the New Effective Date, interest at a rate per annum equal to either (1) SOFR, as adjusted, plus 1.875% per annum or (2) the alternative base rate (which is the greatest of the (a) prime rate, (b) the federal funds effective rate plus ½ of 1%, (c) the overnight bank funding rate plus ½ of 1%, (d) certain rates based on SOFR and (e) 0) (“ABR”) plus 0.875% per annum. On and after the New Effective Date, borrowings under the ING Credit Agreement bear interest at a rate per annum equal to either (1) the SOFR, as adjusted, plus 2.15% per annum, or, following the first year after the New Effective Date, plus 2.05% per annum if the Company has and maintains an investment grade credit rating or (2) the alternative base rate (which is the greatest of the (a) prime rate, (b) the federal funds effective rate plus ½ of 1%, (c) the overnight bank funding rate plus ½ of 1%, (d) certain rates based on SOFR and (e) 0) (“ABR”) plus 1.15% per annum or, following the first year after the New Effective Date, plus 1.05% per annum if the Company has and maintains investment grade credit rating. The Company may elect either an ABR or SOFR borrowing at each drawdown request, and loans may be converted from one rate to another at any time at the Company’s option, subject to certain conditions. Prior to the New Effective Date, the Company paid a commitment fee at a rate of 0.375% per annum on the daily unused portion of the aggregate commitments under the ING Credit Agreement. On and after the New Effective Date, the Company will pay a commitment fee at a rate of 0.375% per annum on the daily unused portion of the aggregate commitments under the ING Credit Agreement, subject to increase to 1.00% per annum on the daily unused amount if the daily unused amount is greater than or equal to 65% of the aggregate commitments under the ING Credit Agreement. At any time during the New Availability Period, the Company may propose an increase in the Increased Maximum Commitment to an amount not to exceed the greater of (a) $1,250.0 million and (b) 150% of shareholders’ equity as of the date on which such increased amount is to be effective, subject to certain conditions, including the consent of the lenders to increase their commitments and of ING. The Company has made customary representations and warranties and is required to comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar credit facilities. Borrowings under the ING Credit Agreement are subject to the leverage restrictions contained in the Investment Company Act. The ING Credit Agreement contains customary events of default for similar financing transactions. Upon the occurrence and during the continuation of an event of default, ING may terminate the commitments and declare the outstanding loans and all other obligations under the ING Credit Agreement immediately due and payable.
|
|||||||||||||||
JPM SPV Facility [Member] | ||||||||||||||||
Capital Stock, Long-Term Debt, and Other Securities [Abstract] | ||||||||||||||||
Long Term Debt, Title [Text Block] | JPM Loan and Security Agreement | |||||||||||||||
Long Term Debt, Structuring [Text Block] | On February 24, 2023 (the “JPM Closing Date”), the Company entered into a loan and security agreement (as amended, the “JPM Loan and Security Agreement”) among OSCF Lending SPV, LLC (“OSCF Lending SPV”), a wholly owned subsidiary of the Company, as borrower, the Company, as parent and servicer, Citibank, N.A., as collateral agent and securities intermediary, Virtus Group, LP, as collateral administrator, the lenders party thereto, and JPMorgan Chase Bank, National Association (“JPM”), as administrative agent, pursuant to which JPM agreed to extend credit to OSCF Lending SPV in an aggregate principal amount up to $150 million at any one time outstanding. Effective on and as of July 5, 2023, the Company entered into Amendment No. 1 (the “JPM Loan and Security Agreement Amendment”) to the JPM Loan and Security Agreement, pursuant to which JPM has increased its commitment to extend credit to OSCF Lending SPV to an aggregate principal amount up to $300 million (the “JPM Maximum Commitment”). The JPM Loan and Security Agreement provides for a senior secured revolving credit facility that has a three-year reinvestment period (the “JPM Availability Period”) and a stated maturity date that is five years after the JPM Closing Date. Subject to certain conditions, including consent of the lenders and JPM, as administrative agent, at any time during the JPM Availability Period, OSCF Lending SPV may propose one or more increases in the JPM Maximum Commitment up to an amount not to exceed $500 million. Borrowings under the JPM Loan and Security Agreement shall be denominated in U.S. Dollars and bear interest at a rate per annum equal to the forward-looking term rate with a three-month tenor, based on the secured overnight financing rate as administered by the Federal Reserve Bank of New York (or a successor administrator), and as published by CME Group Benchmark Administration Limited (or a successor administrator), plus 2.95%.
|
|||||||||||||||
Long Term Debt, Dividends and Covenants [Text Block] | The obligations of OSCF Lending SPV under the JPM Loan and Security Agreement are secured by all of the assets held by OSCF Lending SPV, including certain loans sold or to be sold or transferred or to be transferred by the Company to OSCF Lending SPV (such loans, the “Loans”) pursuant to the terms of the Sale and Participation Agreement, dated as of the JPM Closing Date (the “JPM Sale Agreement” and, together with the JPM Loan and Security Agreement, the “JPM Agreements”), between OSCF Lending SPV, as buyer, and the Company, as seller, pursuant to which the Company will sell Loans to OSCF Lending SPV from time to time. Under the Agreements, the Company and OSCF Lending SPV, as applicable, have made representations and warranties regarding the Loans, as well as their businesses, and are required to comply with various covenants, servicing procedures, limitations on the disposition of Loans, reporting requirements and other customary requirements for similar revolving funding facilities. Borrowings under the JPM Loan and Security Agreement are subject to various covenants under the JPM Agreements as well as the asset coverage requirement contained in the Investment Company Act of 1940, as amended.
|
|||||||||||||||
Common Class I [Member] | ||||||||||||||||
General Description of Registrant [Abstract] | ||||||||||||||||
NAV Per Share | $ 23.48 | 23.71 | $ 23.23 | $ 23.40 | $ 23.42 | $ 23.56 | $ 23.64 | $ 23.23 | $ 23.46 | $ 23.33 | 23.47 | $ 24.03 | $ 23.98 | $ 24.32 | $ 25.04 | $ 0 |
Common Class S [Member] | ||||||||||||||||
General Description of Registrant [Abstract] | ||||||||||||||||
Share Price | 23.48 | |||||||||||||||
NAV Per Share | 23.48 | 0 | 23.23 | 23.40 | 23.42 | 23.56 | 23.64 | 23.23 | 23.46 | 23.33 | 23.47 | 24.03 | 23.98 | 0 | ||
Common Class D [Member] | ||||||||||||||||
General Description of Registrant [Abstract] | ||||||||||||||||
NAV Per Share | $ 23.48 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 |
Significant Accounting Policies (Policies) |
9 Months Ended |
---|---|
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation: The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the consolidated financial statements have been made. The Company is an investment company following the accounting and reporting guidance in FASB ASC Topic 946, Financial Services - Investment Companies ("ASC 946").
|
Use of Estimates | Use of Estimates: The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions affecting amounts reported in the consolidated financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition.
|
Consolidation | Consolidation: The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. The consolidated subsidiaries are wholly-owned and, as such, consolidated into the consolidated financial statements. The assets of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of the Company. As an investment company, portfolio investments held by the Company are not consolidated into the consolidated financial statements but rather are included on the Consolidated Statement of Assets and Liabilities as investments at fair value.
|
Fair Value Measurements | Fair Value Measurements: Our Adviser, as the valuation designee of our Board pursuant to Rule 2a-5 under the Investment Company Act, determines the fair value of our assets on at least a quarterly basis in accordance with ASC 820. ASC 820 defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity. Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows: •Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date. •Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities. •Level 3 — Unobservable inputs that reflect the Adviser's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. The Adviser's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions. Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, the Adviser obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations. The Adviser seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If the Adviser is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within the Adviser's set threshold, the Adviser seeks to obtain a quote directly from a broker making a market for the asset. The Adviser evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. The Adviser also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, the Adviser performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, the Adviser does not adjust any of the prices received from these sources. If the quotations obtained from pricing vendors or brokers are determined not to be reliable or are not readily available, the Adviser values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, the Adviser analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. the Adviser also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. The Adviser may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and the Adviser considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, the Adviser depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. The Adviser estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates. In December 2020, the SEC adopted Rule 2a-5 under the Investment Company Act. Rule 2a-5 permits boards of registered investment companies and Business Development Companies to either (i) choose to continue to determine fair value in good faith, or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Trustees has designated the Adviser to serve as its valuation designee effective September 8, 2022. The Adviser undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments: •The quarterly valuation process begins with each portfolio company or investment being initially valued by the Adviser's valuation team; •Preliminary valuations are then reviewed and discussed with management of the Adviser; •Separately, independent valuation firms prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to the Adviser; •The Adviser compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee; •The Audit Committee reviews the valuation report with the Adviser, and the Adviser responds and supplements the valuation report to reflect any discussions between the Adviser and the Audit Committee; and •The Adviser, as valuation designee, determines the fair value of each investment in the Company's portfolio. The fair value of the Company's investments as of June 30, 2023 and September 30, 2022 was determined by the Adviser, as the Company's valuation designee. The Company has and will continue to engage independent valuation firms each quarter to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material. When the Company determines its net asset value as of the last day of a month that is not also the last day of a calendar quarter, the Company intends to update the value of securities with reliable market quotations to the most recent market quotation. For securities without reliable market quotations, pursuant to the Company's valuation policy, the Adviser’s valuation team will generally value such assets at the most recent quarterly valuation or, in the case of securities acquired after such date, cost, unless, in either case, the Adviser determines that since the most recent quarter end or the date of acquisition for securities acquired after quarter end, as the case may be, a significant observable change has occurred with respect to the investment (which determination may be as a result of a material event at a portfolio company, material change in market spreads, secondary market transaction in the securities of an investment or otherwise). If the Adviser determines such a change has occurred with respect to one or more investments, the Adviser will determine whether to update the value for each relevant investment using a range of values from an independent valuation firm, where applicable, in accordance with the Company's valuation policy. Additionally, the Adviser may otherwise determine to update the most recent quarter end valuation of an investment without reliable market quotations that the Adviser considers to be material to the Company using a range of values from an independent valuation firm. With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax liability," and "credit facilities payable," which are reported at amortized cost, all assets and liabilities on the Consolidated Statements of Assets and Liabilities approximate fair value. The carrying value of the line items titled "due from affiliates," "interest receivable," "receivables from unsettled transactions," "accounts payable, accrued expenses and other liabilities," "dividends payable," "base management fee and incentive fee payable," "interest payable," "payables from unsettled transactions" and "due to affiliates" approximate fair value due to their short maturities.
|
Foreign Currency Translation | Foreign Currency Translation: The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.
|
Derivative Instruments | Derivative Instruments: Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts is recorded within derivative assets or derivative liabilities on the Consolidated Statement of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statement of Operations.
|
Investment Income | Investment Income: Interest Income Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash, and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of June 30, 2023 and September 30, 2022, there were no investments on non-accrual status. In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan. For the Company's secured borrowings, the interest earned on the entire loan balance is recorded within interest income and the interest earned by the counterparty is recorded within interest expense in the Consolidated Statements of Operations. PIK Interest Income The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost bases of these investments in the consolidated financial statements including for purposes of computing the capital gains incentive fee payable by the Company to the Adviser. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s shareholders, even though the Company has not yet collected the cash and may never do so. Fee Income The Adviser or its affiliates may provide financial advisory services to portfolio companies in connection with structuring a transaction and in return the Company may receive fees for capital structuring services. These fees are generally nonrecurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered. Dividend Income The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment.
|
Cash and Cash Equivalents and Restricted Cash | Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less, when acquired. The Company places its cash and cash equivalents with financial institutions and, at times, cash held in bank accounts may exceed the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets. As of June 30, 2023, included in restricted cash was $3.6 million that was held at Citibank, N.A. in connection with the Company’s JPM Agreements (defined below). Pursuant to the terms of the JPM Agreements, the Company was restricted in terms of access to the $3.6 million until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the JPM Agreements.
|
Receivables/Payables from Unsettled Transactions | Receivables/Payables from Unsettled Transactions: Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.
|
Deferred Financing Costs | Deferred Financing Costs: Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities. Deferred financing costs incurred in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs incurred in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Company's Consolidated Statement of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense.
|
Organization and Offering Costs | Organization and Offering Costs: Costs associated with the organization of the Company will be expensed as incurred. Costs associated with the offering of Common Shares of the Company are capitalized as "deferred offering costs" on the Consolidated Statements of Assets and Liabilities and amortized over a twelve-month period from incurrence. For the three and nine months ended June 30, 2023, the Company incurred organization costs of zero and $4, respectively. For each of the three months ended June 30, 2022 and the period from December 10, 2021 (commencement of operations) to June 30, 2022, the Company expensed organization costs of $549. As of June 30, 2023 and September 30, 2022, $402 and $2,132, respectively, of offering costs were capitalized on the Consolidated Statements of Assets and Liabilities. For the three and nine months ended June 30, 2023, the Company amortized offering costs of $725 and $2,517, respectively. For each of the three months ended June 30, 2022 and the period from December 10, 2021 (commencement of operations) to June 30, 2022, the Company amortized offering costs of $255.
|
Income Taxes | Income Taxes: On February 3, 2022, the Company elected to be regulated as a BDC under the Investment Company Act. The Company also intends to elect to be treated as a RIC under the Code as soon as reasonably practicable. So long as the Company maintains its status as a RIC, it generally will not pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that it distributes at least annually to its shareholders as dividends. Rather, any tax liability related to income earned and distributed by the Company would represent obligations of the Company’s investors and would not be reflected in the consolidated financial statements of the Company. The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax year 2022. To qualify for and maintain qualification as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to qualify for RIC tax treatment, the Company must distribute to its shareholders, for each taxable year, at least 90% of its “investment company taxable income” for that year, which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses. In addition, based on the excise tax distribution requirements, the Company is subject to a 4% nondeductible federal excise tax on undistributed income unless the Company distributes in a timely manner in each taxable year an amount at least equal to the sum of (1) 98% of its ordinary income for the calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income realized, but not distributed, in prior years. For this purpose, however, any ordinary income or capital gain net income retained by the Company that is subject to corporate income tax is considered to have been distributed. The Company did not incur a U.S. federal excise tax for calendar year 2022 and does not expect to incur a U.S. federal excise tax for calendar year 2023. The Company holds certain portfolio investments through a taxable subsidiary. The purpose of the Company's taxable subsidiary is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiary is consolidated for financial reporting purposes, and portfolio investments held by it are included in the Company’s consolidated financial statements as portfolio investments and recorded at fair value. The taxable subsidiary is not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statement of Operations. The Company uses the liability method to account for its taxable subsidiary's income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.
|
Portfolio Investments (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Portfolio Composition | As of June 30, 2023 and September 30, 2022, the Company's investment portfolio consisted of the following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment Holdings, Schedule of Investments | The composition of the Company's debt investments as of June 30, 2023 and September 30, 2022 by floating rates and fixed rates was as follows:
The composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of June 30, 2023 and September 30, 2022 was as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Financial Instruments Carried at Fair Value | The following table presents the financial instruments carried at fair value as of June 30, 2023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:
The following table presents the financial instruments carried at fair value as of September 30, 2022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Roll-Forward in the Changes in Fair Value | The following table provides a roll-forward of the changes in fair value from March 31, 2023 to June 30, 2023, for all investments for which the Company determined fair value using unobservable (Level 3) factors:
(a) There were transfers out of Level 3 to Level 2 for certain investments during the three months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity. The following table provides a roll-forward of the changes in fair value from March 31, 2022 to June 30, 2022, for all investments for which the Company determined fair value using unobservable (Level 3) factors:
__________ (a) There were transfers into Level 3 from Level 2 for certain investments during the three months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity. The following table provides a roll-forward of the changes in fair value from September 30, 2022 to June 30, 2023, for all investments for which the Company determined fair value using unobservable (Level 3) factors:
(a) There were transfers into Level 3 from Level 2 for certain investments during the nine months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity. The following table provides a roll-forward of the changes in fair value from December 10, 2021 (commencement of operations) to June 30, 2022, for all investments for which the Company determined fair value using unobservable (Level 3) factors:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Significant Unobservable Inputs for Level 3 Investments | The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which were carried at fair value as of June 30, 2023:
_____________________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participant would take into account market yield when pricing the investment. (c) Used when there is an observable transaction or pending event for the investment. (d) The Adviser generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. The Adviser evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (e) Used when market participant would use such multiple when pricing the investment. The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which were carried at fair value as of September 30, 2022:
_____________________ (a) Weighted averages are calculated based on fair value of investments. (b) Used when market participant would take into account market yield when pricing the investment. (c) Used when there is an observable transaction or pending event for the investment. (d) The Adviser generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. The Adviser evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. (e) Used when market participant would use such multiple when pricing the investment.
|
Share Data and Net Assets (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Changes in Net Assets | The following table presents the changes in net assets for the three and nine months ended June 30, 2023:
The following table presents the changes in net assets for the three months ended June 30, 2022 and the period from December 10, 2021 (commencement of operations) to June 30, 2022:
The following table summarizes transactions in common shares of beneficial interest for the nine months ended June 30, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Distributions | The following table presents distributions that were declared during the nine months ended June 30, 2023:
On July 24, 2023, the Board of Trustees of the Company declared a regular distribution on its outstanding common shares of beneficial interest in the amount per share set forth below:
|
Taxable/Distributable Income (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations | Presented below is a reconciliation of net increase (decrease) in net assets resulting from operations to taxable income for three months ended June 30, 2023 and 2022, nine months ended June 30, 2023 and the period from December 10, 2021 (commencement of operations) to June 30, 2022:
__________________ (1)The Company's taxable income for the three and nine months ended June 30, 2023 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2023. The final taxable income may be different than the estimate.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of Accumulated Overdistributed Earnings | As of September 30, 2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows:
|
Related Party Transactions (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||
Related Party Transactions [Abstract] | |||||||||||||||||||||||||||||||
Schedule of Shareholder Servicing and/or Distribution Fees | The following table shows the shareholder servicing and/or distribution fees the Company pays the Distribution Manager with respect to the Class S, Class D and Class I on an annualized basis as a percentage of the Company’s NAV for such class.
|
Financial Highlights (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment Company [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Portfolio Composition | As of June 30, 2023 and September 30, 2022, the Company's investment portfolio consisted of the following:
|
Commitments and Contingencies (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Unfunded Commitments | A list of unfunded commitments by investment as of June 30, 2023 and September 30, 2022 is shown in the table below:
|
Subsequent Events (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subsequent Events [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Distributions | The following table presents distributions that were declared during the nine months ended June 30, 2023:
On July 24, 2023, the Board of Trustees of the Company declared a regular distribution on its outstanding common shares of beneficial interest in the amount per share set forth below:
|
Significant Accounting Policies (Details) - USD ($) $ in Thousands |
3 Months Ended | 7 Months Ended | 9 Months Ended | 12 Months Ended | |
---|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Sep. 30, 2022 |
|
Accounting Policies [Abstract] | |||||
Amortization period | 12 months | 12 months | |||
Organization expenses | $ 0 | $ 549 | $ 549 | $ 4 | |
Offering costs capitalized | 402 | $ 2,132 | |||
Amortization of deferred financing costs | 725 | $ 255 | $ 255 | 2,517 | |
Restricted cash | $ 3,605 | $ 3,605 | $ 0 |
Portfolio Investments - Narrative (Details) $ in Thousands |
Jun. 30, 2023
USD ($)
borrower
|
Sep. 30, 2022
USD ($)
borrower
|
---|---|---|
Schedule of Investments [Abstract] | ||
Investment owned, fair value | $ | $ 1,279,166 | $ 428,556 |
Number of borrowers | borrower | 108 | 81 |
Portfolio Investments - Composition of Investments (Details) - USD ($) $ in Thousands |
Jun. 30, 2023 |
Sep. 30, 2022 |
---|---|---|
Schedule of Investments [Line Items] | ||
Investment owned, at cost | $ 1,282,585 | $ 444,725 |
Investment owned, fair value | 1,279,166 | 428,556 |
Fair Value | $ 1,269,225 | $ 422,036 |
% of Debt Investments | 100.00% | 100.00% |
Floating rate | ||
Schedule of Investments [Line Items] | ||
Fair Value | $ 1,134,912 | $ 369,698 |
% of Debt Investments | 89.42% | 87.60% |
Fixed rate | ||
Schedule of Investments [Line Items] | ||
Fair Value | $ 134,313 | $ 52,338 |
% of Debt Investments | 10.58% | 12.40% |
Fee Income (Details) - USD ($) $ in Thousands |
3 Months Ended | 7 Months Ended | 9 Months Ended | |
---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2022 |
Jun. 30, 2023 |
|
Revenue from Contract with Customer [Abstract] | ||||
Fee income | $ 654 | $ 93 | $ 113 | $ 882 |
Recurring fee income | $ 27 | $ 20 | $ 40 | $ 188 |
Taxable/Distributable Income - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 7 Months Ended | 9 Months Ended | |||||
---|---|---|---|---|---|---|---|---|
Jun. 30, 2023 |
Mar. 31, 2023 |
Dec. 31, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Sep. 30, 2022 |
|
Income Tax Disclosure [Abstract] | ||||||||
(Provision) benefit for taxes on realized and unrealized gains (losses) | $ 71 | $ 54 | $ 51 | $ 15 | $ 1 | $ 16 | $ 176 | |
Income tax expense (benefit) | 97 | 219 | ||||||
Deferred income tax expense (benefit) | $ (26) | $ (28) | $ (43) | |||||
Cost of investments | $ 444,500 | |||||||
Unrealized appreciation | 1,800 | |||||||
Unrealized depreciation | 17,700 | |||||||
Unrealized appreciation (depreciation) | $ (15,900) |
Taxable/Distributable Income - Reconciliation of Net Increase (Decrease) in Net Assets Resulting from Operations (Details) - USD ($) $ in Thousands |
3 Months Ended | 7 Months Ended | 9 Months Ended | |
---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2022 |
Jun. 30, 2023 |
|
Income Tax Disclosure [Abstract] | ||||
Net increase (decrease) in net assets resulting from operations | $ 25,144 | $ (9,774) | $ (8,834) | $ 49,751 |
Net unrealized (appreciation) depreciation | (6,783) | 11,946 | 11,968 | (11,995) |
Other book/tax differences | 654 | (191) | (190) | 1,250 |
Taxable income | $ 19,015 | $ 1,981 | $ 2,944 | $ 39,006 |
Taxable/Distributable Income - Components of Accumulated Overdistributed Earnings (Details) - USD ($) $ in Thousands |
Jun. 30, 2023 |
Sep. 30, 2022 |
---|---|---|
Income Tax Disclosure [Abstract] | ||
Undistributed ordinary income, net | $ 1,294 | |
Net realized capital losses | 566 | |
Unrealized losses, net | (15,935) | |
Accumulated overdistributed earnings | $ (11,965) | $ (14,075) |
Related Party Transactions - Schedule of Shareholder Servicing and/or Distribution Fees (Details) - Distribution Manager Agreement |
9 Months Ended |
---|---|
Jun. 30, 2023 | |
Related Party Transaction [Line Items] | |
Management incentive rate | 10.00% |
Common Class I | |
Related Party Transaction [Line Items] | |
Management incentive rate | 0.00% |
Common Class S | |
Related Party Transaction [Line Items] | |
Management incentive rate | 0.85% |
Common Class D | |
Related Party Transaction [Line Items] | |
Management incentive rate | 0.25% |
Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands |
Jun. 30, 2023 |
Sep. 30, 2022 |
---|---|---|
Commitments and Contingencies Disclosure [Abstract] | ||
Unfunded commitments | $ 196,628 | $ 68,962 |
0V?N4
MU@B'RG9?2NX_GJCY5']X1%\RJ1ZNDT!ADK4>COM)K5 ;Y6KZ0_?3G$R(.W-&
M^&SP9/-H4(C \/(FJ9=6*T?"F-)*%U!$#!2140=)?232*6N@"VXBAIM(,VYJ
MD]1'(J&R'L8_)+4[FI'1T*U+:L-,Y S[2?UI=7*D5BGM-(%.1%#3F3:05(?
MB83*&NB"JXCA*M+LQ5*;I#X2+97U,/LAJ8?.B+Q+Z,'>^A?]K)TO"TJ1K[^B
M%4MAJJ/5TJ-%ON!F8"XOUBU]HOI1/4416ZE0YW2B;BV*I4#%CN3;?#7- Y>2
MQ_GFAM& "7V!.K_B7+[NZ!M4"[+F_P-02P,$% @ JI((5QKW5:+;"
M8"@ !@ !X;"]W;W)K @W[F4\H/K7&)L_A*19%*TOA+-=E6HSC2)S/885D$%0 7ZN3Y/-
MO5]>J,\%I1DHS:)H?06"RU"*#92E":1='Z
M(CB[>NEEKEZ2ODS2 (L#$>$X7C8J;Q.L79Q^(RF>8_>W)NY!$V9ZZ4PZ TR:"L,
M>HL,:H1!5VQ0Q;&15AAT#0I*9.MXZ*G80^<7B6FPNF^3I9'S*JZY*U ?T+$<
M=1TW\.MH1UW'+?PZS,!UE,T\FN'*78?V5$0[ZCK6R.L@OP;.]X%4^WT@ON1,
M?4>\;DKO\P 357U>R9(AZE_JV \%@6[Q3Y5>L=VB/;?;PNZ#",CY9)!JB];$
M%I[/,'>=55>9+Q]E/GS\?8_]5@#%F5"/),W<5\ZH1/BA5_0D'Q12YX-"JLVF
MYY:??LYXG1>^;I3.>EPWV"QZ*,Z$>B0)K3]'9=$/Z6:2W/G493^5%WXD4H
M>Q V$U6__L3FSD-Q!HNS,!S1A&.:I[ C\Q8=B]9N\SY&,C''3-U%D6_@D5MA
MY%MX9".,O&(CCYB0BR*OD9&)@!WK/D4>!;CH<+TBIEX-XVLNJC^ (L#$>TX!BY);3([Q7'D\LA4!HWJ0*/!FQ:,A1GL#@+
MPQ$Y.*9I>5GMWOWFX?$TI=O,OMT (L
M#$ (L#$=T
MX9B(#>R (L#$ (L#$?$D3CBD/NSRM.U.C2UN.E#C+L$Z;D-PG@WH'BM,-XM*)X1
MQENQ\81'/PCCK2^/1]29.NJ$^<*+CM4O3I+,T]33XZC#BL(G:TFCWB"CMM*H
MM\BH)AQU7B=)X_[CR7647Q\^:&O4):Q!ET!DG#DR1AK=BP[7/W6KIA\+K[FP
MJE.W&)C^O0OUK4-=4I6TNO>*[1'-J5NP6R"ZR1W=X$SP10?KI<9D69UYJE'F
MS0Z^CJ&>-A9G0KU196GB"4;[Y6#H73J%-U[,"T EZFG'V5R:OQ=
MCG5^H3@3[!+O?,05VR.Z=^\D]G#EV,,5^-CV*G1L>TYKV5]S<77"B4PH'B
M3+!+:KH3 (L#$=4XCB\B;S (L
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MP?'W*G!-2H:GDT0JE 0VHQ"*,UB&()!QKL+JH)J7Y\'%[/_O+]M/Q\/']
MYOAA,Z(R2?P*U%-^**[%X@P69V$XH@_';ZR0?N.BP[F_Y45!=_A=CZ*,RR=20S)RC$D*YPAN>A@K'!&
M^):#FL&:D5"<"79(2#/:.HL#9YVCKI[(Q3$K*ZA9N>AX9:^#ZL93S A/]; 3,[EJ"NX 5Y!.^H*;H%78$9=P8J]@J%C
MA<,J'G$):] E$.4[KFX% D%@
MW5(HSL)P1!".$=I C= KCC="$[Z1Z&L":X5"<0:+LS O9G_>[#?OMK^T^I*O<[O=W#^^
MGRTVQ^WLS>FR=G?;A]ZZXO7V\^'^\_885@(V?Q.*:[$X@\59&(XHQG$N4ZES
M.6)9,:98YY,K,5#/NP/2F30MYRULUPK;&>9&](,ZB=F8.F9CJC4;F1FCTFX\
M']J2Q4;3]QT]SS$>6?_+CO4
8X8KL'G%P?2_WIE?HO(EW?V\
M9,*J)0'%&2S.PG!$$H[EF$%K:%YQO!&J\*M0OJP\(SH>5J\*K-D(Q5D8CJC"
M,1LSN=F(G$>>SX=(PEK &HQ07(O%&2S.PG!$-(Y9F
B;3HN/US/NFI-]SKKFX8KG$
M.6JY0'$FU!M5,J(L#$=$X1C)F;PHJ_;K (,>F(N$SPGN8&1BE_N?!H0-6VE#
MP]R'?DPG,8$SQP3.Q"8PGPW$L ;7!)&1#!8[K4M:H5W:L)4V-,S-Z$=R$N\V
M<[S;3.O=_KJ*F/U[]IO_J+,R#UWZ%0<>7"=$AA6;\/F,>\JG/T]&Y@T])[[%
MQC58G(7AB$0<(S?35F:-??%A8,I'ME^3M(,%F=A.*(2QWYMQ/8K
MOX!@6 ,9G>6OZ=]/#XMTH(I$G*U7$=:VA>),AR./J(1F8G#-R*@[%FJCM5#C
MRPP&-^B%?$GYCXPY-LD3BFNQ.-/AB.OJ;0M$127:<)S21NN4QI89#"RBC$%1
M(',DEUATZN6]'[
MI,8$5'U2B[/T6L!:EHU_8)+W*8SK#=6G,-3U$[4XIF8#/8UHT?'B@H&EB2X9
MEEXP6#N3[XT5VQLZP4QB>#:.X=EH#4_UA_S&KU])RW%=#Q-!G[[_H9;WY
M_F%V>[A_N]N_>]#G",4O12\ ;&8A%&>P. O#$:$X;F0.K(29!T_LH0JZ$X@\59&(ZI@GA_#2Z7Q)4$4XW.C9N"89CE.%_K<$B]'+"F
M'Q1G83@F!V+Z-=#T$%<23Z<(SW[+*G?2DH9#ZA6!-?"@. O#,440.["Y*.-#
MW"0_]_MNWGGZ!AY4C\,4__P0G'&_T1X0:M;\8FH3NJC;H')ACBS
M+?*D?NN>3:_KQLG>)L2,_SG&FK%0G/$_#.Y2W(H/(_JG=!*SMB5F;:O=XRD<
M$&G=78K# RH